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SUMMARY
Human viral pathogens place a serious threat on the healthcare system. 
Adequate and efficient disinfection procedures minimise the incidence of 
surface contamination and viral disease transmission. Biocide type, 
environmental conditions and viral characteristics (e.g. presence of 
envelope) influence the disinfection effectiveness. Thus, understanding the 
mechanisms of virucidal action is essential for improving disinfection 
efficacy. PHMB has a wide range o f antimicrobial activities, but its action 
against viruses has been mostly tested on enveloped viruses, which appeared 
to be inactivated. This project aimed at understanding the mechanisms of 
action of two PHMB-based biocides, VANTOCIL1 MTG and 
COSMOCIL imCQ, against non-enveloped viruses including the 
bacteriophages MS2 and FI 16 used as model viruses, and the human 
Adenovirus type5. Biocides were tested in a suspension test at different 
conditions. Hydrophobicity tests, SDS-PAGE, DNA analysis, dynamic light 
scattering and transmission electron microscopy were performed.
Suspension tests at 20°C showed that PHMBs at 800 ppm reduced MS2 and 
Ad5 by 90%. Higher reduction was achieved against FI 16 (99%). Times of 
exposure did not increase the activity, whereas temperature had a great 
effect. At 30°C 99.99% of MS2 was inactivated after 10 min; the efficacy 
against Ad5 was also enhanced, but to minor extent. Despite a modest 
activity, PHMB interacted with the viral capsid producing damage which 
was very specific against Ad5. Viral aggregation played a key role in 
limiting virucidal efficacy of PHMB, especially concerning MS2. It is likely 
that the observed capsid damage caused the inactivation. However, the 
hypothesis o f domain formation by PHMB and thus the inhibition of the 
virus-host interaction cannot be ruled out. The mechanism of binding 
PHMB molecules to the viruses was highly cooperative and occurred 
through first electrostatic and then hydrophobic forces.
Concluding, it is the first time that PHMB-based biocides were shown to 
interact with viral capsid resulting in virucidal activity against non­
enveloped viruses. However, such activity is reduced by formation of viral 
aggregates. Results supported also the use o f MS2 as a surrogate of human 
RNA non-enveloped viruses.
XI
1. GENERAL INTRODUCTION
1.1. Historical background
1.1.1. Virology
Reconstructing the history o f virus establishment within the human 
population is a big challenge. The beginning of animal domestication, the 
demography increase, and higher rates o f commerce caused the spread of an 
increasing number o f viral particles among populations and the development 
o f new forms of virus.
Evidence of viral diseases can be found in ancient records: rabies was 
already mentioned in the Mesopotamian laws, and drawings illustrating the 
consequences of poliovirus infection were found on the Egyptian 
hieroglyphs (Flint et al., 2004c).
Measures to control diseases were taken even before the discovery of 
microorganisms. For instance the variolation, consisting o f inoculating 
healthy individuals with materials from a smallpox postule, was a quite 
common procedure in China and India by the 11th century. In England in the 
1770’s the physician Edward Jenner understood the principal of viral 
immunization, even though the viral agent itself was still unknown. He 
inoculated an individual with the extracts from cowpox lesions, inducing 
only mild symptoms o f the disease but protecting him from the more 
dangerous effects o f smallpox. From these experiments the word 
vaccination (vacca = cow in Latin) was derived.
The famous experiment o f Louis Pasteur, where he demonstrated that a 
boiled medium remained free of microorganisms as long as it was prevented 
contact with airborne microbes, proclaimed the end of the spontaneous 
generation hypothesis (Flint et al., 2004c). Then, the next big step towards 
the science o f microbiology occurred when the German physician Robert 
Koch associated for the first time pathologies with microorganisms. He 
developed a set o f criteria for the identification o f the agent responsible 
(pathogen) for specific diseases.
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Koch’s postulates are as follows:
-  The microorganism must be found in abundance regularly in 
organisms suffering from the disease.
-  The microorganism must be isolated from a diseased 
organism and grown in pure culture.
-  The cultured microorganism should cause disease when 
introduced into a healthy organism.
-  The microorganism must be re-isolated from the inoculated, 
diseased experimental host and identified as being identical 
to the original specific causative agent.
These criteria are still applied today.
Only in 1892 did the Russian botanist Dmitri Iwanowsk discover for the 
first time what we call viruses at the St. Petersburg Academy o f Science. 
While studying mosaic tobacco disease in plants, he found that the agent 
causing the pathology was small enough to pass through ceramic filters used 
to trap all bacteria. He called them filterable agents.
In the 1898, Martinus Beijerinck independently discovered the tobacco 
mosaic virus identifying it as a small distinctive agent able to pass through 
the filter. During the same year two former students and assistants o f Koch, 
Friedrich Loeffler and Paul Frosch, observed that the cause o f foot-and- 
mouth disease, spread among the livestock, was also filterable. In addition, 
they understood that these filterable agents replicated only in their host 
organisms and not in solution as with bacteria.
These events are considered to be the beginning o f virology.
Bacterial viruses were first characterised independently on two occasions at 
the beginning o f the 1900’s. In 1915 a British pathologist described the 
transformation o f Micrococcus by a transmissible agent. Then, two years 
later, in 1917, a Canadian scientist, Felix Hubert d’Herelle, observed the 
lysis o f Shigella culture in broth and understood the viral nature of the 
event. He coined the term bacteriophage (Ackermann, 2003).
The first human virus described was the agent responsible for yellow fever 
in 1901. First the Cuban Carlos Juan Finlay in 1880 proposed that a
2
bloodsucking insect was responsible for transmission of the disease. A 
commission was established in 1899 to further investigate the aetiology of 
yellow fever, and one o f the members, Dr. Jesse Lazear, demonstrated by 
sacrificing his own life that mosquitoes were responsible for the 
transmission.
The discovery o f other human viruses progressed slowly, due to the danger 
and difficulties associated with the experiments, but in 1930 virology 
changed completely with the introduction o f the electron microscope, which 
allowed the visualization o f these agents.
In the last 50 years great progress has been made in understanding viral 
structures and the molecular basis of their replication cycle.
1.1.2. Disinfection practices
Although the concept o f bacterial diseases began to be understood only in 
the nineteenth century, back in time disinfection and preservation 
procedures were already practiced (Fraise, 2004).
Humans carried out disinfection procedures hundreds of years ago, mostly 
related to religious practices (Maillard, 2001). Heat disinfection procedures, 
such as passing metal objects utilized in the kitchen through the fire before 
use, are well documented in the Bible. At the time of the Persian Empire, 
450 BC, it is recorded the use of copper and silver vessels to keep the water 
potable, and the application o f various substances, such as wine, vinegar and 
honey on wounds.
In the fourteenth century, to fight episodic scourges o f plague, it was 
recommended to bum juniper branches and sulphur in rooms where ill 
people were resting.
Chemical disinfectants were used scientifically around 150 years ago, but 
empiric practices can be found in ancient times. In the 1763 ethanol was 
already used in hospital for dressing wounds; formulations o f mercury, lead, 
arsenic, copper, iron and sulphur were introduced by a Swiss physician, 
Paracelsus, in 1493 as disinfectants.
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In 1798 bleaching powder was made and then later used as a deodorant and 
disinfectant by Alcock later in 1827 (Fraise, 2004).
Some chemical disinfectants, which are still in use today, were discovered a 
long time ago. For instance, hydrogen peroxide was investigated in 1893 by 
Traugott, quaternary ammonium compounds were introduced in 1916 by 
Jacobs, and phenols were discovered in 1832 by Reichenbach.
After Kronig, Paul and a Japanese physical chemist Ikeda introduced the 
science of disinfection dynamics in 1916, numerous studies on the subject 
and on the hygiene concept lead to a better understanding of the world of 
disinfection. Since then several new biocides have been introduced and a 
significant amount o f research on their activity against microorganisms has 
been performed.
The last 50 years has seen enormous advances in the prevention of 
infections, but many aspects regarding mechanisms o f action, and possible 
synergistic effects remain unclear.
1.2. Viruses and the healthcare environment
Nosocomial infections are infections that develop as a result o f a period in 
hospital or are produced by microorganisms and viruses acquired during 
hospitalisation. They may be endogenous, arising from an infectious agent 
present within a patient’s body, or exogenous, transmitted from another 
source within the hospital (Aitken & Jeffries, 2001). Annually, 4-10% of 
hospitalized patients acquire infections, and it is estimated that it costs one 
billion pounds per year to the UK’s National Health Service, and between 
17 and 25 billion dollars for the USA (Schabrun & Chipchase, 2006). 
Moreover, nosocomial infections directly cause 5000 deaths and indirectly 
15,000 deaths in the UK every year. A similar situation exists in the USA, 
where 17,500-70,000 patients die by an hospital acquired infection every 
year (Plowman et al., 1999).
Schabrun & Chipchase (2006) reviewed published and unpublished studies 
from 1972 to 2004. The research indicated that nosocomial infections were 
due mainly to contaminated hospital equipment, such as cloths, uniforms,
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bedrails, and catheters. Thirty-three percent of 33 diagnostic ultrasound 
probes were found contaminated, as well as 66% of swabs taken from 
equipment in constant use. The high level of contamination was of 
particular concern, especially for the large number of pathogenic, 
opportunistic and multi-resistant organisms detected on the sampled 
equipments.
Paediatric units (Hall et al., 1980; Butz et al., 1993) and wards with elderly 
patients (Aitken & Jeffries, 2001) are particularly exposed to seasonal 
outbreak of viral infections. In some situations when the origin and the 
transmission route o f an outbreak are uncertain, the closure o f the unit is 
required, increasing further the costs for the affected medical department. In 
the Outbreak Database (Hygiene and Environmental Medicine Charite -  
University Medicine Berlin, 2008), 2204 outbreaks have been registered 
from 1967 and in 1994 the closure of the unit was necessary. The most 
common pathogens which were responsible for the unit closure were 
influenza virus, Severe Acute Respiratory Syndrome coronavirus (SARS), 
Streptococcus pneumoniae, noravirus and rotavirus (Hansen et al., 2007). 
Valenti et al. (1980) found that viruses are the cause of 78% o f  nosocomial 
respiratory pathology, 71% of gastrointestinal illness, 5% o f disseminated 
and blood infections and 2% of skin/soft tissue disease. When adenoviral 
outbreaks occurred in health care facilities, the infection rate was estimated 
to be over 25% (Rutala et al., 2006).
Two to ten percent o f hospital-acquired infections, often caused by 
contaminated drugs or fluids, developed in outbreaks. In a systematic 
review by Vonberg et al. (2007), the characteristics and the most frequent 
occasions in which contaminated substances occur are described.
Viruses are the most common cause o f infectious disease acquired in indoor 
environments (Barker et al., 2001). They cause mostly gastrointestinal and 
respiratory infections. From 1995 to 1996 rotavirus, astrovirus, Norwalk- 
like viruses and caliciviruses were responsible for 48% o f all reported 
outbreaks o f intestinal diseases (Barker et al., 2001). Every year adults 
suffer two to five colds and infants get four to eight colds (Barker et al., 
2001), mostly caused by influenza, rhinoviruses and coronavirus. Person to 
person or person to surface contact are the main route of transmission of
5
viral infections. The viral load o f an infected person can be incredibly high,
12faeces for instance shed up to 10 enteric viruses per ml. Respiratory 
viruses spread even faster than the enteric ones via the airborne route (from 
a sneeze, viral particles travel 3 m at 20 m/s) and have a shorter incubation 
period (Boone & Gerba, 2007).
There are three main measures to control viral infections: i) reducing the 
number of viral sources (use o f masks, gloves); ii) interrupting transmission 
(immunization); iii) reducing the number of disease-producing organisms 
(sterilization and disinfection) (Grossgebauer, 1970). Since viral infections 
are not always easy to treat and vaccines are not available yet for many 
viruses, prevention o f their spread through disinfection and improved 
hygiene standards are important achievements especially in a community 
setting. The assessment o f the hazard of viral contamination can be difficult, 
since the infectious dose can vary significantly with the pathogenicity of the 
organism and the immune status of the host (Barker et al., 2001).
Various studies showed that viruses can persist on inanimate and animate 
surfaces for a prolonged time (Sattar et al., 1987; Mbithi et al., 1992; Tiwari 
et al., 2006). Carpets may harbour viable virus for at least 12 days, even 
after routine vacuum cleaning (Cheesbrough et al., 1997). Viruses from the 
gastrointestinal tract, such as polio- and rotavirus, can persist for 
approximately 2 months on surfaces (Kramer et al., 2006b). SARS 
coronavirus, which appeared between the late 2002 to the first half o f 2003 
causing over 8,436 cases and 812 deaths, can persist for 3 days in faeces and 
17 days in urine both at 20°C (Wang et al., 2005).
There are several examples of large epidemics caused by viruses, such as 
the fatal Lassa fever (Arenaviridae) and the Marburg-Ebola agent 
(Filoviridae), the origin o f which is still not clear, although rodents and 
primates are the suspected reservoirs. During the 1980s HIV virus erupted 
on two continents, North America and Africa, infecting thousands o f people. 
Influenza A and B viral infections are among the most contagious diseases 
of humans. There have been 31 pandemics recorded since their discovery 
(e.g. Hong-Kong flu 1968-69, 0.75-1 million of deaths).
Emerging infectious diseases (EIDs) represent an important problem for 
public health. An EID is a new infection that appears for the first time or a
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known one which increases in prevalence. In the past two decades, several 
countries have been facing big pandemics and outbreaks, such as the 
immunodeficiency viruses, the severe acute respiratory syndrome (SARS)- 
associated coronavirus and Infuenza A (H1N1). The latter posed a big threat 
to the whole world at the beginning of 2009; it has been recorded in forty 
countries, with a total o f 17,410 cases and 115 deaths (WHO, 2009a).
Causes of emerging diseases fall into three categories: viral factors, human 
factors and ecological factors (Ka-Wai Hui, 2006). Viral factors involve the 
rapid evolution and environmental adaptability of the viral agents which 
cause EIDs. They are mostly RNA virus, which have a very high point 
mutation and recombination rate, and gene re-assortment. Human factors 
seem to have the most influence on disease emergence: population size 
increases, favouring an easy and quick spread o f pathogens; travelling, 
migration and globalization o f commerce enhance the spread o f pathogens 
in different parts o f the world (Maillard, 2001; Russell, 2004); social 
changes, such as urbanization, sexual practices, drug abuse and new medical 
care and technology (blood transfusion, transplant, contaminated health care 
facilities) also have big relevance (Kuiken et al., 2003). Climatic changes 
and ecosystem disturbance are the main ecological factors involved. Some 
outbreaks, indeed, take place after extreme natural disasters, such as floods 
and droughts; an example is the emergence of hantavirus pulmonary 
syndrome (HPS) in 1993 in USA. After massive rainfall, the high 
production o f fruit led to a population explosion of the deer mouse. These 
animals contaminated floors and blankets with their dropping (Ka-Wai Hui, 
2006), spreading the virus among the human population.
1.2.1. Respiratory infections
Respiratory infections are caused by rhinoviruses, coronoviruses, influenza 
viruses A and B, and respiratory syncytial virus. They are a major health 
concern; it was estimated that children suffer about four to eight colds and 
adults have at least two a year (Barker et al., 2001). They are also the main 
factor that caused the dramatic pandemics in the past, such as the Spanish
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influenza in 1918, the Asian influenza in 1957 (Cox & Fukuda, 1998) and 
lately, in 2009 the big outbreaks o f a new strain of Influenza A H1N1 
(WHO, 2009b). Respiratory viruses have such success because of their short 
incubation time, between 1 to 8 days, and considerable transmissibility. 
Transmission occurs via the respiratory route, through small droplets 
originated by sneezing and coughing that can spread across large distances, 
and big droplets which are transmitted only by person-to-person or person- 
to-surface contact. In addition, influenza viruses have a quick antigenic 
drift, which means a rapid and unpredictable change of antigens on the viral 
surface (hemagglutinin and neuraminidase) that escape neutralisation by the 
antibodies already present in the human body (Cox & Fukuda, 1998).
These viruses are able to survive on surfaces for long time. For instance 
influenza A virus survives for more than 48 h on stainless steel and plastic 
surfaces; transfer o f viable viral particles from stainless steel to hands was 
possible for 24 h, whereas from paper tissue to hand for only 15 min (Weber 
& Stilianakis, 2008). Furthermore Sattar and colleagues found that 
rhinovirus was able to survive on surfaces for several hours (Sattar et al., 
1983).
The prevention o f respiratory virus can be accomplished by an early 
diagnosis o f the disease in hospitals and healthcare places, and also by good 
disinfection and hygiene practices such as an efficient hand-washing or the 
use of gloves by the personnel (Aitken & Jeffries, 2001; Hota, 2004).
1.2.2. Gastrointestinal infections
Gastrointestinal infections are mainly caused by rotaviruses, noroviruses, 
enteroviruses and hepatitis A virus. They are transmitted through the faecal- 
oral route, but other routes can be considered such as contaminated surfaces 
and aerosol from episodes of vomiting. These infections are extremely 
relevant in developing countries, where it has been estimated that the deaths 
of 800,000 children under 5 years o f age associated with gastrointestinal 
infections (Barker et al., 2001). The Asian Rotavirus Surveillance Network
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collected data from 2001 to 2003 and found that 43% of diarrhoea 
admissions were positive for rotavirus (Nelson et al., 2008b).
Hepatitis A (HAV) is the most common cause of viral hepatitis. It is 
characterised by high morbidity and can be transmitted through 
contaminated food, such as filter-feeding shellfish and water (Barker et al., 
2001). Infected persons are highly contagious two weeks before the 
appearance of symptoms. The incidence of HAV is decreasing in many 
countries in the last decade because of immunization programmes 
(Keystone & Hershey, 2008), but it is still a big threat in developing areas 
due to poor sanitation and unhygienic conditions (Shapiro & Margolis, 
1993).
Enteroviruses comprise picomaviruses, coxsackievirus A and B, poliovirus, 
and enteroviruses 68 to 71. Even though they often cause asymptomatic 
infections, enteroviruses, such as polio and coxsackie, can develop serious 
pathologies such as the paralysis of spinal or bulbar poliomelytis (Aitken & 
Jeffries, 2001).
Resistance to drying is common amongst gastrointestinal viruses. Hepatitis 
A was found to be still infective after several hours on hands and after 
several days on surfaces (Sattar et al., 2000).
Isolation o f infected persons and application o f good hygienic practices are 
essential in preventing the spread of such viruses. Moreover, vaccination 
has helped to decrease the occurrence of such infections, especially those 
that are polio and HAV related.
1.2.3. Blood-borne diseases
The group of blood-borne viruses comprises hepatitis B (HBV), hepatitis C 
(HCV) and HIV, characterised by being able to induce persistent viraemia. 
The blood-borne viruses have been associated with nosocomial infections, 
where person-to-person, and patient-to-personnel transmissions occurred 
(Ross et al., 2009), with alarming situations in many low-income countries 
where HIV transmission can be frequent if not endemic (Ganczak & Barss,
2008).
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Transmission occurred mostly by transferring blood or other fluids through 
contaminated surfaces, medical devices, tissue and contaminated sharps. In 
a survey on sharp injuries at the Aga Khan University Hospital, Pakistan, 
during 2002-2007, 1,382 injuries were reported with the highest number 
associated with junior doctors (28.5%) followed by nurses (20.4%) (Zafar et 
al., 2009). Vaccines exist only for hepatitis B (HBV).
Hepatis C is considered one o f the major health problems worldwide; in fact 
it is estimated there are 170 million infected people. The virus, contrary to 
HBV, develops as a chronic infection in 50%-80% of cases (Helge et al.,
2009), and the high transcription error and the high turnover of viral 
particles enables the virus to escape the immune system. Currently the 
infection is treated with a combination o f pegylated interferon-a and 
ribavirin.
Since the first epidemic occurred in the 1980s HIV, which is the agent 
causing AIDS, has infected over 42 million people. It is a human retrovirus 
and its disease is characterised by a deep immunodeficiency due to a 
quantitative and qualitative deficiency in the subset CD4+T lymphocytes 
(Parisa et al., 2009). At present there are several vaccines under clinical trial 
or under study.
The control o f blood-borne diseases can be mostly accomplished by 
education o f the public and healthcare staff, in addition to good hygienic 
practices. In the UK different guidelines have been issued by the 
Department of Health concerning clearance o f blood-borne viruses (UK 
Department of Health, 2007).
1.3. Viruses
Viruses can be defined by their properties which are summarized as follows:
-  A virus is an infectious, obligate, intracellular parasite;
-  The viral genome is either DNA or RNA;
-  Within an appropriate host, the viral genome is replicated 
and leads to the synthesis o f the other viral components by 
the cellular systems;
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-  Within the host cell, the infectious progeny particles (virions) 
are built de novo from the newly synthesized components;
-  The infectious progeny virion is the vehicle for the 
transmission o f the disease.
Viruses exist in various shapes, sizes and structural complexity.
There are two most commonly used classification systems. One, created in 
1962 by Robert Lwoff and Paula Toumier, is based on the Linnaean 
hierarchical system (family, genera, species), which classified viruses 
principally on their shared properties. Four main characteristics are used in 
their classification: i) nature o f nucleic acids; ii) symmetry of the capsid; iii) 
presence or absence o f an envelope; iv) dimension of the capsid and the 
virion. Following the Lwoff system, the International Committee on 
Taxonomy of Viruses (ICTV) reported approximately 40,000 viruses 
isolated from plant, bacteria and animals, grouped in 3 orders, 56 families, 
233 genera, and 1550 species with some other not yet assigned 
(International Union o f Microbiologist Societies, 2002).
The second system is the Baltimore Classification System (Figure 1-1), 
edited by David Baltimore, and is based on the genetic system of each virus 
and describes the obligatory relationship between the viral genome and its 
mRNA (Flint et al., 2004c).
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Figure 1-1 The Baltimore classification system. Viruses are classified 
according to the nature and polarity of their genome. The translation process 
(production of mRNA) is the unique pathway taken into consideration.
(+) ssRNA 
\
DNA/RN A hybrid
I
dsDNA ssDNA
VI \
dsONA
\
/  O
dsDNA
/
(-) ssRNA
V
mRNA
!
(-) ssRNA
The Baltimore Classification j f V
(+) ssRNA
dsRNA
m
Viruses are distinct among organisms, because of their very small size (20 
nm-300 nm) and because they do not have any metabolic activity 
(Dulbecco, 1980). Viruses can infect bacteria, animal cells, and plants. 
Certain groups of virus possess a host in more than one Kingdom. For 
instance, rhabdovirus has hosts both in the Plantae and Animalia, 
partitiviruses in Plantae and Fungi. Moreover, several families infect across 
different Phyla (insects and vertebrates), such as flavivirus (Dengue virus, 
West Nile virus, yellow fever), and togavirus (Sindbis virus).
The main function of virions is to be effective in the transmission of the 
nucleic acid from one host to another; therefore it is essential to protect the 
genome from potentially lethal environmental factors, such as chemical 
compounds, enzymes, irradiation, or extreme pH and temperature.
Thanks to the electron and cryo-electron microscope, X-ray crystallography, 
and nuclear magnetic resonance (NMR) microscopy, the viral structures 
have been well defined up to the level of small proteins, even though 
complex viruses are relatively less studied.
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A virus is composed of a protective coat (the capsid). the nucleic acid and in 
some viruses a lipidic envelope. In addition, some viruses also contain 
enzymes or other proteins necessary to their infection cycle.
The capsid is composed only of proteins, and is responsible for 60-90% of 
the total weight of the virus. The capsid proteins are coded by viral genes. 
The coat proteins display helical or icosahedral symmetry. The helical 
symmetry is common in the animal enveloped viruses and certain plant 
viruses and bacteriophage. They have a rod-like shape. The helical 
symmetry is considered an open structure, because any volume can be 
enclosed simply varying the length of the helix (Flint et al., 2004d).
The icosahedral symmetry has 20 equilateral triangular faces with 5:3:2 
axes of rotational symmetry. In contrast with the helical symmetry, it is 
considered a closed structure of fixed internal volume. In non-enveloped 
viruses the capsid itself is involved in the attachment to the host cell (Davies 
et al.. 2004).
Some non-enveloped viruses have a complex structure, with the presence of 
various proteins protruding from the capsid involved in specific functions. 
For instance, adenovirus has an icosahedral structure but with long 
projections at the 12 vertices called fibre attached to the 12 penton base. 
Each fibre terminates with a knob that is essential for binding the cell 
surface adenoviral receptor (Rux & Burnett, 2004).
The viral genome is located at the core of the capsid and it can be either 
DNA or RNA, and this may be single- or double-stranded. The proportion 
of the nucleic acid varies from about 1%, as in the influenza virus, to 50% in 
some bacteriophages. Viruses have just one copy of the genome (haploid), 
with the exception of retrovirus.
There are three mechanisms of packaging and condensing the nucleic acid 
in the capsid. The viral genome is in direct contact with the shell, which has 
proteins that interact with the nucleic acid. Using the same proteins to 
construct the shell and package the genome allows for small genetic 
material, which is advantageous for small viruses, such as picomaviruses 
and poliovirus (Flint et al., 2004d). Another mechanism of packaging 
involves specialised proteins, such as the IVa2 protein in adenovirus (Zhang 
et al., 2001). Finally, some viruses, such as papillomaviruses and simian
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virus 40, contain cellular core histones, organizing the genome in a 
chromatin-like structure.
In the enveloped viruses, the envelope is composed of a lipid bilayer 
containing proteins with special functions. Depending on the virus, the 
envelope can have different origins, from the cytoplasmic membrane (e.g. 
influenza virus) or the nuclear membrane (e.g. herpes simplex virus). There 
are two kinds of proteins in the envelope, the glycoproteins and the matrix 
proteins. The first one is exposed on the outer part of the bilayers and has an 
important role in the infectivity of the virus. Matrix proteins are on the inner 
part o f the envelope, in order to establish a bond between the envelope and 
the capsid.
1.3.1. Bacteriophages
Bacteriophages are viruses infecting bacterial cells. They can possess a tail, 
such as T phages or FI 16, and they can be o f different sizes and structures. 
Tails consist o f a central tube, through which the DNA passes during the 
infection process, surrounded by a sheath. At the tip of the tail several fibres 
can be present, which are involved in the attachment to the wall o f the 
bacteria (Figure 1-2A). Other bacterial viruses are constituted just by a head, 
which has usually an icosahedral symmetry, as is the case for MS2 (Figure 
1-2B) or P22.
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Figure 1-2 Different structures o f bacteriophages. A. Tailed bacteriophage 
T4 (Eiserling & Black, 1994). B. Icosahedral bacteriophage MS2.
Phages exist in three different stages: extracellular virions, replicative phage 
and prophage. All bacteriophages can be found as extracellular virions and, 
during their multiplication in the host cell, in a replicative stage. The stage 
of prophage is achieved when the bacteriophage is latent in the host cell and 
the viral genome is integrated into the bacterial chromosome. Those viruses 
able to enter this stage are called temperate. The prophage has the same 
genetic information as other viruses, but during the latent period (lysogeny) 
the expression of viral genes is blocked by a specific repressor codified by 
the virus itself (Kissmann et a l , 2008).
There are two kinds o f infection cycles, the virulent and the lysogenic the 
latter being performed just by temperate phage (Figure 1-3).
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Figure 1-3.Infection cycles o f bacteriophages.
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The infection cycle of virulent bacteriophages consists of attachment, 
adsorption, transcription and replication inside the host, maturation, and 
then release of the virions. The cycle lasts as little as 30 min. The phage- 
host attachment is highly specific. Once attached to the host, several 
changes happen on the cell membrane, leading to an increase of 
permeability in order to allow entry of the phage. These alterations cause 
metabolic changes and a rearrangement of all macromolecular synthesis. In 
fact, the cellular DNA replication is replaced by the DNA-RNA viral 
synthesis, and viral proteins initiate to be transcribed. Then, all components 
are assembled to form mature infectious phages, which are released outside 
the host cell after the rupture of the cell wall.
Temperate virions, in contrast, do not immediately generate mature 
bacteriophages, but their DNA persists indefinitely in the host cell. During 
the lysogenic state, the viral nucleic acid can integrate into the bacterial 
genome. A process linked to the lysogeny is transduction, where the 
bacterial DNA is transferred from one cell to another through a 
bacteriophage. The transduction can be either generalized, when any portion 
of the bacterial genome can be inserted in new viral particles, or specialized, 
when a specific group o f bacterial genes is integrated into the genome of the 
virus, generally substituting some viral genes (Kissmann et al., 2008). The 
transduction process has several applications in biology, such as providing 
an important mechanism for gene transfer, or supplying a model for viral 
oncogenesis (Dulbecco, 1980).
Phages can have receptor sites on different parts of the host cell. These so 
called somatic phages recognise sites located on the cell wall and are 
present at all times; they include members of the family Myoviridae, 
Siphoviridae, Podoviridae and Microviridae. Other phages have receptors 
located on specific sites on the host, such as the male-specific phages 
(Inoviridae and Leviviridae), that use sites on the pilus o f host bacteria 
which are produced only under optimal conditions and in the logarithmic 
growth phase (Grabow, 2001).
Considering the increase in bacterial resistance to antibiotics, phage therapy 
is likely to have an important role in medical and veterinary infectious
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diseases. In Eastern Europe phages are already commonly used as part of 
general care, as a treatment for dysentery, respiratory tract inflammation, 
otitis, meningitis, septicaemia and in application to wounds and bums 
(Duckworth & Gulig, 2002).
Recently, bacteriophages have been proposed for food industry as 
antimicrobials, and as a tool to detect pathogens. Phage have been used i) 
against salmonellosis (Berchieri et a l 1991) and colibacillosis (Murray et 
al., 2008) in poultry, ii) to reduce E. coli 0157:H7 infection of sheep and 
cattle (Garcia-De-Lomas et al., 2008), and iii) to prevent Staphylococcus 
aureus growth in raw milk (Kok et al., 2000) and dairy products (Garcia et 
a/., 2007).
Phages have an important role in molecular biology: nowadays a multitude 
of studies on isolation, sequence analysis, mutagenesis, expression, and 
transduction of DNA in different hosts depend on them. Furthermore, the 
development of phage-display technology, the process o f inserting new 
genetic material to be expressed on the phage surface, has been applied to 
recombinant antibodies, diagnostic procedures, and targeted therapies 
(Arap, 2005).
1.3.1.1. F116
FI 16 is a pilus-specific Pseudomonas phages and member of the 
Siphoviridae. It was first isolated from a strain of P. aeruginosa obtained 
from a Melbourne hospital by B.W. Holloway (Holloway et al., 1960). Its 
head is icosahedral (70 nm in diameter) and it possesses a 70-nm-long 
noncontractile rod-shaped tail with helical symmetry. The genome is linear 
double-stranded DNA of 61.7 kb. FI 16 attaches to the host pili, whose 
retraction brings the phage in contact with the bacteria where the DNA is 
released into the cell (Byrne & Kropinski, 2005). Phage FI 16 is a temperate 
phage.
F 116 has been used to determine the effect o f disinfectants on several 
occasions (Maillard, 2001) due to the high resistance to some biocides
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(Maillard, 2001) and because its large size facilitates analysis of structural 
damage (Maillard et al., 1995).
1.3.1.2. MS2
Bacteriophages containing single-stranded RNA genome show an incredible 
adaptation to their parasitic life, a sophisticated way to control and 
coordinate the synthesis o f all phage elements, and a specific way of 
assemblage. The RNA phages parasitizing E. coli have been used several 
times as a model to understand the mechanisms of infection. They are 
classified serologically into five groups, but group I, including MS2, f2, 
R17, R23, and group III, with Qp, are the most relevant. RNA coliphages 
are about 24-26 nm in diameter, with a molecular mass that ranges from 3.6 
x 106 to 4.2 x 106 Dalton. The RNA is around 30% of the total weight, and 
consists of a chain o f 3300-4500 nucleotides (Hindley, 1973). One 
interesting property is the capacity of the RNA to exist as a compact folded 
structure due to the high degree of secondary structure, involving 63%-82% 
of the bases. The secondary structures consist mainly o f hairpin-like 
structures, formed by a helical, hydrogen-bonded stem and a terminal loop 
of not less than 3 nucleotides (Weissman et al., 1973). The ability to 
compact itself lets the RNA form quasispherical structures easily, even in 
solution, around which the capsid could assemble (Hohn, 1976).
One of the main proteins coded is the p subunit of the enzyme complex 
replicase. It is a very important feature of the RNA phages, which ensures 
their specificity and the efficacy to replicate just the phage RNA among all 
o f the various RNA species in the cell (Blumenthal & Carmichael, 1979). 
Coat proteins, in addition to their structural function, are also involved in 
translational repression. In the late phase of infection, when the demand for 
coat proteins is maximal, they bind specifically to a RNA segment that 
includes the start o f the subunit replicase cistron, inhibiting its translation 
(Hindley, 1973).
F-RNA phages are often used as a surrogate/model for mammalian viruses 
(mostly enteric viruses) due to their physical structure, composition, and
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morphology. Furthermore, they have been shown to have similar or higher 
resistance to unfavourable conditions and to disinfection processes 
(Grabow, 2001). Therefore, F-RNA phage have been used to assess the 
virological quality of raw and treated water (Havelaar et al., 1993), and in 
laboratory experiments to test the viricidal properties of biocides (Dawson 
et al., 2005; Koivunen & Heinonen-Tanski, 2005).
1.3.2. Mammalian viruses
Mammalian viruses infect eukaryotic cells, implying several differences to 
bacteriophages in their cycle and their strategies o f infection. In a eukaryotic 
cell metabolic processes occur in separate compartments, mRNAs are 
processed before transcription and each eukaryotic RNA molecule codifies 
just one polypeptide. Instead, in bacteria mRNAs are polycistronic, so 
translation will yield several polypeptides (Kissmann et al., 2008). 
Furthermore, mammalian cells do not have a peptidoglycan wall, so the 
entire virus very often enters the cell through endocytosis.
Depending on the type o f virus, the host cell can be affected in different 
ways. Acute infection leads to the death of the cell and to the release of 
virions (cytopathic viruses, e.g. poliovirus, rotavirus); persistent infections 
yield virions without causing immediate cell death (non-cytopathic viruses). 
The latter are differentiated between chronic infections which are eventually 
cleared (e.g. measles virus), and latent infections that last the whole life of 
the host. Latent viral infections are characterised by the absence of 
expression of productive cycle viral genes, a reduction in the immune 
detection of the infected cell, and by the persistence o f the viral genome 
intact as a chromosome in a non-dividing cell (e.g. neurone; herpes simplex 
virus, varicella-zooster virus), or as an autonomous self-replicating 
chromosome (e.g., Epstein-Barr virus), or integrated into the host 
chromosome (e.g., adeno-associated virus) (Flint et al., 2004a).
Mammalian viruses can be differentiated by the type o f genome (single- and 
double-stranded DNA or RNA), by the presence or not o f the lipid 
envelope, or, for some families, by their replication strategies (Table 1-1).
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Table 1-1. Most important mammalian virus families and their main 
characteristics.
Geno
me
Genom e
strandedness
Infectivi 
ty o f  
RNA
Sym m etry o f  
capsid
Non-lipidic 
(NLE) or 
lipidic (LE) 
envelope
Family Exam ples
+ Icosahedral NLE Picornaviridae
Enterovirus,
poliovirus,
coxsackievirus,
rhinovirus
- Helical LE Rhabdoviridae
Rhabdovirus 
(Rabies), VSV 
(vesicular stom atitis 
virus), flanders 
virus
RNA
Single­
stranded - Helical LE O rthom ixoviridae
Influenza virus A, 
influenza virus B, 
influenza virus C
+ Icosahedral LE Retroviridae
Virus inducing 
tum our (HIV, 
Leukosis viruses, 
Sarcom a viruses, 
etc.)
+ Icosahedral NLE Caliciviridae
N orw alk virus, 
Sapporo virus, 
feline calcivirus
Double­
stranded Icosahedral
NLE Reoviridae
Reoviruses 
(respiratory enteric 
orphan virus)
Single­
stranded Icosahedral NLE Parvoviridae
Adeno-associated 
virus (defective 
viruses depending 
upon the 
m ultiplication o f  
adenovirus)
DNA
Icosahedral NLE A denoviridae
Adenovirus 
(infections in 
tonsils, adenoids, 
and lymphoid 
tissues)
Double­ Icosahedral NLE Papovaviridae
Polyoma virus, 
SV40
stranded
Icosahedral LE H erpesviridae
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Chapter 1 -  General Introduction
RNA viruses are wide-spread parasites, responsible for many diseases 
(Figure 1-4). In the past 25 years several RNA viruses, such as HIV, 
hepatitis C virus, and severe acute respiratory syndrome coronavirus 
(SARS-CoV), have emerged. They have been either new to medical science 
or increased to such an extent that they raise concern for public health 
(Moya et al., 2004).
Four characteristics are considered most relevant to understand their 
importance. First, their large population size: the number of viral particles in 
a given organism might be as high as 10 . Second, natural selection is more 
efficient in a large population, such as the one produced during an explosive 
replication of RNA viruses in the host. A single infection, for instance, can 
produce an average o f 100,000 viral copies in 10 h. Thirdly, RNA viruses 
posses the highest rate o f mutation among all the organisms, due to the 
absence of a proofreading activity in their polymerase enzyme. Finally, the 
small size of their genome, ranging from 3 kb to 30 kb, when added to the 
high mutation rate leads to the development of new beneficial mutations in a 
short time (Moya et al., 2004).
Figure 1-4. Shapes and dimensions of different families of RNA virus.
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I.3.2.I. Adenovirus
Adenoviruses have the ability to infect a wide range of species and mostly 
attack the respiratory and gastrointestinal tissue. General symptoms are 
conjunctivitis, pharyngitis, pneumonia and diarrhoea. There are 51 human 
serotypes, subdivided into six subgroups (A to F) based on their ability to 
agglutinate erythrocytes o f human, rat and monkey and on their 
oncogenicity in rodents (Russell, 2009). The Adenoviridae family comprises 
four genera: Aviadenovirus, Mastadenovirus, Atadenovirus, and
Siadenovirus.
Thanks to X-ray crystallography and to cryo-electron microscopy, the 
structure of the adenovirus is clear. They are formed by a capsid, fibres, a 
core, and associated proteins. The capsid is icosahedral, non-enveloped and 
measures 80-110 nm with a molecular mass of 150-180 x 106Da.
The capsid is formed o f 252 capsomers. The main component is the 
homotrimeric hexon situated on the 20 faces with 240 copies; at the 12 
fivefold apices there are penton bases and extended fibres (Russell, 2009). 
Each hexon consists o f a hexagonal base with a central cavity, and its size 
can vary with the serotype. The penton capsomere is a covalent complex of 
two proteins: the homopentameric penton base and the homotrimeric fibre 
protein. The fibre has a tail, shaft and a knob. There are also other small 
polypeptides on the capsid with some associated with the virus core (Figure 
1-5) (Table 1-2). The genome is not segmented and contains a single 
molecule of linear double-stranded DNA. The complete genome is 35800- 
36200 nucleotides long.
The fibre is the first component that interacts with the host tissue, and after 
binding the receptor, the virus is internalised via clathrin-coated vesicles and 
into endosomes (Russell, 2009). The rupture of the endosome releases the 
virus into the cytoplasm which then attaches to the nucleus and inserts the 
DNA. The immune response is induced during the attachment to the cell 
membrane and when the rupture of the endosome occurs.
Adenoviruses have been intensively studied for over 50 years as models of 
virus-cell interactions and also as gene vectors. Recently adenovirus type 5 
has been used in gene therapy and genetic vaccination (Rexroad et al., 2003; 
Maheshwari et a l ,  2004). There are more than 160 human clinical trials
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involving adenoviral vectors (Rexroad et al., 2006). Adenoviruses have also 
been used as a model for testing virucidal efficacy of disinfectants 
(Sauerbrei et al., 2004a), and a recent study recommended the use of 
serotypes 5 and 44 because o f their high resistance to biocides (Sauerbrei et 
al., 2004a).
Figure 1-5. A. Adenovirus diagram. B. Adenovirus micrograph. The arrows 
point to the detached fibres. Both images provided by ICTVdB 
(International Union of Microbiologist Societies, 2002).
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Table 1-2. Adenovirus structural proteins (Rux & Burnett, 2004).
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1.4. Biocides and mechanisms of viricidal action
Disinfection refers to the elimination or inactivation o f contaminating 
microorganisms (Terpstra et al., 2007). It can be carried out through 
physical removal, thermal kill, UV or gamma irradiation, or through the use 
o f chemicals. Chemicals used on inanimate surfaces are called disinfectants, 
the ones used on skin and tissues are called antiseptics. Virus disinfection 
has the intention to interrupt a chain o f infection. Amongst the viruses, those 
which are resistant outside the host body and are transmitted by air, dust and 
direct contact are most relevant (Grossgebauer, 1970).
The use of biocides, as a chemical substance capable o f killing different 
forms of living organisms, can control the transmission o f viruses in many 
environments, such as the home, public places, day-care centres, schools, 
hospitals and other healthcare institutions.
There are specific criteria relevant to developing and then selecting an 
appropriate biocide. Firstly, the compound has to be safe for the 
manufacturing workers, healthcare personnel and the patients. There have 
been cases o f toxicity, such as glutaraldehyde-based biocides which caused 
dermatitis in 11% of the personnel in a dental surgery (Ravis et al., 2003); 
sodium hypochlorite and chlorine gas have been responsible for 
occupational illness (Sattar, 2006). The environmental impact is also a 
factor to be considered when biocides are used. Biocides have been found in 
ground and surface water (Adolfsson-Erici et al., 2002), affecting the 
quality of food and water and also possibly damaging the fauna by 
disrupting their hormone function (Murr & Goldman, 2005).
Antimicrobials used in routine disinfection in healthcare settings need to 
have a broad spectrum o f activity, inactivating bacteria, fungi and viruses 
and to be effective after a reasonable contact time.
Improper use o f biocides can have important consequences. There is a 
controversy on the efficacy of disinfection procedures. Some German 
scientists in two reviews (Dettenkofer et al., 2004; Hota, 2004) stated that 
there is a lack of evidence which links the decrease o f nosocomial infections 
to increasing cleaning and disinfection procedures in hospitals and health
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care centres. This argument underlines the huge increase in using biocides 
and antiseptics, particularly in many household products, which is in 
contrast with the principle that disinfectants must be used when necessary 
and with a full appreciation o f the factors influencing their activity. The 
uncritical use of biocides, especially at low concentrations, might cause the 
development of resistance by pathogenic organisms (Dettenkofer & Block, 
2005). Lately, evidence has been found in laboratory-based studies o f the 
ability of microorganisms to become resistant to antibiotics after that have 
developed resistance to biocides (Levy, 2002; Sattar, 2006).
The type of vehicles\surfaces on or in which the virus is present and the 
kind of virus itself has to be taken into consideration when the viricidal 
action is studied (Maillard, 2001).
Several factors, such as temperature, pH, organic load, concentration, 
contact time and virus structure influence the capacity o f a biocide to kill or 
inactivate organisms (Thurman & Gerba, 1988b; Russell & McDonnell, 
2000; Maillard, 2001).
pH can change the ionic composition of the biocide, affecting its binding to 
the virus target. Brion et al. (1999) found that iodine inactivates MS2 more 
at pH 7.0 than 8.0, even though some works demonstrated that inactivation 
of virus with iodine is more effective at alkaline pH (Alvarez & Obrien, 
1982; Sobsey et al., 1991). Furthermore, viruses have surface isoelectric 
points (pi) which are pH values at which virus proteins carry no net 
electrical charge. Consequently, at a pH below the pi, the viral particle has 
an overall net positive charge, above the pi, it carries a net negative charge. 
This can alter the sensitivity o f target sites in or on the virus (Thurman & 
Gerba, 1988b), changing their spatial arrangement or inducing clumping or 
aggregation, perhaps by increasing virion hydrophobicity (Sharp & Leong, 
1980; Vrijsen et al., 1983).
The presence or absence of organic load is a significant influencing factor 
on the efficacy o f the biocide, competing and interfering with the 
attachment o f the biocide to virus targets (Wallbank et al., 1978; Weber et 
al., 1999; Ferrier et al., 2004).
The mechanisms o f inactivation by a biocide are various. Viruses present 
multiple target sites to the disinfectant. Generally, the viral structures
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subjected to viricides are classified into four features: the envelope; the 
capsid; the glycoprotein receptors, and the viral genome.
The viral envelope, being highly lipophilic and negatively charged, is quite 
susceptible to a wide range o f membrane-active agents (particularly cationic 
biocides). Hence, the enveloped viruses appear to be more sensitive to 
biocide than the non-enveloped viral particles.
The capsid is the most important part in protecting the virus from the outer 
environment. The efficacy o f the biocide might depend on the size o f the 
capsid itself; a larger capsid provides more target sites than a smaller one. 
This could explain why larger virus are generally more sensitive than 
smaller ones (Maillard, 2001). The main components o f the capsid can be a 
target for disinfectants reacting with -N H 2 groups (e.g. glutaraldehyde, 
ethylene oxide), or with -S H  groups (e.g. iodine, hydrogen peroxide).
Loss o f viral infectivity due to biocides can be caused by the alteration of 
glycoproteins, which are, in fact, responsible for specificity, and for 
releasing viral genome into the host cytoplasm.
The nucleic acid is the infectious part of the virus and it is well protected. Its 
complete destruction will cause complete viral inactivation. The viral 
genome can differ in size, in content (DNA or RNA) and appearance 
(circular, linear, or segmented). In addition, it can be bound to the capsid 
proteins with different degrees o f strength. It has been shown, for instance, 
that the helicoidal capsid is linked more closely to the genome than the 
icosahedral structure. Chlorine compounds (Charrel et al., 2001), paracetic 
acid (Maillard, 2001; Jursch et al., 2002), ozone and glutaraldehyde 
(Charrel et al., 2001) have been found to alter the viral acid nucleic.
1.4.1. Biguanides
Biguanides are a wide range of compounds showing antimicrobial activity. 
Chlorhexidine is the most important and common biguanide used especially 
in veterinary antisepsis, in contact -  lens solutions and in the dental field. It 
is one o f a family N 1, N 5 -  substituted biguanides (Figure 1-6) available in a 
number of pharmaceutical formulations. Chlorhexidine has a wide spectrum
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of antibacterial activity. It is bacteriostatic at lower concentrations, 
inhibiting membrane enzymes and promoting leakage o f cellular 
constituents. At higher concentrations bactericidal activity is demonstrated 
associated with coagulation o f cytoplasmic constituents (Maillard, 2001). Its 
efficiency is reduced in presence o f serum and organic matter, and due to its 
cationic nature, its activity decreases in the presence of soaps and other 
anionic compounds. Being a membrane -  active agent, an interaction 
inducing alteration of the membrane is possible. Viricidal activity has been 
showed against such enveloped viruses as herpes simplex virus and HIV 
(Montefiori et al., 1990; Wood & Payne, 1998; Baqui et al., 2001), but not 
against non-enveloped viruses (Springthorpe et al., 1986). A study with 
phage FI 16 showed that chlorhexidine caused structural damage to the FI 16 
bacteriophage (Maillard et al., 1995) and that it did not affect proteins 
(Maillard, 2001) or nucleic acid (Maillard, 2001).
Figure 1-6. Examples o f biguanide disinfectants. A. Chlorhexidine. B. 
Polyhexamethylene biguanide
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Polymeric biguanides, for example polyhexamethylene biguanide (PHMB), 
have been used as antiseptics in medicine and as disinfectants in the food 
industry, and current applications include impregnation o f fabrics to prevent 
microbial growth, water treatment, disinfection of various solid surfaces, 
prevention o f Salmonella infection, and lately as a component in wound 
dressings (Mueller & Krebsbach, 2008).
Their composition is a mixture of polymeric biguanides o f structure [- 
(CH2)6 .NH.C(=NH).NH.C.NH-]n, where n can vary from 2 to 40, resulting 
in a molecular mass range o f 400-8000 (Allen et al., 2006) (e.g.
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VANTOCIL™ TG n=5.5). The antimicrobial activity is directly correlated 
with the number of polymers. Specifically, in bacteria, PHMB’s induce 
phospholipid phase separation, causing loss of membrane function, with 
precipitation o f intracellular constituents (Allen et al., 2006).
VANTOCIL™ TG, which is a commercial bactericide for use in industrial, 
institutional and domestic applications, causes domain formation of the 
acidic phospholipids o f the cytoplasmic membrane, bringing permeability 
changes and altering enzyme function (Chawner & Gilbert, 1989b). This 
mechanism affects most bacteria, but it is less active against fungi. There is 
very little information regarding its viricidal activity.
It is likely that PHMBs can interact with viral cell membrane components. It 
was found active in vitro against Herpes simplex virus at a concentration of 
0.02%, but was ineffective when tested in vivo on infected rabbit (Valluri et 
al., 1997). Krebs et al. (2005) found PHMB active in vitro against both cell- 
free and cell-associated HIV-1, and able to interfere with viral binding and 
entry.
More detailed studies using HIV demonstrated that PEHMB (polyethylene 
hexamethylene biguanide) inhibited virus infection (binding and entry) by 
interacting with the HIV-1 co-receptor CXCR4 (Thakkar et al., 2009). Other 
substituted biguanides, such as 1-isopropylbiguanide hydrochloride and 1,1- 
dimethylbiguanide hydrochloride, possess antiviral properties, in particular 
against Lee influenza virus grown in chick embryo (Pilcher et a l ,  1961). 
Furthermore, alkyl substituted biguanides were shown to be effective 
against vaccinia and influenza viruses and their antiviral activity was 
directly correlated to the length of the alkyl chain (Fara et al., 1974).
1.4.2. Isothiazolinones
The isothiazolinones are heterocyclic compounds, and three derivatives are 
used in significant amounts: methylisothiazolinone (MIT, MI),
chloromethylisothiazolinone (CMIT, CMI, MCI), and benzisothiazolinone 
(BIT) (Mbithi et al., 1992) (Figure 1-7).
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They are antimicrobials used to control bacteria, fungi, and algae in cooling 
water systems, fuel storage tanks, pulp and paper mill water systems, oil 
extraction systems, wood preservation and antifouling agents (Nicoletti et 
al., 1993; Vicini et al., 2002; Critchley & Bentham, 2009). They are 
frequently used as preservatives in personal care products such as shampoos 
and other hair care products, as well as certain paint formulations. From 
2002 to 2005, there was a notable increase use of isothiazolinones as a 
preservative, especially in the product category paints/lacquers (Flyvholm,
2005).
Figure 1-7. Isothiazolinone compounds. A. General structure. B.
Methylisothiazolinone.
Benzisothiazolinone.
Chloromethylsothiazolinone. D.
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1.5. Disinfection
1.5.1. Testing for viricidal activity
Official tests for approval o f viricides are limited. In Europe there are just 
three organizations who provided protocols: in the United Kingdom DEFRA 
(Central Veterinary Laboratory, 1970), the Association Fran^aise de 
Normalisation in France (AFNOR, 1989), and the Deutsche Vereinigung ztir 
Bekampfimg der Viruskrankheiten in Germany (Anonymous, 1999). New
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protocols have been developed, such as prEN 14476 for testing viricidal 
activity in a suspension test (Anonymous, 2002), on fingerprints (Sattar & 
Ansari, 2002), and a protocol which uses contaminated hands (ASTM, 
1999). However the main problem in developing a standard protocol to 
assess the virucidal activity o f a biocide is the variability o f resistance and 
survival of viruses, which makes the comparison between tests difficult.
The activity of chemicals against viruses is assessed by two principal 
methods: quantitative suspension and carrier tests.
The suspension test consists o f mixing a known concentration of virus, with 
or without organic load, with a larger volume o f the biocide at its use 
dilution. The mixture is kept for a defined contact time, at fixed pH and at a 
specific temperature, then after neutralising the biocide activity, viable 
viruses are titrated. Suspension tests are easy to perform but this test does 
not challenge the product strongly enough (Abad et al., 1997). Therefore, 
they are only suitable for screening the activity of formulations under 
development and they are particularly recommended for viruses which are 
inactivated by drying.
Carrier tests simulate more realistic circumstances o f disinfection practice, 
using animate or inanimate surfaces contaminated by viruses. The viruses 
are suspended in an appropriate soil load and a known volume o f it is dried 
on a surface. The dried inoculum is exposed to the biocide for a specific 
contact time and temperature. Then the sample is eluted and titrated to 
determine the reduction o f virus viability. The most important problem in 
this method is that some viruses do not survive after the drying process, 
hence appropriate control tests have to be performed (Sattar & Springthorpe, 
2001).
Some factors must be considered in the design and performance of 
suspension tests and especially carrier tests, such as the type and the strain 
o f virus(es) to be used, and the nature o f the carrier, which can be inanimate 
or animate. Among the inanimate surfaces cylinders and discs of stainless 
steel, glass, or plastic have been used. For antiseptics, hands and fingerprints 
o f human volunteers can been used. The neutralisation o f the biocide is 
another important factor to take into account, because of its possible toxicity 
on the tested virus and on the host cells. Elimination of cytotoxicity and
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control of the environmental parameters o f the experiment (pH, temperature, 
organic load, contact time) are all important features in elaborating a 
protocol.
Some viruses can be difficult to propagate in vitro and may be hazardous to 
handle in the laboratory. To avoid these problems surrogate viruses, which 
are considered as a substitute o f the interested organism, have been used 
(Ferrier et a l, 2004; Steinmann, 2004; Jimenez & Chiang, 2006; Kramer et 
al., 2006a).
There are some considerations in selecting a surrogate virus. They must be 
easy to handle and stable on storage and as well on drying; they should have 
a high pool titre and they should possess a level o f resistance to biocides 
that is representative o f the class o f virus under consideration. Moreover, 
disadvantages o f using surrogates are the underestimation or overestimation 
of a products’ activity or the resistance o f naturally growing pathogens. 
Bacteriophages have often been chosen as a surrogate for mammalian 
viruses, because of their ease to grow and enumerate. Coliphages MS2, K 
and d>X174, being structurally similar to the enteric viruses and to 
poliovirus, have been used in viricidal tests as substitutes (Jones et al., 1991; 
Davies et al., 1993; Abad et al., 1994; von Rheinbaben et al., 2000; 
Maillard, 2001). They have also been used as indicators for enterovirus in 
waste water and polluted water (Kim et al., 1980; Harakeh, 1984; Havelaar 
et al., 1993; Brion & Silverstein, 1999).
1.5.2. Environmental factors, viral resistance and adaptation
Disinfectants can prevent contamination and transmission o f infections. 
There are three different routes of transmission: horizontal, through person- 
to-person droplet infection and person-to-person intimate contact; vertical 
occurs during birth by transplacental infection or by vaginal passage; zig­
zag is a very common way of transmission; it can be animal to insect to 
animal, or animal to animal (animate), or can be animal to fomite to 
animal/human (inanimate). The last route is the only one that can be 
meaningfully controlled by disinfection procedures.
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Disinfection can be ineffective because of: environmental factors; type, 
structure and composition o f the microorganisms; the ability o f the 
microorganisms to degrade the compound (not valid with viruses) (Figure 
1- 8 ).
Figure 1-8. Classes o f variables which influence biocide effectiveness.
Chemical
disinfectant
Composition
Concentration
Temperature coefficient (Qio) 
Concentration exponent
Environmental pH
factors Temperature
Contact time
Organic load (kind and quantity)
Virus Concentration
Degree of purity
Virus carrier (skin, fabric, tile)
Type o f virus
Assays Type o f test (Suspension test, carrier test)
Among the environmental factors, organic load is the most common (Weber 
et al., 1999). The organic matter can be represented by serum, blood, faeces, 
food residues, and earth. The interference can be attributed to the reaction 
that occurs between the organic materials and the biocides and to the 
possible protective layer that it is formed around the microorganisms 
(Russell, 2004). A study o f the efficacy of biocides against Adenovirus 8 
(Rutala et al., 2006) showed that by adding organic load during the carrier 
tests, the viricidal activity was reduced from 4 to 1 Logio- This loss of 
activity leaded to reclassification of some biocides, such as Chlorox [1:50] 
at 5 min, as no longer effective. Poschetto et al. (2007) found that different 
biocides were strongly influenced by organic load during their activity 
against Norovirus and Feline calicivirus. The concentration o f an organic 
acid needed to be eight times higher to achieve the same viral reduction in 
clean and dirty conditions; similar results for the peroxide biocide were 
achieved which had to be ten times more concentrated.
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pH can influence the virucidal activity by modifying the compound 
(protonation, dissociation), and by changing the surface properties o f viral 
particles. For instance the efficacy o f a formulation of silver and hydrogen 
peroxide against MS2 was reduced at higher pH (Pedahzur et al., 2000).
The development o f viral forms of resistance which alter the kinetics of the 
time/biocide efficacy reaction have been described although not extensively. 
Viruses show a variety o f intrinsic and acquired mechanisms of resistance. 
The acquired mechanisms are distinct owing to single or multiple genetic 
mutations or to transmissible elements. The intrinsic ones are due to the 
structure of the viral particles themselves, such as the presence of an 
envelope, the virus surface properties or features arising due to the 
interaction between the biocide and the viral particles (McDonnel, 2007). 
Clumping is a phenomenon that develops after contact with disinfectants 
due mostly to a change o f the viral surface properties. Viruses sometimes 
generate clumps in the cell, in the form of crystals. Then, after being 
released from the host, virions can remain clumped in water due to shifts in 
the pH or salt concentration, or associated with cellular debris (Floyd & 
Sharp, 1977). Clumps o f 16 identically sized virions are required to form a 
protective coat around one virus of the same size, enough to protect it from 
contact with disinfectants. Factors that influence aggregate formation are i) 
the virus species and serotype, particularly the viral surface charge, ii) viral 
concentration, and iii) chemical properties o f the surrounding medium, such 
as pH, ionic strength, and the nature of the ions present (Gassilloud & 
Gantzer, 2005). Studies showed that aggregation is correlated to the 
isoelectric point (pi) o f viruses, in particular virions tend to be dispersed at 
their pi, even though it is not possible to find a general pattern because each 
virus responds differently in different buffers and pHs (Floyd & Sharp, 
1979).
During disinfection procedures, aggregation can greatly influence biocide 
efficacy and can cause the underestimation of viable viral particles. The 
formation of clumps can, in fact, protect viruses which are trapped inside, 
avoiding the contact with biocide. As a consequence, some resistant 
subpopulations remain present in the medium or on the surface, as 
demonstrated with reovirus during bromine disinfection in water (Sharp et
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al., 1975) and coxsackie virus after chlorine treatment (Jensen et al., 1980). 
In addition, particulate matter can enhance further the formation o f a layer 
around viruses and clumps, protecting viral particles from the environment 
(Thurman & Gerba, 1988b).
Another characteristic of viruses is their capacity for adaptation to the 
environment. The susceptibility o f viruses to disinfectants can change after 
prolonged exposure, by modification of physical structures or by altering 
interactions with the host cells (Maillard, 2001).
Multiplicity reactivation is a further process o f resistance, in which damaged 
and inactive viruses combine their resources, producing infectious virions 
(Thurman & Gerba, 1988b). This phenomena was discovered by Luria 
(1947) as the explanation for an increase in concentration o f f2 after a 
previous reduction in viability due to disinfection. The process seems to 
happen when inactivated virions clump together and hybridize their gene 
pool.
In order to have truly functional disinfection and to avoid the viruses ability 
to acquire resistance to biocides, the capsid proteins have to be destroyed 
impeding the host-virus linkage and the released genome must be degraded 
and then dispersed such that the likelihood of multiplicity reactivation is 
diminished (Thurman & Gerba, 1988b).
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1.6. Aims
The overall aim o f the PhD project is to understand the mechanisms of 
action of PHMB-based biocides against viruses. Isothizolinone was used as 
a reference biocide.
Specifically this will be achieved through various steps:
-  Investigating the interactions o f PHMB-based and 
isothiazolinone-based disinfectants with bacteriophages 
(MS2 and FI 16), used as a virus model;
-  Investigating the effects o f PHMB-based disinfectants on 
phage capsid proteins;
-  Electron microscopy investigations will be considered to 
analyze structural damages;
-  Investigating the development o f forms o f resistance;
-  Understanding the mode of action o f PHMB against a 
mammalian virus, Adenovirus.
Since the viricidal activity o f PHMB has not been well studied compared to 
the amount of investigations performed on other disinfectants, and since 
products based on biguanides are commonly used as bactericides, this 
project aims to produce preliminary data which will be useful for the 
enhancement of this category of biocides. Clearly, these results will have 
important implications for use o f this type o f biocide in healthcare.
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2. GENERAL MATERIALS AND METHODS
2.1.Chemicals
2.1.1. Biocides
The biocides, COSMOCIL™ CQ, VANTOCIL™ TG, and PROXEL™ 
were provided by Arch Chemicals (Manchester, UK).
VANTOCIL™ TG contains 20% w/v (200000 ppm) polyhexamethylene 
biguanide hydrochloride (PHMB). The sample provided, batch b x l2 1 1, has 
a molecular weight o f 2678. COSMOCIL™ CQ is a PHMB-based 
disinfectant, containing 20% w/v (200000 ppm) o f the active compound 
with molecular weight o f 3016. Concentrations used during the project were 
2 ppm, 20 ppm, 200 ppm and 800 ppm of the active ingredient.
PROXEL™ ultra 10 is an isothiazolinone preservative biocide, composed of 
l,2-benzisothiazol-3(2H)-one [9% - 12% w/v] and potassium hydroxide 
[2% - 5% w/v]. The concentration required for its use has been 400 ppm 
(0.04% w/v). PROXEL™ was used as a comparative biocide.
Biocides were prepared with sterile deionised water (Inorganic at 25°C 1 to 
> 15 MQ-cm, TOC<30 ppb) in pre-sterilized glass bottles and were stored 
for a maximum of 2 months in a dark environment at approx. 20°C.
2.1.2. Neutraliser
The neutralization step is an important passage during the suspension test in 
order to stop accurately the biocide activity at a time o f exposure and to 
eliminate any toxicity if cell culture, embryonated eggs or animals are used 
to count the surviving viruses (Maillard, 2001). The neutralizer reacts with 
the active region o f the compound which would bind and consequently 
inactivate the microorganism.
The neutraliser used for quenching all the studied biocides, both the PHMB- 
based and the isothiazolinone, was composed o f Tween 80 [6% w/v], 
Lecithin [0.45% w/v], and L-Histidine [0.1% w/v]. N eutralises were 
sterilized by autoclaving at 121°C for 15 min (British Pharmacopoeia, 2008) 
and store at 4°C.
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2.2.Bacterial host culture
2.2.1. Propagation, enumeration and host suspension
Escherichia coli (NCIMB 9481) and Pseudomonas aeruginosa (NCIMB 
10548) are the host bacteria for the MS2 and FI 16 phage respectively. They 
were grown in 10 ml TSB (Oxoid, Cambridge, UK) for 24 h at 37°C. Then 
the broth was centrifuged for 15 min at 3276 xg  (Mistral 1000 centrifuge, 
MSE, London, UK) and the bacterial pellet was resuspended in 5 ml of 
phage buffer (SM buffer) (0.79% w/v (0.05M) Tris/HCl pH 7.4, 0.2 % w/v 
MgSC>4 , 0.02% w/v gelatine).
Bacterial enumeration was performed through the drop counting method 
(Miles & Misra, 1938). The suspension was serially diluted by adding 100 
pi of bacterial suspension in 900 pi of phage buffer and three 10 pi drops of 
the chosen dilution were plated on TSA plates. Three replicates were 
prepared for each suspension. After 24 h incubation at 37°C, the numbers of 
colonies for each drop were counted. Viable count and measurement o f the 
optical density at 540 nm (Helios a  UV-Vis spectrophotometer, Thermo 
Scientific, Waltham, USA) were performed for every new culture. 
Furthermore, 20 cryogenic vials (Coming, NY, USA) of stock cultures were 
prepared by mixing 800 pi o f bacteria suspension with 200 pi o f glycerol 
(Fisher Scientific, Leicestershire, UK) and frozen at -80°C.
2.3. Phage
FI 16 (NCIMB 10882) is a temperate, pilus-specific, generalized 
transducing phage belonging to the Podoviridae family, infecting P. 
aeruginosa. It is non-enveloped with a head and a short tail with 6 fibers. 
The nucleocapsid is icosahedral, 60 nm in diameter, and composed by 72 
capsomers per nucleocapsid. The genome is a linear double-stranded DNA, 
with a GC content o f 63.2%. Its molecular weight (MW) is about 48 x 106 
Da (International Committee on Taxonomy of Viruses, 2002).
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MS2 (NCIMB 10108) belongs to Leviviridae family, and the host is E. coli. 
This non-enveloped coliphage consists of an icosahedral capsid without a 
tail. The capsid has a diameter o f 24-26 nm and its molecular weight is 3.5 x 
106 Da. The genome is not segmented and contains a single molecule of 
linear positive-sense, single-stranded RNA (International Committee on 
Taxonomy of Viruses, 2002). FI 16 was propagated at 30°C, whereas MS2 
at 37°C.
2.3.1. Phage propagation and suspension
In order to have good bacteriophages infectivity (Mandel & Higa, 1970), 
agar and broth were supplemented with calcium chloride (CaCC). Taking 
into account results from Maillard (2001), different calcium chloride 
concentrations were tested, and the best result was found using 5x1 O'4 M 
CaCb for MS2 and 1x10‘3M CaCb for FI 16. In addition, stocks o f phage
o
suspension (10 PFU/ml) were prepared to assure available viruses as 
required. For each species, 800 pi of phage suspension was mixed with 200 
pi o f glycerol in cryogenic vials and stored at -80°C.
The propagation of both phages was performed using broth culture and plate 
culture. The broth culture consisted of inoculating 10 ml o f broth (Oxoid, 
Cambridge, UK) supplemented with CaCb with the host bacteria (5xl07
n
CFU/ml) and the bacteriophage (10 PFU/ml). The numerical ratio between 
the phage and the host was chosen according to the multiplicity o f infection 
(MOI) results [see section 2.3.3]. After 24 h o f incubation at 37°C in a 
shaking incubator at 70 RPM, the mixture was centrifuged for 15 min at 
3276 xg  (Mistral 1000 centrifuge, MSE, London, UK). The supernatant 
containing the phage particles was filtered through a 0.22 pm membrane 
filter (Millipore, Cork, Ireland) and stored at -4°C.
In the plate culture technique, phages were collected from infected plates 
where more than 30 plaques were observed. Five ml o f SM buffer was 
poured into the plate, and the 65% agar layer [see section 2.3.2], where 
phages have been reproducing, was removed by a sterile plastic L-shape 
spreader and poured in a centrifuge tube. After being centrifuged for 15 min
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at 11000 xg  at 4°C (Rotor JA25.50, Avanti J-25, Beckman Coulter, 
Fullerton, USA), the supernatant was filtered through a 0.22 pm membrane 
filter (Millipore, Cork, Ireland) to avoid the passage of bacterial cells and 
large debris. The filtered phage suspension was stored at -4°C. A stock was 
mixed with 20% w/v glycerol and stored at -80°C.
2.3.2. Phage enumeration (soft overlay agar technique)
The plaque counting method was used to calculate phage concentration 
(plaque forming units per ml, PFU/ml). One hundred pi of the host cells 
(approx. 108 CFU/ml) and the diluted phage solution were mixed with a 
gelling agent (65% nutrient agar, Oxoid, Cambridge, UK) and poured in a 
plate on top of an already set nutrient agar. The use o f 65% agar restricted 
the spread of bacteriophages only to the adjacent cells. It was assumed that 
each clear plaque was formed by the infection resulting from one virus. The 
phage-specific amount o f CaCl2 was added to 5 ml o f 65% molten agar. The 
mixture, after being autoclaved, was kept in the water bath at 45°C, ready to 
be used for experiments.
After 24 h o f incubation at the phage-specific temperature, plaques were 
counted and the PFU/ml was calculated.
2.3.3. Multiplicity of infection
The multiplicity of infection (MOI) test was performed to calculate the 
infectivity capacity o f phages. The result gave the optimum ratio between 
the host cell and the virus, which was used to get the highest yield o f viral 
particles during the propagation in broth.
Phage suspension and host culture were mixed at different ratios in 10 ml of 
nutrient broth supplemented with CaCI2 [see section 2.3.1] (Phage/Bacteria 
ratio: 100/1; 80/1; 50/1; 10/1; 3/2; 1/1; 2/3; 1/10; 1/50; 1/80; 1/100). An 
aliquot was taken from the inoculated bottle to measure the pH (Hanna 
Instruments Sri, Padova, Italy). The mixture was then incubated at 37°C.
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After 24 h incubation, the broth was centrifuged at 3276 xg  for 15 min 
(Mistral 1000, MSE, London, UK) and the supernatant was then filtered 
through a 0.22 pm membrane filter (Millipore, Cork, Ireland). The phage 
suspension was then serially diluted and enumerated. The ratio that gave the 
highest concentration o f bacteriophage was determined.
Optimum ratios were 50/1 for MS2 with E. coli and 30/1 for FI 16 with P. 
aeruginosa (Figure 2-1, Figure 2-2).
Figure 2-1. Multiplicity o f infection graph o f MS2 hosted by E. coli.
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Figure 2-2. Multiplicity o f infection graph o f FI 16 hosted by P. aeruginosa.
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2.4. Concentrated phage stock
Five ml of SM buffer was poured onto plates showing confluent lysis and 
was allowed to stand for 15 min. The top agar layer was then scraped and 
poured into a centrifuge tube. Then the mixture was centrifuged at 11000 xg 
for 15 min at 4°C and the supernatant was filtered through a 0.22 pm filter 
(Millipore, Cork, Ireland). After centrifuging at 19000 xg for 2 h at 4°C, the 
pellet was re-suspended into 1/10 of the initial volume. Starting from 109 
PFU/ml, the final concentration obtained was approximately 1011 PFU/ml.
2.5. Purification of viral particles
2.5.1. Concentration of phage
The modified protocol was based on a method described by Sambrock & 
Russel (2001). The phage suspension prepared from confluent lysis plates 
was mixed with 10% w/v PEG 8000 and NaCl to achieve a final 
concentration of 1 M. The mixture was stirred and kept at 4°C for at least 5 
h. It was then centrifuged at 11000 xg  for 30 min at 4°C. The precipitate was 
resuspended in 1:20 o f the initial volume of SM buffer and an equal volume 
of chloroform was added to extract PEG and cell debris. It was then 
vortexed for 30 sec and centrifuged at 3000 xg  for 15 min at 4°C (J4-14 
rotor, Avanti J20 XP centrifuge, Beckman Coulter, Fullerton, USA) to 
separate the aqueous from the organic phase. The aqueous phase was 
recovered and used during the isopycnic separation.
2.5.2. Isopycnic separation
CsCl (0.5 g/ml) was added to the concentrated viral suspension. Different 
densities of CsCl were prepared using SM buffer as diluents for MS2.
Table 2-1 showed the properties of the CsCl solutions used. According to 
the MS2 buoyant density in CsCl (1.38 g ml"1) (Kuzmanovic et al., 2003), 
three densities (p = 1.36 g ml"1, p = 1.45 g m l'1, p = 1.70 g m l'1) were chosen
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in order to detect the band containing the coliphage. A 13.5 ml polyallomer 
centrifuge tube (Beckman Coulter, Fullerton, USA) was filled with 2.6 ml 
of each CsCl density. A line was drawn outside the tube at the interface 
between p = 1.36 g ml’1 and p = 1.45 g ml’1. The virus suspension (5.2 ml) 
was layered on top of the gradient and then centrifuged at 200000 xg  for 8 h 
at 20°C (Vti 65 rotor, Optima LE-80K Ultracentrifuge, Beckman Coulter, 
Fullerton, USA). The band corresponding to the phage (in the p = 1.36 g ml' 
1 zone) was harvested by gently inserting a sterile needle to remove it. The 
infectivity was checked.
The purified phage was dialysed (Spectra/Por Float-A-Lyzer, MWCO 3500 
Da) overnight against SM buffer and then filtered through a 0.22 pm filter 
(Millipore, Cork, Ireland). Aliquots of 1 ml were stored at -80°C.
Table 2-1. Densities and respective concentrations o f CsCl solutions 
prepared in 10 ml o f SM buffer.
Density p (g/ml) M (g-mole/L) CsCl (g) SM buffer (ml)
1.36 2.92 4.92 8.74
1.45 3.60 6.00 8.50
1.70 5.65 9.50 7.50
F rom  S am b ro ck  &  R u sse l (2 0 0 1 ).
2.6. Statistical analysis
All experiments were repeated three times, except the suspension test which 
was performed five times. All data were transformed into Logio to assure 
that data were normally distributed.
Any differences among results were analyzed by parametric tests, one-way 
ANOVA test and t-test using Statistica 7.0 software (StatSoft Inc., Tulsa, 
USA). If the analysis o f variance resulted in significance, post-hoc Tukey 
test was performed. When the data were not normally distributed, even after 
being transformed, the Mann-Whitney U Test was used.
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2.7. Validation
The drop count technique and the phage enumeration technique have been 
validated by performing the experiments 10 times. The resulting data were 
subjected to a One Way ANOVA in Statistica 7.0 software package 
(StatSoft Inc, Tulsa, USA). Validation was deemed successful when P>0.05 
and the data was normally distributed according to the Anderson-Darling 
test (Bacterial drop counting method ANOVA, F].2o=0.66, Z^O.05; phage 
enumeration technique ANOVA, Fi,i8=0.11, /*>0.05).
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3. EFFECT OF PHMBs ON THE VIABILITY OF FI 16 AND MS2 
PHAGES
3.1. Introduction
The use of biocides is crucial for the control of microbial contamination and 
infection in the healthcare environment (Maillard, 2001). Although the 
number and the use of products containing an antimicrobial are increasing, 
there is generally a lack o f understanding of their mechanisms of action 
against viruses. Several biocides (e.g. quaternary ammonium compounds, 
biguanides, phenolics) have been described to have a virucidal activity 
against enveloped viruses, but only low efficacy against certain non­
enveloped ones (Wood & Payne, 1998; Krebs et al., 2005; Sauerbrei et al.,
2006). The reason for such diversity of activity has been based on the 
interaction of these chemical agents with the viral envelope and an absence 
of activity against the protein capsid (Maillard, 2001).
Testing the virucidal activity of biocides is undertaken mainly with two 
tests: the suspension test and the carrier test. Suspension test is less 
challenging to the microorganisms, but is essential as a first screening of the 
efficacy of a new or previously un-tested biocide. It is important that the 
environmental conditions (pH and temperature) are kept constant for the 
whole treatment and that a defined contact time in ensured by the use of a 
neutralizer able to quench the biocide activity. In Europe the suspension 
tests most commonly used are the German DVV (Anonymous, 1999), the 
French AFNOR (AFNOR, 1989) and the European EN 13610 (CEN, 
2002a). They all require a 4 Logio reduction of viral concentration, but are 
based on different parameters, such as the biocide concentration and the 
volumes ratio used. Moreover, the German guideline recommends as a 
standard test virus strains of polio 1 (wild type), adenovirus type 2, vaccinia 
virus and papovavirus SV40, whereas the French test mentions polio 1 
(vaccine type), adenovirus type 5 and vaccinia virus (Steinmann, 2001). In 
the USA, the ASTM guideline (ASTM, 1989b) requires a lower reduction (3 
Logio) and suggests more standard virus strains: influenza virus, rhino virus, 
herpes simplex, polio and vaccinia virus (Bellamy, 1995).
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The carrier test is a simulation o f “real life”, where a known concentration 
of a viral suspension is dried on surfaces (different types) and then treated 
with the biocide. The challenge for the microorganisms is higher than in a 
suspension test, but the main obstacle in performing this test is the risk of 
inactivation of the virus during the drying step (Maillard, 2001). In Europe 
there are several types of surface suggested (Sattar et al., 1987; Sattar et al., 
2003; Ferrier et al., 2004), but there is no standard procedure. However in 
the USA, the ASTM developed a carrier test standard procedure (ASTM, 
1989a).
The main obstacle in developing a standard protocol, which allows a 
comparison of results, is the choice of a representative virus. The 
heterogeneity of viral response to biocides and therefore the difficulties to 
find a standard response pattern are well-known. The only attempt was 
made by Klein and Deforest 40 years ago (Klein & Deforest, 1965). They 
explained the nature of viral inactivation by the chemical properties o f the 
virus surface. They divided viruses into three groups (A, B and C) based on 
their lipidic nature that consequently influences their sensitivity to chemical 
agents. Table 3-1 summarises the sensitivity to biocides based on the Klein- 
Deforest classification. The lipophilic property is based on the adsorption to 
lipids, such as cholesterol, palmitic acid, and hexadecylamine, on particle 
destruction by diethylether, and as well by inactivation using lipophilic 
germicides, such as the quaternary ammonium compounds (QACs) (Prince 
& Prince, 2001).
Table 3-1 Sensitivity to biocides based on Klein-Deforest classification.
Klein-
Deforest
category
Solubility Lipidicmembrane Sensitivity
A Lipophilic + High (Herpes, HIV, Myxoviruses)
B Hydrophilic - Low (Poliovirus, Rhino virus, Coxsackie virus)
C Intermediate - Moderate (Adenovirus, SV-40, Rotavirus)
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MS2 was often used as a surrogate virus. In a study o f Koivunen et al. 
(2005), MS2 was found to be resistant to peracetic acid; a dose of 0.07%- 
0.17% w/v was needed to produce 1-1.5 Logio reduction. They also found 
that combined treatments, such as peracetic acid and UV or hydrogen 
peroxide and UV, did not achieve synergistic effects.
Other investigations conducted in vitro using MS2 as a surrogate, showed 
0.5 Logio reduction after treatment with 70% ethanol over 60 sec 
(Woolwine & Gerberding, 1995), and approximately 0.35 Logio reduction 
with 0.5% chlorhexidine gluconate/70% ethanol within 60 sec (Woolwine & 
Gerberding, 1995). The only high level reduction (2.29 Logio) o f MS2 was 
achieved in a carrier test (fingerprints) through the use o f plain soap for an 
exposure time o f 30 seconds (Davies et al., 1993).
PH MBs are cationic agents which interact with the acidic bacterial 
membrane lipids causing phase separation and domain formation. Such 
mechanism provoke lethal leakage of cytoplasmic materials (Gilbert & 
Moore, 2005). A polymer size-dependent activity was shown by PHMB, 
where larger molecules produce larger domains and therefore more 
membrane disruption (Broxton et al., 1984). Thereby, it is likely that 
PHMB-based biocides are more active against enveloped viruses, such as 
herpes simplex virus and HIV (Wood & Payne, 1998; Baqui et al., 2001).
3.1.1. Inactivation kinetics
The disinfection reaction rate was analysed by Chick (1908) by exposing 
bacteria to a disinfectant at a constant concentration and enumerating the 
surviving organisms at successive times. He considered the reaction 
analogous to a bi-molecular chemical reaction, such as:
k,
xN + nC —> p (inactive microorganisms)
where N is number o f organisms, C is the compound concentration and p is 
the product (number o f inactive microorganisms).
48
Considering the concentration o f the disinfectant constant and the reaction 
irreversible, it can be described by the rate law:
dN/dt = -kN
where dN/dt is the rate o f change o f the viable count o f organisms with time 
t (survival ratio)
ki is the reaction rate constant
Nt is the number o f organisms at time t
t is time
If No is the number o f organisms at time 0, the above equations can be 
integrated to a pseudo first-order relationship:
Nt/No = e 'kt or
Ln(N,/N0) = -kt
For this relationship, to be valid, it has to follow some assumptions (Floff & 
Akin. 1986):
-  Viruses are discrete units equally susceptible to the 
disinfectant;
-  Viruses and disinfectants have to be uniformly distributed in 
the medium;
-  The disinfectant is stable (concentration and chemical 
composition) through the duration o f the experiment;
-  The medium where the reaction occurs does not have any 
interfering substances.
However, these conditions are frequently not fulfilled in real life. Figure 3-1 
is a semi-log plot o f the inactivation rate against contact time. The ideal 
first-order inactivation kinetic (exponential kill, curve A) can be affected by 
several environmental conditions (type o f organisms, medium, pH,
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temperature, biocide) causing a deviation from the linear relationship 
(Churn et al., 1984).
Figure 3-1. Inactivation curve o f virus caused by disinfectant action (Gyurek 
& Finch. 1998).
— A, Exponent 1*1 kill 
--- B, Shoulder ♦ Exponential kill 
"  C, Shoulder + Tellln^-off 
—* D, TaJllng-off
6 100 2 4 6
Contact time, min.
Different behaviours could occur. The “shoulder” effect (curves B and C) 
can be caused by an improper mixing, by a delay due to diffusion o f the 
disinfectant, by the necessity of multiple targets for the viral inactivation 
or/and the presence o f aggregates. The “tailing o f f ’ curve (D) describes a 
rapid initial inactivation followed by a decrease in the killing rate yielding 
to a complete lack o f activity. It can be attributed to an depletion o f the 
disinfectant concentration, or to the presence o f more resistant 
subpopulations caused by clumping or capsid conformational changes 
(Hoff, 2002).
Polyhexamethylene biguanide (PHMB) is a cationic antimicrobial agent 
used for over 40 years in the healthcare environment, food and water 
industries. Although its interaction with viruses has not been described, 
PHMB has been found active against HIV-1 (Krebs et al., 2005). Other
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biguanide derivatives were shown to be effective against polio, vaccinia and 
influenza viruses (Fara et a l 1974).
3.2. Aims
The aims of this chapter are to assess the effect o f VANTOCILIM TG and 
COSM OCIL im CQ on the viability of the phage FI 16 and MS2. The 
isothiazolinone-based biocide. PROXEL1 M was used as a comparative 
biocide.
Specifically:
• Verify the toxicity of a tween-based neutraliser on the tested 
microorganisms;
• Assess the neutraliser ability to quench the antimicrobial 
activity o f the PHMB-based and isothiazolinone-based 
biocides;
• Assess the virucidal activity o f the two PHMB-based and the 
isothiazolinone-based biocides against MS2 and FI 16.
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3.3. Materials and methods
3.3.1. Neutraliser tests
Prior to any virucidal activity tests, the neutraliser toxicity test on the 
organisms (hosts and phages) and the neutraliser efficiency test to measure 
the ability to quench the biocidal activity were performed. Measurement of 
pH of the phage-neutraliser mixture was taken after performing the serial 
dilution (pH meter. Hanna Instruments Sri. Padova, Italy).
3.3.1.1. Neutraliser toxicity test
One ml o f the overnight host cell suspension (107 CFU/ml) [see chapter 2, 
section 2.2J was mixed with 9 ml of neutraliser (6% w/v tween 80, 0.45% 
w/v lecithin, and 0.1% w/v L-histidine). After 10 min contact, 1 ml of 
sample was taken and serially diluted (10-fold). Five drops o f 10 pi o f three 
different dilutions were plated on agar in duplicate. Plates were then 
incubated for 24h at 37°C for Escherichia coli and 30°C for Pseudomonas 
aeruginosa. The reduction factor (RF) was calculated as Logio (CFU/ml 
initial inoculum) -  Logio (CFU/ml after exposure).
The procedure was similar with the phages. One ml of phage suspension 
[see chapter 2, section 2.3] and 9 ml of neutraliser were mixed together for 
10 min. Then 1 ml o f the sample was withdrawn and serially diluted (10- 
fold). Two dilution factors (in duplicate) were used to enumerate the phage 
concentration [see chapter 2, section 2.3]. The reduction factor (RF) was 
calculated as Logio (PFU/ml initial inoculum) -  Logio (PFU/ml after 
exposure).
3.3.1.2. Neutraliser efficacy test
This experiment was performed to assess the efficiency o f the neutraliser to 
halt the virucidal activity o f the biocides. Different relatives proportion of 
disinfectants and neutraliser (1/1 and 2/1) were used in this investigation to 
reflect the different experiments. The reduction factor (RF) was calculated. 
The pH was also measured.
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The biocide and neutraliser were mixed at ratios o f 1/1 (5 ml + 5 ml) and 
2/1 (8 ml + 4 ml). Then 1 ml o f the overnight bacterial host cell (107 
CFU/ml) was poured into the mixture and left for 10 min. One ml o f the 
experimental sample was taken and serially diluted (10-fold). Five drops of 
10 pi o f three different dilution factors were plated in duplicate, and 
incubated at the bacteria-specific temperature for 24h.
Regarding the bacteriophage, 1 ml of phage suspension (10 PFU/ml) was 
added to the mixture o f biocide and neutraliser at the relative proportions, 
1/1 (5 ml + 5 ml) and 2/1 (8 ml + 4 ml). After 10 min, 1 ml o f sample was 
serially diluted (10-fold). Two dilution factors were plated in duplicate to 
measure the PFU/ml [see chapter 2, section 2.3], Controls consisted of 
testing the microorganism with the neutraliser mixed with sterile water, 
instead of biocide. The reduction factor (RF) was calculated as Logio 
(CFU/ml or PFU/ml control) -  Logio (CFU/ml or PFU/ml after exposure).
3.3.2. Suspension test
The purpose o f the suspension test was to determine the virucidal activity o f 
the biocides against FI 16 and MS2. The pH was measured as described 
above.
Biocides were tested at 20°C. Four different contact times, 1, 5, 10 and 30 
min, were considered according to a previous study on biocide interaction 
with bacteriophages (Maillard, 2001). Testing contact times over 30 min 
would not be representative o f the use o f the biocide in the disinfection 
procedure.
One ml o f phage solution was added to 9 ml o f biocide, and after the 
appropriate contact time, 1 ml was added to 9 ml o f neutraliser. After 2 min 
contact, 1 ml o f sample was taken and serially diluted (10-fold). Two 
dilution factors were plated in duplicate to measure the surviving phages. 
Controls consisted o f testing the microorganisms against sterile water 
instead o f PHMB.
The reduction factor (RF) was calculated as Logio (PFU/ml control) -  Logio 
(PFU/ml after exposure). A decrease in concentration greater than 4 Logio
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was necessary to consider the biocide active against the virus, as defined in 
prEN: 13610 (CEN, 2002a).
3.3.3. Statistical analysis
Significant differences were assessed by ANOVA and t-test [see Chapter 2, 
section 2.6]. Pearson's correlation and determination factor were calculated 
between the survival ratio, ln(Nj/No), and contact time after each treatment 
(Statistica 7.0, StatSoft Inc, Tulsa, USA).
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3.4. Results
3.4.1. Neutraliser tests
3.4.1.1. Neutraliser toxicity test
3.4.1.l.a.Host culture
Escherichia coli and Pseudomonas aeruginosa (Table 3-2) were not 
affected by the neutraliser showing no significant differences in CFU/ml 
between the control and after treatment (E. coli: t-test, P>0.05; P. 
aeruginosa: t-test, I*>0.05).
Table 3-2. Neutraliser toxicity test against E. coli and P. aeruginosa.
CFU/ml before 
treatment ± sd
CFU/ml after 
treatment ± sd RF
E. coli 8.96 ±0.07 9.20 ± 0.20 0*
P. aeruginosa 9.18 ±0.28 9.17 ± 0.19 0.01 ±0 .24
* 0 means no reduction.
RF: reduction factor.
Data are expressed as Logio- Mean and standard deviation of three experiments.
3.4.1.l.b.Phages
The neutraliser was determined as not toxic to either MS2 or FI 16 (MS2: t- 
test, P>0.05; FI 16: t-test, P>0.05) (Table. 3-3).
Table. 3-3 Neutraliser toxicity test against MS2 and FI 16.
PFU/ml before PFU/ml after ^
treatment ± sd treatment ± sd
MS2 11.40 ± 0.00 11.38 ± 0 .29  0.01 ±0.28
FI 16 8.02 ± 0.63 8.39 ± 0.75 0*
* 0 means no reduction.
RF: reduction factor.
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Data are expressed as Logi0. Mean and standard deviation of three replicates.
3.4.1.2. Neutraliser efficacy test
3.4.1.2.a. Host culture
The neutraliser quenched efficiently the activity o f VANTOCILrM TG at 
both relatives proportion o f biocide and neutraliser against E. coli and P. 
aeruginosa (E. coli: ratio 1/1 ANOVA, F] 4=8.40, 7*>0.05; ratio 2/1
ANOVA. Fi 4=7.73. 7^0.05. P. aeruginosa: ratio 1/1 ANOVA, Fi 4=2.61,
/*>().05; ratio 2/1 ANOVA, F14=0.59, 7>>0.05).
COSMOC1Lim CQ activity was halted when the ratio of neutraliser/biocide 
was 1/1 {E. coli: ratio 1/1 ANOVA, F 1.4=0.64, 7^0.05. P. aeruginosa: ratio 
1/1 ANOVA, Fi.4=2.65, 7*>0.05) and against P. aeruginosa at ratio 2/1 
(ANOVA, Fi 4=0.37. 7^>0.05) (Table 3-4; Table 3-6). However at the ratio 
2/1, the number of surviving E. coli after the treatment was significantly 
higher (E. coli: ratio 2/1 ANOVA, Fi.4=8.55, P<0.05.). Since the increased 
number o f bacterial cell was low, these results were considered as natural 
variation among counts.
The neutraliser was also efficacious in stopping any bactericidal activity of 
PROXEL™ (E. coli: ratio 1/1 ANOVA, F M=0.39, 7>>0.05; ratio 2/1
ANOVA, F 1.4=0.61, P>0.05. P. aeruginosa: ratio 1/1 ANOVA, F 1.4=0.22,
7L>0.05; ratio 2/1 ANOVA, F M=0.37, 7^0.05) (Table 3-6).
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Table 3-4. N eutraliser efficacy  test on V A N T O C IL 1 M TG against E. coli
and P. aeruginosa.
VANTOCIL™ _Ratio pH
CFU/ml 
control ± sd
CFU/ml after 
treatment ± sd RF ± sd
1/1 6.82 ± 0.005 9.08 ±0.10 8.87 ±0.05 0.21 ±0.15
E. coli
2/1 6.81 ±0.01 9.04 ± 0.05 9.15 ±0 .07 0*
1/1 6.80 ± 0.005 9.63 ± 0.24 9.39 ± 0 .16 0.24 ± 0.22
P. aeruginosa
2/1 6.83 ± 0.005 9.47 ±0.10 9.54 ±0.17 0*
* 0 means no reduction.
The relatives proportion of biocide and neutraliser.
RF: reduction factor.
Data are expressed as Logi0. Mean and standard deviation of three replicates.
Table 3-5. Neutraliser efficacy test on COSMOCIL rM CQ against E. coli
and P. aeruginosa.
COSMOCIL™ Ratio pH
CFU/ml CFU/ml after RF ± sdCQ control ± sd treatment ±  sd
E. coli
1/1
2/1
6.85 ± 0.04 
6.90 ± 0.02
9.08 ±0 .10  
9.04 ± 0.05
9.03 ± 0.03 
9.13 ± 0 .04
0.04 ± 0.09 
0*
1/1 7.34 ± 0 .06 9.63 ± 0.24 9.40 ±0.15 0.24 ±0.21
P. aeruginosa
2/1 7.41 ±0 .08 9.47 ±0 .10 9.52 ±0.15 0*
* 0 means no reduction.
The relatives proportion of biocide and neutraliser.
RF: reduction factor.
Data are expressed as Logio- Mean and standard deviation of three replicates.
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Table 3-6. N eutraliser efficacy  test on PR O X E LTM  against E. coli and P.
aeruginosa.
PROXEL™ Ratio pH
CFU/ml 
control ± sd
CFU/ml after 
treatment ± sd RF ± sd
1/1 8.49 ± 0.06 9.78 ±0.54 9.79 ± 0.40 0*
E. coli
2/1 8.80 ± 0 .0 6 9.78 ±0.54 9.52 ±0 .88 0.26 ±0.33
1/1 8.66 ± 0 .1 9 10.07 ±0.03 10.03 ±0.05 0.04 ± 0.05
P. aeruginosa
2/1 8.78 ± 0 .02 10.42 ±0.23 10.42 ±0 .22 0.35 ± 0.26
*0 means no reduction
The relatives proportion of biocide and neutraliser.
RF: reduction factor.
Data are expressed as Log 10. Mean and standard deviation of three replicates.
3.4.1.2.b. Phages
The virucidal activity o f the two PHMB-based biocides was stopped 
effectively by the neutraliser (Table 3-7; Table 3-8) against both 
bacteriophages. MS2 (VANTOCIL™ TG: ratio 1/1 t-test, P>0.05; ratio 2/1 
t-test, T>0.05. COSMOCIL™  CQ: ratio 1/1 t-test, P>0.05; ratio 2/1 t-test, 
P>0,05) and FI 16 (VANTOCIL™  TG: ratio 1/1 t-test, P>0.05; ratio 2/1 t- 
test, />>0.05. COSMOCIL™  CQ: ratio 1/1 t-test, P>0.05; ratio 2/1 t-test, 
/>>0.05).
The neutraliser was also effective in halting any virucidal activity of 
PROXEL™ (Table 3-9). MS2 (ratio 1/1 t-test, P>0.05; ratio 2/1 t-test, 
P>0.05) and FI 16 (ratio t-test, P>0.05; ratio 2/1 t-test, P>0.05) did not show 
any significant reduction.
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Table 3-7. N eutraliser efficacy  test on V A N T O C IL IM TG against M S2 and
FI 16.
VANTOCIL™ Ratio pH PFU/ml before PFU/ml after RF ± sdTG treatment ± sd treatment ± sd
MS2
1/1
2/1
7.12 ±0.01 
7.22 ± 0.04
8.79 ± 1.50
8.79 ± 1.50
8.46 ± 1.82 
8.45 ± 1.77
0.33 ±0.33 
0.34 ± 0.34
FI 16
1/1
2/1
7.39 ± 0 .19  
7.49 ± 0 .16
11.17 ± 0.14
11.17 ± 0.14
10.71 ±0.63
10.71 ±0.81
0.23 ± 0.26 
0.29 ± 0.44
The relatives proportion of biocide and neutraliser.
RF: reduction factor.
Data are expressed as Logi0. Mean and standard deviation of three replicates.
Table 3-8. Neutraliser efficacy test 
FI 16.
on COSMOCIL™ CQ against MS2 and
COSMOCIL™
CQ Ratio pH
PFU/ml before 
treatment ± sd
PFU/ml after 
treatment ± sd RF ± sd
1/1 7.23 ± 0.07 7.90 ±0.27 7.60 ±0.35 0.31 ±0.31
MS2
2/1 7.25 ± 0.09 7.90 ±0.27 7.72 ± 0.30 0.18 ±0.04
1/1 7.55 ± 0.00 9.37 ±0.58 9.13 ±0 .77 0.24 ± 0.20
F116
2/1 7.63 ± 0.02 9.37 ±0.58 8.92 ± 0.93 0.45 ± 0.43
The relatives proportion of biocide and neutraliser.
RF: reduction factor.
Data are expressed as Logio- Mean and standard deviation of the three replicates.
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Table 3-9. N eutraliser efficacy  test on  P R O X E L 1 M against M S2 and FI 16.
PROXEL™ Ratio pH
PFU/ml before 
treatment ± sd
PFU/ml after 
treatment ± sd RF ± sd
1/1 8.63 ± 0.06 9.02 ±0.30 8.78 ±0.48 0.24 ±0.21
MS2
2/1 8.93 ± 0.06 9.02 ± 0.30 8.87 ±0.45 0.15 ± 0.16
1/1 8.59 ± 0.04 10.06 ±0.81 9.87 ± 1.03 0.19 ±0.28
FI 16
2/1 8.82 ±0 .13 10.06 ±0.81 9.89 ± 1.04 0.17 ±0.26
The relatives proportion of biocide and neutraliser.
RF: reduction factor.
Data are expressed as Log|0. Mean and standard deviation of three replicates.
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3.4.2. Suspension test
3.4.2.I. PHMB-based biocides -  VANTOCIL™ TG and 
COSMOCIL™ CQ
3.4.2.1.a.MS2
VANTOCIL™ TG. at 200 ppm. reduced the coliphage MS2 viability by 
approximately 90% (1 Logio reduction) (Table 3-10). The range o f Logio 
reduction varied from 0.14 to 2.02 Logio, and longer contact times did not 
increase the efficiency o f the biocide (ANOVA, Fj i6 = 0.03; P>0.05).
At 800 ppm, the biocide activity was still low (Table 3-11) and did not 
produce more than 2 Logio, with high variability among replicates. Contact 
time did not enhance the VANTOCIL™ TG efficacy (ANOVA, F i.I6 = 
0.71; T^O.05). The reduction factors at the two concentrations did not differ 
significantly (t-test, P>0.05), even though the figures appeared higher at 200 
ppm.
The coliphage resulted to be more resistant to COSMOCILrM CQ. At 200 
ppm its concentration was reduced by less that 90% after 1, 5 and 10 min 
contact time, whereas after 30 min the reduction was significantly higher 
than after the other treatment period (ANOVA, Fij6= lL 78 , P<0.05), but 
still lower than 1 Logio (Table 3-12). Increasing the concentration to 800 
ppm, the biocide was able to decrease the phage viability of 1.07 ± 0.30 
after 30 min, although the contact time was not influencing significantly the 
virucidal activity (ANOVA, Fi,i6=l .61, /*>0.05).
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Table 3-10. Suspension test results. VANTOCIL™ TG at a concentration of 
200 ppm against MS2.
VANTOCIL™ TG MS2
Contact time „  
(minute) ^
PFU/ml before 
treatment ± sd
PFU/ml after 
treatment ± sd Mean RF ± sd
1 7.91 ±0.03 
5 7.91 ±0.03 
10 7.91 ±0.03 
30 7.90 ± 0.05
8.77 ± 0.09
8.77 ± 0.09
8.77 ±0.09
8.77 ± 0.09
7.71 ±0.63
7.62 ± 0.54 
7.65 ±0.55
7.62 ± 0.60
1.06 ±0.61
1.15 ± 0.53 
1.12 ± 0.55
1.15 ±0.64
RF: reduction factor. Data 
five replicates.
are expressed as Logj0. Mean and standard deviation of
Table 3-11. Suspension test results. VANTOCIL™ TG at a concentration of 
800 ppm against MS2.
VANTOCIL™ TG MS2
Contact time H 
(minute) ^
PFU/ml before 
treatment ± sd
PFU/ml after 
treatment ± sd Mean RF ± sd
1 7.61 ±0.18 
5 7.64 ±0.21 
10 7.64 ±0.23 
30 7.64 ± 0.22
8.88 ±0.91
8.88 ±0.91
8.88 ±0.91
8.88 ±0.91
8.44 ± 1.30 
8.27 ± 1.16 
8.11 ± 1.22 
7.86 ±0.91
0.44 ± 0.67 
0.61 ± 0 .59  
0.77 ±0.85 
1.02 ±0.43
RF: reduction factor. Data are expressed as Logio- 
five replicates.
Mean and standard deviation of
Table 3-12. Suspension test results. COSMOCIL™ CQ at a concentration o f 
200 ppm against MS2.
COSMOCIL™ CQ MS2
Contact time „  
(minute) ^
PFU/ml before 
treatment ± sd
PFU/ml after 
treatment ± sd Mean RF ± sd
1 7.75 ±0 .13  
5 7.75 ± 0.09 
10 7.78 ± 0 .09  
30 7.74 ±0.11
9.73 ±0.61
9.73 ±0.61
9.73 ±0.61
9.73 ±0.61
9.75 ±0.51 
9.77 ± 0 .56  
9.62 ±0.53 
9.13 ±0.83
0*
0*
0.11 ± 0 .19  
0.60 ± 0.22
*0 means no reduction
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RF: reduction factor. Data are expressed as Log|0. Mean and standard deviation of 
five replicates.
Table 3-13. Suspension test results. COSMOCILfm CQ at a concentration of 
800 ppm against MS2.
COSMOCIL™ CQ MS2
Contact time 
(minute) pH
PFU/ml before 
treatment ± sd
PFU/ml after 
treatment ± sd Mean RF ± sd
1 7.58 ±0.16 8.17 ±0.46 7.63 ± 0.69 0.54 ±0.36
5 7.64 ±0.16 8.17 ±0.46 7.40 ± 0.45 0.77 ±0.45
10 7.69 ±0.15 8.17 ±0.46 7.40 ±0.52 0.77 ± 0.40
30 7.66 ±0 .10 8.17 ±0.46 7.10 ±0 .49 1.07 ±0 .30
RF: reduction factor. Data are expressed as Log!0. Mean and standard deviation of 
five replicates.
3.4.2.1.b. FI 16
The number o f viable FI 16 phage was not affected by VANTOCILrM TG at 
200 ppm (Table 3-14). The activity at different contact times did not differ 
(ANOVA; F| i6 = 0.56; P>0.05). In fact, longer contact time did not increase 
the efficacy o f VANTOCIL™ TG.
Raising the concentration o f the biocide to 800 ppm, the activity of 
VANTOCIL1 M TG increased greatly, even though 4 Logio reduction was 
not achieved (Table 3-15). The range of reduction factors varies from 1.53 
to 3.04 Log]o PFU/ml. The time of exposure did not increase the virucidal 
activity (ANOVA; F U6 = 0.69; P>0.05).
The other polyhexamethylene biguanide compound, COSMOCIL™ CQ, 
showed the same activity as VANTOCIL1 M TG. At 200 ppm the Logio 
reduction achieved varied from 0.45 Logio at 1 min contact time to 0.85 
Logio for the highest time o f exposure (Table 3-16).
At 800 ppm, FI 16 was more affected by the biocide which decreased its 
viability by 99 %. In fact, COSMOCIL[M CQ achieved a reduction factor of 
a minimum of 2.17 at 1 min to a maximum of 2.63 at 30 min (Table 3-17). 
At both concentration the contact time did not influence the reduction o f
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FI 16 (200 ppm: ANOVA; F,,j6 = 0.25; P>0.05. 800 ppm: ANOVA; F U6 = 
1.55; Z^O.05).
Table 3-14. Suspension test results. VANTOCILrM TG at a concentration of 
200 ppm against FI 16.
VANTOCIL1'1 TG F116
Contact time. . .  pH (min)
PFU/ml before 
treatment ± sd
PFU/ml after 
treatment ± sd Mean RF ± sd
1 8.02 ± 0.24 
5 8.01 ±0.15 
10 8.01 ± 0 .14  
30 8.00 ± 0 .10
10.08 ±0.66
9.61 ±0.98
9.61 ±0.98 
9.80 ±0.75
10.03 ±0.69  
9.67 ± 1.01 
9.75 ± 1.17 
9.95 ± 0.62
0.05 ± 0.22 
0* 
o*
0*
*0 means no reduction
RF: reduction factor. Data are expressed as Logi0. 
five replicates.
Mean and standard deviation of
Table 3-15. Suspension test results. VANTOCIL1M TG at a concentration of 
800 ppm against FI 16.
VANTOCIL™ TG F116
Contact time ¥I 
(min) PH
PFU/ml before 
treatment ± sd
PFU/ml after 
treatment ± sd Mean RF ± sd
1 7.67 ± 0.03 
5 7.70 ± 0.02 
10 7.73 ± 0 .04  
30 7.70 ± 0 .06
10.42 ±0.18
10.42 ±0.18
10.42 ±0.18
10.42 ±0.18
8.28 ±0.39  
8.05 ± 0.28 
8.04 ± 0.39 
7.89 ±0 .47
2.17 ±0.43
2.40 ± 0.29
2.40 ± 0.43 
2.56 ±0 .54
RF: reduction factor. Data are expressed as Logio- 
five replicates.
Mean and standard deviation of
Table 3-16. Suspension test results. COSMOCILrM CQ at a concentration of 
200 ppm against FI 16.
COSMOCIL™ CQ F116
Contact time . .  
t . . pH (mm)
PFU/ml before 
treatment ±  sd
PFU/ml after 
treatment ±  sd Mean RF ± sd
1 7.62 ±0 .17 9.81 ±0.48 9.35 ± 0.70 0.44 ± 0.45
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5 7.73 ±0.16 9.81 ± 0 .48
10 7.73 ±0.13 9.81 ±0 .48
30 7.73 ±0.15 9.81 ±0 .48
9.09 ± 0.94 0.72 ± 0.72
9.09 ± 1.04 0.72 ±0 .84
8.95 ± 1.08 0.86 ±0 .88
RF: reduction factor. Data are expressed as Log)0. Mean and standard deviation of 
Five replicates.
Table 3-17. Suspension test results. COSMOCILIM CQ at a concentration of 
800 ppm against FI 16.
COSMOCIL1'1 CQ F116
Contact time
/ • \ pH (min)
PFU/ml before 
treatment ±  sd
PFU/ml after 
treatment ± sd Mean RF ± sd
1 8.01 ±0.07 10.18 ±0.66 8.45 ± 0.77 1.73 ±0.40
5 8.00 ± 0.08 10.18 ±0.66 8.32 ±0.83 1.86 ±0.39
10 8.08 ± 0.03 10.18 ±0.66 8.02 ±0.85 2.16 ± 0.37
30 8.02 ± 0.03 10.18 ±0.66 7.99 ± 0.99 2.19 ±0.48
RF: reduction factor. Data are expressed as Logio. Mean and standard deviation of 
Five replicates.
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3.4.2.2. PROXEL™
3.4.2.2.a. MS2
PROXELIM was tested against MS2 at the highest in use concentration of 
400 ppm. It did not affect the coliphage concentration, resulting in no 
reduction at the different contact times tested (Table 3-18). There was no 
significant difference in reduction over time (ANOVA, F] ]6 = 0.59; 
P>0.05).
During some experiments, it was possible to see some increase in the 
number of virions compared to the control. These increases could have 
occurred as an expression o f replicate variability or as a consequence of 
aggregates breaking up by the tween-based neutraliser. The differences were 
not statistically significant (t-test, R>0.05).
Table 3-18. Suspension test results. PROXELIM at a concentration o f 400 
ppm against MS2.
PROXEL™ MS2
Contact time 
(min) pH
PFU/ml before 
treatment ± sd
PFU/ml after 
treatment ± sd Mean RF ± sd
1 7.81 ±0 .08 9.98 ± 0.90 10.00 ±0.88 0*
5 7.83 ± 0 .07 9.98 ± 0.90 10.13 ±0.66 0*
10 7.84 ± 0.08 9.98 ± 0.90 10.10 ± 1.08 0*
30 7.84 ± 0.03 9.98 ± 0.90 10.22 ±0 .92 0*
*0 means no reduction
RF: reduction factor. Data are expressed as Log|0. Mean and standard deviation of 
five replicates.
3.4.2.2.b. FI 16
The isothiazolinone PROXEL1M at 400 ppm was examined against the 
tailed phage FI 16. Results showed that the activity o f the biocide was low
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(Table 3-19). Increased contact time did not improve the efficacy of the 
compound against FI 16 (ANOVA, F] j 6 = 0.32; T^O.05).
Table 3-19. Suspension test results. PROXELIM at a concentration of 400 
ppm against FI 16.
PROXEL1'1 F116
Contact time 
(min) pH
PFU/ml before 
treatment ± sd
PFU/ml after 
treatment ±  sd Mean RF ± sd
1 7.95 ± 0.45 10.36 ±0.23 10.36 ±0 .22 0.00 ±0.19
5 8.07 ± 0 .33 10.36 ±0.23 10.30 ±0 .17 0.06 ±0.15
10 8.06 ± 0 .33 10.36 ±0.23 10.34 ± 0 .28 0.02 ± 0.24
30 8.05 ± 0.36 10.36 ±0.23 10.25 ± 0 .22 0.11 ±0.16
RF: reduction factor. Data are expressed as Log|0. Mean and standard deviation of 
five replicates.
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C hapter 3 -  PHM B efficacy against phages
3.4.3. Inactivation kinetics
3.4.3.I. PHMB
3.4.3.1.a. MS2
The disinfection kinetic curve plots the survival ratio (N]/No) against the 
contact time. The relationship between the inactivation rate and the time of 
exposure at the two different concentrations was not linear (Table 3-20) 
except the case of COSMOCIL™ CQ at 200 ppm. Treatment with 
VANTOCIL™ TG and COSMOCIL™ CQ against MS2 generally produced 
generally “tailing o f f ’ curves, indicating reducing activity as contact time 
increased (Figure 3-2).
Figure 3-2. Disinfection kinetics of MS2 treated with PHMB biocides at 200 
and 800 ppm.
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*
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C on tact tim e (min)
N(/No is the survival ratio, where Nj is the PFU/ml after the treatment; and N0 is 
PFU/ml before treatment.
V200: VANTOCIL™ TG at 200 ppm; V800: VANTOCIL™ TG at 800 ppm. 
C200: COSMOCIL™ CQ at 200 ppm; C800: COSMOCIL™ CQ at 800 ppm.
The error bars describe the standard deviation of 5 replicates.
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Fable 3-20. Linear regression analysis: Correlation coefficients for MS2 
inactivation. Treatment with VANTOCIL1M TG and COSMOCILIM CQ at 
200 ppm and 800 ppm.
Phage Treatment r R2 P
MS2 VANTOCIL™ TG 200 ppm -0.42 0.18 0.48
MS2 VANTOCIL™ TO 800 ppm -0.86 0.74 0.06
MS2 COSMOCIL™ C'Q at 200 ppm -0.98 0.96
MS2 COSMOCIL™ CQ at 800 ppm -0.80 0.65 0.10
3.4.3.l.b. FI 16
The treatment against tailed phage FI 16 showed a similar pattern to MS2 
(Figure 3-3. ). The decrease in the number of phage over time did not follow 
first-order kinetics (T>0.05 all cases; Iable 3-21); indeed after an initial 
decrease in FI 16 number, the inactivation curves reached a plateau where 
the biocide action ceased. VANTOCIL,M TG at 200 ppm showed some 
increase in PFU (Ni/N0 increasing); this is likely to represent experimental 
variation.
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C hapter 3 -  PHMB efficacy against phages
Figure 3-3. Disinfection kinetics of FI 16 treated with PHMB biocides at 
200 and 800 ppm.
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N|/N0 is the survival ratio, where Nj is the PFU/ml after the treatment; and N0 is 
PFU/ml before treatment.
V200: VANTOCIL™ TG at 200ppm; V800: VANTOCIL™ TG at 800ppm. C200: 
COSMOCIL™ CQ at 200 ppm; C800: COSMOCIL™ CQ at 800 ppm.
The error bars describe the standard deviation of 5 replicates.
Table 3-21. Linear regression analysis: Correlation coefficients for FI 16
*rw
inactivation kinetic curves. Treatment with VANTOCIL TG and 
COSMOCIL™ CQ at 200ppm and 800ppm.
Phage Treatment r R2 P
FI 16 VANTOCIL™ TG 200 ppm 0.86 0.74 0.06
FI 16 VANTOCIL™ TG 800 ppm -0.52 0.27 0.36
FI 16 COSMOCIL™ CQ at 200 ppm -0.71 0.51 0.18
FI 16 COSMOCIL™ CQ at 800 ppm -0.56 0.32 0.32
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Chapter 3 -  PHMB efficacy against phages
3.4.3.2. PROXEL™
PROXEL™ was found to be inactive against both bacteriophages even at 
long exposure time (Figure 3-4). No significant linear relation was found.
Figure 3-4 Disinfection kinetics for FI 16 and MS2 treated with PROXEL™ 
at 400 ppm.
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Ni/N0 is the survival ratio, where Ni is the PFU/ml after the treatment; and N0 is 
PFU/ml before treatment.
The error bars describe the standard deviation of 5 replicates.
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3.5. Discussion
The F-specific coliphage MS2 is used as a model of enteric viral behaviour 
and as an indicator of faecal pollution in environmental waters (Bichai & 
Barbeau. 2006; Ogorzaly & Gantzer. 2006; Clevenger et a l.  2007). since it 
is found frequently in sewage and in animal faeces, and similarly to human 
enteric viruses (noroviruses. polioviruses). it is well adapted to the intestinal 
tract (Dawson et al.. 2005).
MS2 is also used as a model to test biocide efficacy, because of its structural 
similarity and a comparable resistance profile to enteric and non-enveloped 
respiratory viruses (Jones et al.. 1991; Davies et al.. 1993; Koivunen & 
Heinonen-Tanski. 2005; Sickbert-Bennett et al.. 2005; Park et al., 2007). It 
has been used as a surrogate for clinically-important RNA non-enveloped 
viruses, such as picornaviridae and calciviridae. to evaluate the efficacy of 
hand hygiene agents (Sickbert-Bennett et al.. 2005).
Studies on the virucidal activity of PHMB-based biocides are very few. 
There are no reports on COSM OCIL im CQ. VANTOCIL™ TG tests against 
some mammalian viruses (foot & mouth disease virus, rotavirus and Polio 
type3) showed reduction factors less than 4 Logio (P. McGreechan, Arch 
Chemicals, personal communication), reflecting our suspension test results 
with MS2. The bis-biguanide Chlorhexidine showed the same efficacy as 
the PHMBs investigated here. It was able to inactivate 90% of the coliphage 
titre both in suspension tests (Maillard, 2001) and in carrier tests using glass 
slides and ceramic tiles (Woolwine & Gerberding, 1995).
The MS2 resistance observed here against PHMB-based biocides is in line 
with the literature reporting similar reduction in coliphage number (Davies 
et al.. 1993; Woolwine & Gerberding, 1995).
FI 16 instead was slightly more susceptible to the biocides (99% of 
reduction after 30 min) than MS2. In previous studies, chlorhexidine was 
found unable to inactivate FI 16 (Maillard, 2001), a result confirmed by the 
lack of damage o f the phage proteins (Maillard, 2001) and nucleic acid
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(Maillard, 2001). There are no other studies on virucidal activity against 
FI 16 by PHMB-based disinfectants or other compounds.
However, other biocides appeared to be more effective in inactivating FI 16. 
For instance, treatment with 0.001 % sodium hypochlorite for 30 sec and 
damaged severely the phage structure, inactivating FI 16 infectivity 
(Maillard, 2001).
As MS2 and FI 16 showed, the general trend demonstrated that the virucidal 
activity of the two PHMBs is low and that even while increasing the time o f 
exposure the inactivation rate of both phages remained unchanged. The 
main disinfection pattern observed was the “tailing o f f  curve, which has 
been well characterised during water disinfection (Sharp et al., 1975; Jensen 
et al.. 1980). It can be caused by depletion o f the active compound in the 
solution, or by the presence of resistant subpopulations due to 
conformational aspects or aggregate formation. Since the concentration of 
both biocides was in excess, aggregation or/and conformational 
impediments might be the possible reasons for the limited sensitivity. This 
will be further investigated by electron microscopy and hydrophobicity 
tests.
In conclusion, the two PHMB-based biocides, VANTOCILrM TG and 
COSMOCILIM CQ, showed low virucidal activity at 20°C with both model 
viruses, MS2 and FI 16. The lack o f interaction between the PHMB and the 
viral capsid may be the explanation for low activity. Another possible 
explanation can be extrapolated from the disinfection curve, which leads to 
the hypothesis o f clump formation. Aggregation could hinder dramatically 
the virucidal activity o f these biguanides limiting contact between viruses 
and biocides.
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4. STRUCTURAL DAMAGE
4.1. Introduction
Biocides can cause structural damage to viruses. Targets will differ 
according to biocide chemistry. Initial interactions can be based on covalent 
binding, or on ionic and hydrophobic forces (Lambert, 2004). Since capsid 
and genome are the major components of non-enveloped viruses (Kissmann 
et al., 2008), proteins and nucleic acids are then considered potential targets 
for a biocide.
The capsid is formed by proteins and it is in direct contact with the 
environment. It is likely that biocides such as hydrogen peroxide, 
glutaraldehyde and hypochlorite could induce damage, reacting with amino 
and sulphydryl groups (McDonnell & Russell, 1999). Specifically, 
aldehydes were found to react irreversibly with the amino groups by 
alkylation (Lambert, 2004). In fact, aldehyde-based products have been 
shown to posses virucidal activity against norovirus (Magulski et al., 2009) 
and poliovirus (Bailly et al., 1991) based on the interactions with the amino 
group o f the lysine residues on the capsid (Chambon et al., 1992; Chambon 
et al., 2004).
Oxidizing agents (peracetic acid and hydrogen peroxide) belong to another 
biocide category. They have a wide spectrum of activity among viruses 
(Sauerbrei et al., 2004a; Lombardi et al., 2008; Martin et al., 2008) and their 
action involves the oxidation o f N-H and S-H groups o f the capsid proteins 
(Lambert, 2004). Similar mechanisms of action were found during ozone 
disinfection, which caused inactivation o f the bacteriophage f2 (Kim et al., 
1980), norovirus (Hudson et al., 2007) and enteric virus (Roy et al., 1981) 
through peroxidation o f proteins (Murray et a l ,  2008).
The genome is the infectious part o f the virus and its contact with the 
biocide can occur only in the presence o f a broken head or through capsid 
permeability (Maillard, 2001). Several biocides appear to damage viral 
genome (RNA and DNA) (Maillard, 2001; Li et al., 2004), which is not, 
however, always correlated with complete viral inactivation. Chlorine 
dioxide, for instance, damaged poliovirus 1 genome, but genome analysis 
underestimated viral inactivation (Simonet & Gantzer, 2006). Sauerbrei et
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al. (2004b) showed that, even though the genome of some adenovirus 
serotypes was destroyed by 2.5% o f  liposomal povidone-iodine and by 0.5% 
peracetic acid, the degree of genome degradation was not comparable to the 
loss o f viral infectivity.
Among the diverse techniques employed to assess structural damage, SDS- 
page and nucleic acid agarose gel electrophoresis have been widely used 
(Churn et al., 1984; Maillard, 2001; Sauerbrei et al., 2004b; Sauerbrei et al.,
2007). In the last decade, in addition to the usual application in 
morphological studies (Chichon et al., 2009; Liu et al., 2009; Zhang et al., 
2009), electron microscopy has been used to understand the mechanisms of 
action of biocides against viruses by observing the magnitude and type of 
structural damage (Prince et a l ,  1993; Maillard et al., 1995; Wutzler & 
Sauerbrei, 2000).
Only a few studies have specifically involved the biguanide chlorhexidine. 
For example, SDS-PAGE electrophoresis suggested that no damage 
occurred to the protein capsid o f FI 16 exposed to the biguanide (Maillard, 
2001) and this result was in agreement with the lack o f inactivation 
measured in a suspension test (Maillard, 2001). In addition, studying the 
effect o f several biocides on the FI 16 genome, Maillard et al (2001) 
observed that while peracetic acids affected significantly the viral DNA, 
chlorhexidine did not.
Therefore, there is a need to further explore the interactions between 
PHMB-based biguanides and biological macromolecules. PROXELrM was 
not used anymore in the next investigations since the lack o f activity 
observed in the suspension tests (Chapter 3).
4.2. Aims
This chapter focuses on identifying the damage caused to phage structure 
following treatment with the two PHMB biocides, VANTOCILIM TG and 
COSMOCIL™ CQ.
The aims are to:
• Examine the nature o f damage by electron microscopy;
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• Study the possible alterations to phage proteins through sodium 
dodecyl sulphate polyacrylamide gel electrophoresis;
•  Investigate the interaction between viral genome (DNA) and PHMB.
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4.3. Materials and methods
4.3.1. Transmission electron microscopy
Transmission electron microscopy was used in an attempt to visualize any 
structural damage caused by the biocides.
One ml of concentrated phage stock (FI 16 and MS2 at 1011 PFU m l'1) [see 
Chapter 2] was treated with 1 ml o f biocide at 200 ppm and 800 ppm. After 
10 min exposure, 20 pi o f sample was mixed with 30 pi of 2% methylamine 
tungstate for 10 min. A drop o f the negatively stained phage was placed on a 
nickel- or copper-coated grid and left drying for 20 min. The excess liquid 
was removed with filter paper. The grid was examined in a Philips EM 
400T electron microscope operating at 80 kV accelerating voltage at a 
magnification of x28000-44000. The control consisted of MS2 or FI 16 
treated with distilled deionised water instead o f PHMBs.
4.3.2. Transmission electron microscopy -  purified MS2
Since purified MS2 was used during some assessments, comparisons of 
structural damage between purified and un-purified suspension were 
undertaken. Smaller volumes were used. The purified MS2 (0.1 ml) was 
mixed with 0.1 ml o f VANTOCIL™ TG and COSMOCIL™ CQ to achieve 
a final concentration o f 200 and 800 ppm. The control consisted o f using 
distilled water instead o f  the biocide. The protocol followed that described 
in section 4.3.1.
4.3.3. Protein analysis
4.3.3.1. Lowry method -  protein quantification
The Lowry procedure is a widely-used protein assay, first described by 
Lowry et al. (1951). Here, it was used to measure the quantity of phage 
proteins prior to protein electrophoresis.
The reagents used were: reagent A (2% w/v Na2CC>3 , 0.1 M NaOH); reagent 
B (0.5 w/v C uS04-5H20 ; 1% w/v Na2Tartrate-2H20 ); reagent C (50 ml o f A
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and 1 ml o f B); and 2N Folin-Ciocalteu reagent (50% w/v 2N Folin- 
Ciocalteu reagent) (Sigma, St. Louis, MO, USA).
After treatment with biocides [see 4.3.3.2.a], 200 pi o f the mixture was 
mixed with 1 ml o f reagent C and allowed to stand at room temperature in 
the dark for 20 min. 0.1 ml o f Folin-Ciocalteu reagent was added and left to 
react for 30 min at room temperature in the dark. The optical density (O.D.) 
was then measured at 750 nm against a blank, which consisted o f water and 
reagent C and Folin mixed following the same protocol used for the protein 
samples. The amount o f protein was calculated using a standard curve made 
from bovine serum albumin (BSA) (Acros Organics, Geel, Belgium) as 
follows: a stock solution o f BSA of 1 mg/ml was prepared. After mixing the 
Lowry reagents with different dilutions o f the BSA stock, the OD 750 was 
measured. A curve plotting protein concentration against the OD 750  
(calibration curve) was constructed (Figure 4-1).
Figure 4-1 BSA calibration curve.
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4.3.3.2. PhastSystem -  SDS-PAGE
The PhastSystem (Amersham Pharmacia Biotech AB, Buckinghamshire, 
UK) is a quick and highly reproducible technique to perform SDS-PAGE
y = 0.1463x 
R2 = 0.9678
0 0.2 0.4 0.6 0.8 1
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electrophoresis. It works with small pre-cast gels and it is able to detect 
small amounts of peptides and proteins (Scherberich et a l , 1989). 
Prospectively this system is appropriate to analyse protein yields from small 
particles such as bacteriophages and mammalian viruses.
4.3.3.2.a. Sample preparation -  pilot experiment
Concentrated stock o f FI 16 and MS2 [see Chapter 2] were used to perform 
the SDS-PAGE. A volume o f the phage suspension (0.375 ml) was mixed 
with 0.125 ml o f PHMB or PROXELrM to get a total volume of 0.5 ml. The 
PHMB concentrations tested were 200 and 800 ppm. Proxel at 400 ppm was 
used as a comparative biocide. The control was treated with deionised water 
instead of biocide.
After 5 min contact time, 0.2 ml was withdrawn to perform the Lowry 
titration and 0.3 ml was used for the following experiment. Cold acetone (- 
20°C) (1.2 ml) was added to the 0.3 ml o f sample and then incubated for 5 
hours at -20°C to precipitate the proteins. After centrifugation at 19000 xg  
for 15 min at 4°C, the pellet was air dried keeping the tubes open in the 
laminar flow cabinet for 10-15 min. The pellet was re-suspended in 20 pi o f 
sample buffer (0.125M Tris-HCl, pH 6.8, 20% v/v glycerol, 4% w/v SDS, 
10% v/v 2-mercaptoethanol, 0.005% w/v bromophenol blue) (Laemmli, 
1970), and boiled for 5 min. In order to precipitate any insoluble materials, a 
quick centrifugation (10 sec) was performed before loading 10 pi o f sample 
on the SDS-Polyacrylamide 20% homogeneous gel. Low range molecular 
weight marker (M.W. 6500-66000) (Sigma, St. Louis, MO, USA) was used, 
5 pi of the marker was directly loaded onto the gel.
4.3.3.2.b. Sample preparation -  refined experiment
In order to clarify the protein band profile on the gel [see Results], the 
purified MS2 suspension was used instead of the concentrated suspension 
[see Chapter 2]. PROXELIM was not tested further, because of the 
established lack of activity [Chapter 3] and damage [Section 4.4.3.2.b] to 
MS2. The protocol followed was according to section 4.3.3.2.a.
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4.3.3.2.C. Controls
Controls consisted o f the reacting mixture without the phage using the same 
protocol as for the phage suspension preparation [see Chapter 2]. 
Specifically, plates with 65% agar were inoculated only with the bacteria 
and incubated for 24 h. The upper layer was removed and centrifuged for 15 
min at 11000 x# at 4°C (Rotor JA25.50, Avanti J-25, Beckman Coulter, 
Fullerton, USA). After filtering the supernatant through 0.22 pm membrane 
filter, samples was prepared for the SDS-PAGE electrophoresis [see
4.3.3.2.a]. Only E. coli was used and only the two PHMBs were tested as 
biocides.
4.3.3.2.d. Gel preparation
SDS-Polyacrylamide 20% homogeneous gel (GE Healthcare Bio-Sciences 
AB, Uppsale, Sweden) was used, following the Separation Technique File 
No. 110 (Anonymous, 1986a). Silver staining according to Development 
Technique File No. 210 was used (Anonymous, 1986b).
4.3.4. Genome analysis
One o f the possible biocide targets is the genome o f the virus. Two different 
treatments were performed to assess the effect o f PHMB on phage DNA. 
The analysis was performed only with FI 16. Firstly entire phage particles 
were treated in a suspension test and then the phage DNA was extracted and 
the damage analysed, providing information on the ability o f PHMB to 
penetrate the capsid.
Secondly, extracted phage DNA was directly treated with the biocides in 
order to assess the potential interaction between PHMB and phage nucleic 
acid.
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4.3.4.I. Treatment of FI 16 with PHMBs
4.3.4.1.a. Phage treatment
Two ml of phage suspension (1010 PFU/ml of FI 16) was mixed with 2 ml o f 
PHMB. Distilled water was used as a control. After 5 min of contact time 
the mixture was centrifuged at 19000 xg  (J4-14 rotor, Beckman, Fullerton, 
USA) for 20 min at 15°C. The pellet was re-suspended with 1 ml o f ultra 
pure water. The sample was centrifuged again for 20 min at 13000 xg 
(MiniSpin, Eppendorf, Hamburg, Germany), and the pellet re-suspended 
with 200 pi of PBS buffer.
The DNA was extracted using QIAamp DNA Mini Kit (QIAGEN, West 
Sussex, UK) following the manufacture’s protocol for suspension samples. 
The DNA concentration was estimated by measuring the absorbance at 260 
nm (A26o), which is the peak of light adsorption for nucleic acids 
(Biophotometer, Eppendorf, Hamburg, Germany). Since DNA is associated 
with protein, the purity o f the extracted DNA is measured from the ratio of 
A 26o and A 2go, where A 2go is the absorbance at 280 nm where the protein 
peak light adsorption occurred. An A26o/A2go ratio between 1.7 and 2.0 
represents a high-quality DNA sample.
4.3.4.1.b. Restriction endonuclease and DNA digestion
Restriction endonucleases are enzymes able to cleave DNA at specific sites 
on each of the two sugar-phosphate backbones o f the double helix. Different 
endonucleases yield different sets o f cuts, but one endonuclease will always 
cut a particular base sequence the same way, no matter what DNA molecule 
it is acting on (Alberts et al., 2002).
The use of restriction endonucleases should generate nucleotide segments, 
increasing the possibility to detect alterations on the FI 16 genome caused 
by PHMB. The analysis was performed to investigate possible general 
damage to the genome; it was not focused on any specific sequence.
Two different endonucleases were used, Apa I (Sigma, St. Louis, MO, 
USA) and Hind III (Sigma, St. Louis, MO, USA). The tool NEBcutters 
V2.0 (Vincze et al., 2003) was used to find the restriction enzymes’ cut
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positions on the FI 16 genome. The complete FI 16 genome sequence was 
taken from the NCBI GenBank database (NCBI, 2009; accession number 
NC 006552). Table 4-1 summarises the characteristics of the two enzymes.
Table 4-1. Summary o f restriction endonuclease characteristics and cut 
positions on FI 16 DNA.
R estriction
endonuclease
R ecognition  sequences C ut position C utters
5 ' . . . G G G C C^C . . . 3 ' 7328/7324
Apa I
3 ' . . . C^C C G G G . . . 5 ' 46535/46531
2 cutters
▼ 19901/19905
Hind II
5 1 . . A A G C T T . . . 3'
32323/32327 3 cutters
3 ' . . . T T C G AaA . . . 5 ' 62757/62761
Restriction endonuclease cleavage is accomplished by incubating the 
enzyme with the DNA under appropriate reaction conditions. Hence, 20 pi 
o f extracted DNA (from 0.6 to 1.12 pg/ml) was mixed with 2 pi o f the ten­
fold concentrated restriction buffer (Sigma, St. Louis, MO, USA). The 
restriction endonuclease was added at a concentration o f 10 Unit/pg DNA. 
The mixture was then incubated for lh  at 37°C or 30°C with H indlll and 
Apa I respectively to allow the cleavage reaction to proceed. The reaction 
was halted by incubating the sample at 65°C for 10 min.
4.3.4.I.e. Electrophoresis
Gels for electrophoresis were prepared using agarose for routine use (Sigma, 
St. Louis, MO, USA). The 1% w/v agarose was prepared in Tris-borate- 
EDTA buffer with 0.033% v/v o f ethidium bromide. The gel tray was left to 
set and refrigerated until needed.
Ten pi o f DNA (from 0.6 to 1.12 pg/ml) extracted from each samples 
(which consisted o f the phage treated with VANTOCILIM TG and 
COSM OCIL1M CQ at 800 ppm and the control) were mixed with 5 pi o f 
running buffer (Sigma, St. Louis, MO, USA). Fifteen pi of samples and 10
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pi o f DNA ladder (Sigma, St. Louis, MO, USA) were added to the wells of 
the 1% agarose gel and the electrophoresis was performed at 80 V for 1 h 
using a PowerPac™ Basic power supply (Bio-Rad Laboratories Ltd, 
Hempstead, UK). The gel was then viewed under UV light using Bio-Rad 
Gel Doc 1000 and Bio-Rad Molecular Analyst software (Bio-Rad 
Laboratories Ltd, Hempstead, UK).
4.3.4.2. Treatment of FI 16 DNA with PHMBs
Twenty pi o f extracted DNA (from 0.4 to 0.9 pg/ml) was mixed directly 
with 20 pi of biocides to achieve a PHMB final concentration of 800 ppm. 
After 5 min the biocide activity was quenched adding 20 pi of neutraliser 
(see Chapter 2, section 2.1.2). 140 pi o f PBS buffer was added to give a 
final volume o f 200 pi as suggested by the manufacturer o f the extraction 
kit. The nucleic acid was extracted again using the QIAamp DNA Mini Kit 
(QIAGEN West Sussex, UK) and prepared for agarose electrophoresis [see
4.3.4. l.c].
4.3.5. Statistical analysis
Electron microscopy data were collected during the observation o f 30 
different fields/micrograph. Results were analysed by non parametric tests, 
y2 test using Statistica 7 software (StatSoft, Tulsa, USA).
SDS-page was repeated three times, whereas DNA analysis was performed 
twice.
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4.4. Results
4.4.1. Transmission electron microscopy
Electron microscopy was used to qualitatively measure damage caused to 
the phage following biocide treatment; electron microscopy observations 
cannot be linked to inactivation data (Maillard et a l , 1995).
In order to categorise the phage damage, representative samples of 150-200 
phages were randomly observed. Each observation was then placed in one 
of several different categories according to the structural damage. The 
categories for FI 16 were: intact phage (Figure 4-2A); head (Figure 4-3A); 
empty head (Figure 4-2D); tail (Figure 4-2B); collapsed head (Figure 4-2C); 
broken head (Figure 4-2B); broken head with tail (Figure 4-2B). MS2 
observation was separated into just two groups: intact phage (Figure 4-4A) 
and broken capsid (Figure 4-5B). Only 10 min exposure time was 
considered in the investigation, since contact time did not previously appear 
to affect significantly the efficacy of the biocides [see Chapter 2].
The untreated sample o f FI 16 comprised of mainly intact phages, 55.1%, 
and 20% of full heads with no tail. The presence o f heads without tails in 
the control might be caused by mechanical stresses during filtration o f the 
phage suspension to eliminate any debris and bacterial cells. Significant 
damage to the capsid after PHMB treatment was visible in the micrographs 
{% test, P<0.01) (Figure 4-2, Figure 4-3). The treated samples contained 
mostly empty heads, 37% and 49%, and a smaller amount o f broken heads, 
12% and 13%, for VANTOCIL™ TG and COSMOCIL™ CQ, respectively 
(Table 4-2).
Similar results to FI 16 were obtained with the coliphage. 99.2% of the 
control was the intact phage, whereas the amount o f broken capsid increased 
remarkably (x2 test, ^<0.01) to 58.9% and 28% after treatment with 
VANTOCIL™ TG and COSMOCIL™ CQ, respectively (Table 4-3).
In addition to capsid damage, aggregates were visible in the treated phage 
micrographs (Figure 4-3, Figure 4-5). This occurred mostly after treatment 
at 800 ppm and it was more noticeable with MS2 (Figure 4-5); aggregates of
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several viral particles, intact and damaged, were observed in 30 separate 
fields.
Figure 4-2. Micrographs of FI 16 treated with PHMBs at 200 ppm.
Broken
head
Collapsed
head
■PPPHHMIIii
■
Broken
head
Empty
head
C ondensed
genom e
D
A, FI 16 untreated; B and C, FI 16 treated with VANTOCIL™ TG; D, FI 16 treated 
with COSMOCIL™ CQ. These micrographs are representative of the observations 
from 30 separate fields. Arrows indicate FI 16 particles.
85
__
Chapter 4 -  Structural damage
Figure 4-3. Micrographs of FI 16 treated with PHMB at 800 ppm.
Broken head
A, FI 16 untreated; B, FI 16 treated with COSMOCIL™ CQ, aggregates are present 
with intact and broken heads; C and D, FI 16 treated with VANTOCIL™ TG, small 
aggregates with intact and broken heads are visible. These micrographs are 
representative of the observations from 30 separate fields. Arrows indicate FI 16 
particles.
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Figure 4-4 Micrographs of MS2 treated with PHMB at 200 ppm.
Broken MS2
A, MS2 untreated; B, MS2 treated with VANTOCIL™ TG; C, MS2 treated with 
COSMOCIL™ CQ. These micrographs are representative of the observations from 
30 separate fields. Arrows indicate MS2 particles.
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Figure 4-5 Micrographs of MS2 treated with PHMB at 800 ppm.
A, MS2 untreated; B and C, MS2 treated with VANTOCIL™ TG; D, MS2 treated 
with COSMOCIL™ CQ. Aggregates (arrows) and damaged phage (circles) are 
shown in pictures C and D. These micrographs are representative of the 
observations from 30 separate fields.
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Table 4-2. Electron microscopy investigations with FI 16 phages treated 
with VANTOCIL™ TG and COSMOCIL™ CQ at 800 ppm.
Phage aspect
Sample Intactphage Head
Empty
head Tail
Collapsed
head
Broken
head
oilm en
head + 
tail
Control 55.12 19.02 6.83 9.27 2.44 4.39 2.93
VANTOCIL™ TG 12.42 24.84 37.89 3.11 4.97 12.42 4.35
COSMOCIL™ CQ 13.25 15.89 49.01 7.95 0.66 13.25 0.00
The phage aspect is expressed as a proportion of the population viewed. 
Proportions are in %, taken from 205 control phages, 161 VANTOCIL™ TG 
treated phages, and 151 COSMOCIL™ CQ treated phages.
Table 4-3. Electron microscopy investigations with MS2 phages treated 
with VANTOCIL™ TG and COSMOCIL™ CQ at 800 ppm.
Phage aspect
Sample Intact phage Broken capsid
Control 99.2 0.8
VANTOCIL™ TG 4E1 58.9
COSMOCIL™ CQ 72 28
The phage aspect is expressed as a proportion of the population viewed. 
Proportions are in %, taken from 250 control phages, 124 VANTOCIL™ TG 
treated phages, and 168 COSMOCIL™ CQ treated phages.
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4.4.2. Transmission electron microscopy -  purified MS2
The untreated sample showed a preparation of the coliphage without any 
residual bacterial debris (Figure 4-6A). Unfortunately, when the samples 
were treated with PHMBs, it was impossible to observe clearly any phages 
in the micrographs. Furthermore, the micrographs were mostly black and it 
is likely that the cationic biocides reacted strongly with the negative stain.
TW
Only one observation of treated phage could be made (VANTOCIL TG at 
200 ppm) and few damaged phages were visible (Figure 4-6B). The 
assessment was performed twice, with the same result.
Figure 4-6. Micrographs o f purified MS2.
■ ABC1497
B
A, un-treated phage; B, MS2 treated with VANTOCIL™ TG at 200 ppm. Arrows 
show MS2. Circles show broken capsid.
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4.4.3. Protein analysis
4.4.3.1. F116
Contrary to MS2 [see section 4.4.3.2], it was not necessary to purify FI 16. 
The protein profile revealed approximately 15 bands consistent with other 
works (Byrne & Kropinski, 2005).
The quantity of protein loaded onto the gel was in the range of 0.4-0.8 
mg/ml and the protein pattern was highly reproducible (n=3).
Protein bands from FI 16 treated with VANTOCIL™ TG and 
COSMOCIL™ CQ at 200 ppm did not differ from the control (Figure 4-7 
A). On increasing the concentration of the PHMB to 800 ppm, the FI 16 
protein profile changed as some protein bands disappeared, particularly P I4 
and PI 5 (Byrne & Kropinski, 2005) of respectively 12.5 KDa and 7.5 KDa 
molecular weight (Figure 4-7 B).
The isothiazolinone at 400 ppm did not cause any damages to the proteins. 
Figure 4-7. Silver-stained SDS-PAGE gels of FI 16 protein.
A, VANTOCIL™ TG and COSMOCIL™ CQ at 200 ppm; B, VANTOCIL™ TG 
and COSMOCIL™ CQ at 800 ppm and PROXEL™ at 400 ppm at 20°C. 
Molecular weights are in KDa.
Arrows indicates proteins P I4 (12.5KDa) and P I5 (7.5 KDa) (Byrne & Kropinski, 
2005).
F I 16
control
Marker V2GCL C800 P400 V800
A B
91
O
n
 
'V
*
Chapter 4 -  Structural dam age
4.4.3.2. MS2
4.4.3.2.a. Controls
Controls consisted of analyzing the mixture without phage inoculation, in 
order to assess the background bands produced by the presence of bacterial 
debris. Even though protein patterns were highly inconsistent between the 
experiments (n=3), bands derived from bacterial residuals were always 
present (Figure 4-8).
Figure 4-8. SDS-PAGE o f mixture without phage. Treatment was performed 
with VANTOCIL™ TG and COSMOCIL™ CQ at 800ppm.
Marker
y
A B
4.4.3.2.b. Pilot experiment
The pilot experiment of SDS-PAGE with the coliphage MS2, revealed the 
necessity to purify the phage suspension (Figure 4-9). Gels with the un­
purified coliphage suspension were overloaded with bands derived from 
bacterial debris, making difficult detection of any alterations in the two 
protein bands comprising MS2, the coat protein and A protein (Kuzmanovic
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et a l 2006). Moreover, the reproducibility of the proteins profiles was not 
consistent.
Figure 4-9. Silver-stained SDS-PAGE gels of MS2 phages treated with 
VANTOCIL™ TG and COSMOCIL™ CQ at 200 and 800ppm and 
PROXEL™ at 400 ppm at 20°C.
MS2
Marker V 200ppm C 200 ppm control
. i / h i  .. j -. Ml, mm
P400 C800 V800
The phage suspension was not purified.
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4.4.3.2.C. Refined experiment
Figure 4-10 shows the protein analysis performed on the purified MS2. The 
protein pattern arising from the untreated phage (control; Figure 4-10) 
comprised of 3 main protein bands and was highly reproducible between 
experiments (n=3). The quantity o f protein loaded on the gel was between 
1.2 and 1.5 mg/ml.
The bands presented in the untreated sample corresponded to the coat 
protein (13.7 KDa) and A protein (44 KDa). The band at approximately 24 
KDa represented the coat protein homodimer (Kuzmanovic et al., 2006). 
PHMB treatment at 20°C did not alter the phage protein profile.
Figure 4-10. Silver-stained SDS-PAGE gels o f MS2 phages treated with 
VANTOCIL™ TG and COSMOCIL™ CQ at 200 ppm and 800 ppm at
20°C.
A
C800 C'200 V8Q0
m  ^
MS2
control
Marker
S * 6 6  KDa
3 m
 29 KDa
« » 2 4  KDa 
— 20 KDa
,— 14.2 KDa
The arrows indicate the two proteins which formed MS2, coat protein (13.7 KDa) 
and A protein (44 KDa).
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4.4.4. Genome analysis
4.4.4.I. Treatm ent of FI 16 with PHMBs
The DNA concentration was in the range of 20-70 fig/ml, and a high purity 
was achieved after the extraction (A260/A280 from 1.78 to 1.92). The 
experiment was performed twice, providing consistent results.
As Figure 4-11 shows, the restriction enzymes did not cut the nucleic acids 
as expected [see section 4.3.4.1.b]. Indeed the 3 or 4 segments expected 
following treatment with, respectively, Apal and Hindlll did not arise either 
for untreated or treated samples.
The treatment with the two PHMBs at 800 ppm altered the DNA profile, 
producing bands o f lower molecular weight on the agarose gel compared 
with the untreated sample (Figure 4-11).
Figure 4-11. Agarose gel o f DNA of FI 16 using two different 
endonucleases, Apal and Hindlll.
A p a l H ind
Control Cosmodl Vartocil 
Ladder _ v w t o d i  Control Condi
The PHMB treatment at 800 ppm was on the entire phage.
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4.4.4.2. Treatm ent of FI 16 DNA with PHMBs
The quantity of DNA treated directly with PHMB or water was in the range 
of 0.12-0.24 pg in 20 pi, with a purity of A26o/A28o= l-71-1.82. The results 
were consistent between the experiments (n=2).
PHMB did not show any activity against the nucleic acid. It did not alter the 
DNA pattern (Figure 4-12).
Figure 4-12. Agarose gel o f the DNA of FI 16.
D N A
ladder
F116 Coomocil
control 800ppm
Vantocll P ro x o l
800ppm 400ppm
10000 A8000 mm
4000
1000
The treatment was directly on the genome.
96
4.5. Discussion
This chapter investigated the interactions between the PHMBs and the 
protein and nucleic acid, macromolecules of the two phages.
The electron microscopy investigation showed a variety o f structural 
damage to FI 16 (Figure 4-2 and Figure 4-3). The proportion of intact 
phages (head + tail only) decreased from 51% (control) to 12-13% (treated). 
The damage, mostly observed after the treatment with VANTOCIL™ TG 
and COSMOCIL™ CQ at 800 ppm, resulted principally in empty heads. 
These findings suggested that PHMB might have a precise target on the 
capsid that leads to the release o f the genome. Whether this process was 
responsible for FI 16 inactivation is still to be verified. However, a 99% (2 
Logio) reduction in infectivity was observed in the suspension test after 
treatment with 800 ppm [see Chapter 3], which is higher than might be 
estimated from the structural damage observed under the electron 
microscope. Such discrepancy could be possibly explained by steric 
hindrance. In fact, the decreased infectivity could be also caused by an 
impediment o f the phage to interact with the specific receptor on the host 
membrane due to the attachment o f PHMB molecules to the FI 16 capsid. 
Moreover, visible structural changes might be a late manifestation of 
functional failure/damage which affects infectivity. These results are, 
however, partially in line with previous findings. Indeed, another biguanide- 
based biocide, chlorhexidine, was found to produce only small amount of 
damage to the FI 16 phage (Maillard et al., 1995), but in this case it was 
consistent with the low reduction factor measured in a suspension test 
(Maillard, 2001).
The first observation during the DNA analysis was the absence o f cleavage 
by the restriction enzymes (Figure 4-11). This might be explained by high 
FI 16 DNA methylation that impeded the action o f the enzymes (Kissmann 
et al., 2008). Secondly, both biocides interacted differently with the DNA 
according to whether or not the DNA was associated with the capsid. In 
fact, the migration o f the DNA bands on the agarose gel extracted from the 
treated phage appeared altered, possibly because o f a slight conformational
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change. Conversely, when the nucleic acid was treated directly with the 
PHMBs, no conformational alteration was observed (Figure 4-12). Allen et 
al. (Allen et al., 2006) analysed the interaction between PHMB and various 
nucleic acids (DNA, RNA, double and single strand). Interestingly, they 
found that the biocide bound cooperatively to the nucleic acids, causing 
precipitation o f the complex PHMB/DNA(RNA) but without damaging the 
integrity o f the macromolecule. These results appeared to conflict with the 
nucleic acid analysis, because if precipitation had occurred then higher 
molecular weight bands would be expected on the gel. In contrast, lower 
molecular weight bands were observed. It is likely that the association with 
phage proteins inhibited the complex formation and thus the precipitation. 
The SDS-PAGE o f the FI 16 phage gave approximately 15 bands (Figure 
4-7). The protein profile o f the phage treated with the biocides, when 
compared with the untreated, revealed an altered pattern only when 
VANTOCIL™ TG and COSMOCIL™ CQ were used at 800 ppm. Only 
two proteins, P14 and P I 5, resulted to be affected. P I5 has not been 
associated to a function yet, whereas P14 was identified as one o f the three 
virion structural proteins (Byrne & Kropinski, 2005). These findings might 
explain the structural damage observed, confirming the mechanism o f action 
as deduced from the electron microscopy investigation. Overall, these 
observations on FI 16 suggest that PHMB molecules, after breaking the 
capsid, enter the viral particle and interact with the DNA. A similar 
mechanism of action was also found between chlorine and poliovirus 
(O'Brien & Newman, 1979). In fact, the poliovirus RNA appeared to be 
sensitive to chlorine degradation only when associated with the capsid, and 
only then the release occurred.
Regarding the coliphage MS2, the electron microscopy investigations 
revealed damage to the capsid after the treatment with VANTOCIL™ TG 
and COSMOCIL™ CQ (50% and 28 % o f broken heads) (Figure 4-4 and 
Figure 4-5). The low amount o f damage probably reflects the low virucidal 
activity seen in the suspension tests [Chapter 3]. Moreover, the SDS-PAGE 
gels showed a lack o f damage to the capsid proteins (Figure 4-10). This 
investigation appears to contradict what found during the electron
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microscopy investigation (presence o f broken capsid). However, the 
reducing SDS-PAGE technique used 2-mercaptoethanol which reduces 
disulphide bonds, overcoming forms o f tertiary protein folding and breaking 
up quaternary protein structure (Hames, 2002). Therefore, any alterations 
detected are referred only to the primary sequence and structure. Another 
result revealed by the electron microscope images was the increased 
presence of aggregates as the concentration o f PHMB increased. Further 
investigation is needed to assess whether the MS2 clumping reflected a 
preparation artefact or a consequence o f the contact with the biocides. The 
latter could further explain the low virucidal activity, since aggregation 
could have hindered any activity (Sharp et al., 1975).
In conclusion, PHMB showed a different interaction with the two phages.
FI 16 appeared to be affected more by the biocides, which initially provoked 
capsid breakage allowing the PHMB inside the viral head. Secondly, an 
interaction with the DNA occurred, producing a possible a conformational 
alteration. Damage by PHMBs was also visible on MS2 capsid, but possibly 
modifying only the tertiary or quaternary structure o f the capsid proteins and 
not affecting the primary structure, as observed with FI 16.
Overall, the PHMB appeared to interact with proteins and DNA. Further 
studies about the nature o f the interactions need to be performed.
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5. PHAGE RESISTANCE TO PHMBs
5.1. Introduction
The virucidal activity o f biocides can vary depending on the type o f virus 
and the environmental conditions (Maillard, 2001). The presence o f organic 
load, contact time and temperature can alter greatly the interaction between 
the biocide and the virus (Russell, 2003) [see Chapter 1].
Viruses react differently with different biocides (Chambon et al., 1994; 
Sauerbrei et al., 2004a; Sauerbrei et al., 2004b). The only attempts to 
classify viruses based on their susceptibility to antimicrobial compounds 
were first performed in 1965 (Klein & Deforest, 1965) then modified in 
1983 (Klein & Deforest, 1983). They found that the presence o f the lipidic 
envelope was responsible for higher susceptibility; therefore “lipophilic” 
viruses (e.g. Herpes simplex virus) were considered more sensitive, 
especially to biocides such as cationic surfactants (e.g. QACs), 
chlorhexidine, isopropanol and chloroform.
Little is known about penetration of disinfectants into viruses. However, in a 
study by Maillard et al. (1995) about the mechanisms o f action of 
chlorhexidine diacetate and cetylpyridinium chloride against the 
bacteriophage FI 16, a positive relationship between the virucidal activity 
and the degree o f binding to the viral surface was observed.
Viruses show various forms o f resistance (McDonnel, 2007). Some are 
acquired mechanisms, such as genetic mutations and multiplicity 
reactivation. The latter was first described by Luria (1947) and consisted o f 
the exchange o f genetic material among viral particles, inactive and active, 
developing new infective particles. Other forms o f resistance associated 
with intrinsic viral features are related to their surface properties 
(McDonnel, 2007). pH and salt concentration, for instance, change the 
charge and therefore the hydrophobicity o f the virus (Thurman & Gerba, 
1988b). These properties can influence the viral distribution in a hydrophilic 
environment, inducing clump formation. Aggregation was found responsible 
for the low virucidal activity o f some biocides (Sharp et al., 1975; Jensen et 
al., 1980); more details on aggregation can be found in Chapter 1.
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The adaptation to new environmental conditions, such as prolonged contact 
with a biocide, has to be considered a further way to acquire resistance. In 
this context, it was observed that FI 16 was becoming more resistant to 
sodium hypochlorite (Maillard, 2001) after several exposures. Another 
study on acquired resistance showed that poliovirus gradually developed 
resistance to chlorine inactivation after repeated cycles o f sublethal 
exposure (Bates et al., 1977).
5.1.1. Temperature coefficient
Most disinfectants increase their activity with an increase in temperature. 
Their dependence on temperature can be expressed by the temperature 
coefficient per degree rise (0 ) or per 10°C rise (Qio)-
The relationship between temperature and biocide activity follows an 
Arrhenius-type dependency (Lambert, 2003):
kt = k20 x e <T'20)
Where KT is the disinfection rate constant at temperature T;
K20 is the disinfection rate constant at 20°C;
0  is the temperature coefficient per degree.
If the concentration is constant during the reaction, 0  is calculated as:
e <TrV = t,/t2
Where fi is the extinction time for a given population at temperature Tj 
t2 is the extinction time at temperature T2 .
Therefore the Qio value can be calculated as (Smith, 2004):
Qio = [Time to kill at Ti] / [Time to kill at (Ti+10)°C]
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Qio values for disinfectants vary from 1.5 for formaldehyde, between 3 and 
5 for phenols, between 30 and 50 for aliphatic alcohols (Bean, 1967), to 
almost 300 for ethylene glycol monoethyl ether (Smith, 2004).
5.2. Aims
Previous investigations [see Chapter 3] suggested that aggregation was a 
possible cause of the low virucidal activity of PHMB-based biocides. MS2 
was chosen as the model organism to test this hypothesis. This was studied
by:
• Comparing the surface properties o f MS2 after treatment;
• Assessing the effect of temperature, sonication and 
surfactants on the efficacy o f VANTOCIL™ TG and 
COSMOCIL™ CQ;
• Measuring the degree of clumping by dynamic light 
scattering following treatment.
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5.3. Materials and methods
5.3.1. Hydrophobicity tests
These tests measure the hydrophobic character o f the bacteriophage surface 
and how the presence o f the PHMB might influence that property.
5.3.1.1. Adsorption to lipids
The experiment is based on the original performed on animal viruses by 
Klein and Deforest (1983) and modified for bacteriophages by Maillard 
(2001). A 5% w/v cholesterol emulsion was prepared adding 0.01% v/v of 
Tween 80 to increase the lipid solubility. The suspension was kept at 4°C 
and used at room temperature during the experiments.
The biocide concentrations tested were 2, 20, 200 and 800 ppm. One ml of 
MS2 suspension (1010 PFU/ml) was mixed with 9 ml o f PHMB biocide or 
deionised water for the control. After 5 min contact time, 1 ml was mixed 
with 4 ml of the cholesterol emulsion. The mixture was constantly agitated 
at 150 RPM for 30 min at room temperature and then centrifuged twice for 
30 min at 5000 xg  at 20°C in order to separate the lipidic phase from the 
aqueous phase. The resultant phage content in the supernatant was measured 
by plaque formation. The experiment was repeated three times in duplicate. 
The percentage o f MS2 partitioned was calculated as: (PFU/ml adsorbed to 
the cholesterol in the control/ PFU/ml adsorbed to the cholesterol 
suspension after treatment) x 100.
5.3.1.2. Microbial adhesion to hydrocarbon
The microbial adhesion to hydrocarbon (MATH) method uses hydrocarbons 
to measure the hydrophobicity (Denyer et al., 1993) o f microorganisms. 
Hexadecane was utilised in this experiment. The biocide concentrations 
tested were 2 ppm, 20 ppm, 200 ppm, and 800 ppm.
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One ml of MS2 suspension (1010 PFU/ml) was mixed with 9 ml o f PHMB 
biocide or deionised water for the control for 5 min. Then 1 ml o f mixture 
was mixed with 0.2 ml o f hexadecane and held at room temperature for 10 
min. After 60 sec o f vortexing, the two phases were allowed to separate at 
room temperature for further 10 min. The amount of phage in the aqueous 
phase was measured. The experiment was repeated three times in duplicate. 
The percentage of MS2 partitioned was calculated as: (PFU/ml adsorbed to 
the hexadecane in the control / PFU/ml adsorbed to the hexadecane after the 
biocide treatment) x 100.
5.3.2. Dynamic light scattering
Dynamic light scattering (N4plus, Beckman Coulter, Fullerton, USA) was 
used to measure the size o f  the aggregates o f phage before and after PHMB 
treatment.
Purified virus suspension [see Chapter 2, section 2.5] was dialysed 
overnight against 0.25M KC1 and then filtered through 0.22 pm filter. Four 
different concentrations were tested, 2, 20, 200 and 800ppm at three 
different temperatures; 10°C, 20°C and 40°C.
Particle size measurement occurred after 5 minutes o f phage/biocide contact 
time, and ran for 200 sec and repeated in triplicate using a laser angle o f 90°. 
The mean of the 3 measurements was used to categorise the size of 
aggregates. Different size categories were chosen to simplify the reading of 
results. The threshold o f the smaller category size was chosen according to 
the theory of “the 16 particles aggregate”. This theory established that an 
aggregate formed o f 16 particles o f identical diameter is needed to capture 
one particle inside the aggregate, giving complete protection from the 
medium around (Thurman & Gerba, 1988a). In the case o f MS2 (diameter 
24 nm) the threshold calculated was 60 nm, with the assumption that 
aggregates are globular.
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5.3.3. Sonication treatment
In order to further investigate the existence of aggregation and its influence 
on the efficacy o f PHMB, sonication was used with the intention of 
breaking up aggregates. Sonication consisted of treating phages with 
ultrasound waves at a specific frequency and amplitude, which are not lethal 
to the virus. The waves separate the aggregates into single particles 
(Burleson et al., 1975).
Sonication treatment was added to the standard suspension test [see Chapter 
3, section 3.3.3] and lasted for the duration of the contact time. It was 
performed in a Soniprep 150 sonicator (MSE, London, UK) at 23 KHz and 
at a wave amplitude o f 10 pm. In addition, sonication was performed at two 
different temperatures; 10°C where the test vessel was kept in a water bath, 
and at room temperature. However in this case the temperature increased in 
the vessel to 30°C between 1 and 5 min and to 40°C between 10 and 30 min. 
Control tests were performed to check phage survival under such conditions 
without the presence o f  biocide. The pH and temperature were measured 
after the experiments.
5.3.4. Effect of temperature (Qio)
Suspension tests were performed at different temperatures, from 10°C to 
50°C with increments o f 10°C. The temperature was kept constant using a 
water bath, and the solutions were equilibrated at the precise temperature 
before starting the experiment. The suspension test was performed as 
described in Chapter 3 Section 3.3.3. pH and temperature were recorded. 
Controls were performed to check phage survival after exposure to the 
different temperatures. The experiments were repeated three times.
5.3.5. Formulations
Three formulations comprising VANTOCILIM TG (800 ppm) and a range 
o f surfactants at different concentrations were tested in a standard
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suspension test [see Chapter 3, section 3.3.3]. These formulations, labelled 
F I, F2, F3 (Arch Chemicals, Manchester, UK) are described in Table 5-1.
Table 5-1 Characteristics o f the three VANTOCIL™ TG-based 
formulations.
Formulation
code
Composition
FI (pH 4.20) DI water 67.37% 
VANTOCIL™ TG 25% 
Armeen 2MCD 5%* 
32% HC1 2.63%
F2 (pH 5.70) DI water 70% 
VANTOCIL™ TG 25% 
Neodol 23-6.5 5%*
F3 (pH 5.70) DI water 70% 
VANTOCIL™ TG 25% 
Synperonic 91/6 5%*
*Armeen 2MCD: Cocodimethylamine; Neodol 23-6.5: alcohol ethoxylate; 
Synperonic 91/6: Polyoxyethylene (6) C9-C11 alcohol
5.3.6. Suspension test -  Purified MS2
Since the purified MS2 has been used in several assessments, a suspension 
test using this phage preparation was performed. The two PHMB biocides 
were tested only at 800 ppm at the highest time o f exposure, 30 min. The 
protocol was as described in Chapter 2.
5.3.7. Protein analysis
SDS-PAGE was performed as described in Chapter 4 section 4.3.2. 
Treatment with PHMB was performed at 40°C.
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5.3.7.I. Eosin Y staining
In addition to the normal SDS-page, attachment of the biocides to phage 
proteins was measured qualitatively with a colourimetric assay based on the 
property of PHMB to change the pK o f certain indicators, such as Eosin Y 
(Gilbert & Moore, 2005). The protein separation was run in duplicate gels. 
One gel was silver stained, whereas the other was dyed with Eosin Y. The 
gel was first fixed in 7% v/v acetic acid for 10 min and then for another 20 
min in 50% v/v methanol. A washing step was performed for 20 min. The 
gel was finally soaked in 10% w/v sodium acetate (100 ml), 0.024% w/v 
Eosin Y (250 ml) and water (150 ml) (Gilbert & Moore, 2005), until pink 
bands were visible (1 to 3 h). A last step o f washing was performed to wash 
away all the dye not attached to the biocide.
Controls, which consisted o f PHMB mixed with deionised water (final 
concentration 200 ppm and 800 ppm) and processed through the cold 
acetone precipitation, were performed to assess the presence o f the biocide 
in solution after the SDS-PAGE protocol (negative control). No pink bands 
resulted, indicating that the free biocide in the medium (not attached to the 
virus) was washed out during the procedure.
5.3.8. Statistical analysis
The phage concentration measured in the controls was used to calculate the 
Log io reduction after treatment. Each suspension test was repeated three 
times in duplicate. Statistical analysis was performed using Statistica 7.0 
software (StatSoft Inc., Tulsa, USA). Any differences among results were 
analyzed by the parametric one-way ANOVA test. Where analysis showed 
significant differences a post-hoc Tukey test was used to underline which 
couple of variables produced the difference. Light scattering results were 
analyzed by the non parametric tests, %2 test and Kruskal-Wallis ANOVA.
A Pearson correlation coefficient was calculated for the inactivation kinetic 
curves at each treatment (sonication and temperature).
The Qio coefficient was calculated for each 10°C increment. A fitted line 
was drawn for each treatment temperature and the equation was used to
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extrapolate the time o f exposure required to achieve 4 Logio reduction. The 
estimated contact time was then used to calculate the Qio coefficient, as: 
time to kill at T2 / time to kill at T i.
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5.4. Results
5.4.1. Hydrophobicity tests
5.4.1.1. Cholesterol test
The treatment with PHMBs altered the hydrophobic properties of the 
coliphage. The MS2 partitioned in the lipidic (cholesterol) phase increasing 
significantly with concentration (Cholesterol test: VANTOCIL1 M TG 
ANOVA, Fi>8 = 7.4, P<0.05; COSMOCIL™ CQ, ANOVA, F,,8 = 162.1, 
P^O.OS). At 800 ppm the phage was found entirely (100%) in the 
hydrophobic phase (Figure 5-2). The negative results observed with lower 
concentrations of PHMB, might be explained by the addition of Tween 80 
in the cholesterol suspension. Tween 80 is a surfactant which might help 
disaggregation of clumps to produce a higher count.
Figure 5-1. Cholesterol test of VANTOCIL™ TG and COSMOCIL™ CQ 
against MS2. MS2 partitioning in the lipidic phase (cholesterol). Bars are 
standard deviation.
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5.4.I.2. MATH
The MATH confirmed the results achieved with the cholesterol test. The 
number o f phages recovered in the aqueous phase in the control was taken 
into account when the effect o f the biguanides on hydrophobicity was 
calculated. This number was considered as the number of phage prior to 
treatment. VANTOCIL™ TG and COSMOCIL™ CQ clearly modified the 
surface properties of the phage. The hydrophobicity increased significantly 
with increasing PHMB concentration: all of the phage particles were 
partitioned with the hydrocarbon (hexadecane) phase after treatment with 
both PHMBs at 800 ppm (MATH test: VANTOCIL™ TG, ANOVA, F,,8 =
146.4, P<f).05;COSMOCIL™ CQ, ANOVA, F,,8 = 32.6, P<0.05) (Figure
5-2).
Figure 5-2 MATH tests o f VANTOCIL™ TG and COSMOCIL™ CQ 
against MS2. MS2 partitioning in the hydrocarbon phase. Bars are standard 
deviation.
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5.4.2. Dynamic light scattering
Dynamic light scattering is a technique which determines the size 
distribution of particles in suspension. When a beam of light passes through 
a suspension, particles scatter light which is detected by a device. The 
detector measures the time-dependent fluctuations of the scattered intensity. 
These fluctuations arise from the random thermal (Brownian) motion of the 
particles, and the distance between them is therefore constantly varying. The 
time dependent fluctuations are then analysed to calculate the particle size 
distribution (Berne & Pecora, 1976). Here, to simplify the readings, 
arbitrary size range categories were used [see section 5.3.2]. Results were 
expressed as % of intensity which reflects the mean value o f the number of 
viral particles/aggregates within the size range taken on three separate 
readings.
Controls which represented the pre-treatment distribution of the phage in the 
medium (KC1), were mainly characterised by single phage particles (from 
Figure 5-3 to Figure 5-8).
At 10°C and 20°C as the concentration of VANTOCILIM TG (Figure 5-3 
and Figure 5-4) or COSMOCIL™ CQ (Figure 5-6 and Figure 5-7) 
increased, the size o f the particles/aggregates increased significantly (X  
test, .P<0.01). At 800 ppm, all MS2 particles were in aggregates o f a size 
into the micrometer range (Figure 5-3, Figure 5-4, Figure 5-6, and Figure 
5-7). When the treatment was performed at 40°C, the aggregates were much 
smaller than at 10°C and 20°C, their diameter being o f approximately 300 
nm (Figure 5-5 and Figure 5-8)
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Figure 5-3. Dynamic light scattering. MS2 treated with VANTOCIL™ TG 
at 10°C.
■ Control □ V2
□ V20 □ V200
■ V800
<60 nm 61-300 nm 301-500 nm 501-999 nm >1000 nm 
Size categories
Distribution of five size groups of MS2 aggregates as a function of the percentage 
intensity of the light scattered. V2: 2 ppm, V20: 20 ppm, V200: 200 ppm, V800: 
800 ppm.
Figure 5-4. Dynamic light scattering. MS2 treated with VANTOCIL™ TG 
at 20°C.
■ Control □ V2
□ V20 HV200
■ V800
<60 nm 61-300 nm 301-500 nm 501-999 nm >1000 nm
Size categories
Distribution of five size groups o f MS2 aggregates as a function of the percentage
intensity of the light scattered. V2: 2 ppm, V20: 20 ppm, V200: 200 ppm, V800:
800 ppm.
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Figure 5-5. Dynamic light scattering. MS2 treated with VANTOCIL™ TG 
at 40°C.
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Distribution of five size groups of MS2 aggregates as a function o f the percentage 
intensity of the light scattered. V2: 2 ppm, V20: 20 ppm, V200: 200 ppm, V800: 
800 ppm.
Figure 5-6. Dynamic light scattering. MS2 treated with COSMOCIL™ CQ 
at 10°C.
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Distribution of five size groups o f MS2 aggregates as a function of the percentage
intensity of the light scattered. C2: 2 ppm, C20: 20 ppm, C200: 200 ppm, C800:
800 ppm.
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Figure 5-7. Dynamic light scattering. MS2 treated with COSMOCIL™ CQ 
at 20°C.
.2> 50
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■ Control □ C2
□ C20 □ C200
■ C800
<60 nm 61 -300 nm 301 -500 nm 501 -999 nm 
Size categories
>1000 nm
Distribution of five size groups of MS2 aggregates as a function of the percentage 
intensity of the light scattered. C2: 2 ppm, C20: 20 ppm, C200: 200 ppm, C800: 
800 ppm.
Figure 5-8. Dynamic light scattering MS2 treated with COSMOCIL1 M CQ 
at 40°C.
■ Control □ C2
□ C20 ■ C200
■ C800
<60 nm 61-300 nm
Size categories
Distribution of five size groups of MS2 aggregates as a function of the percentage
intensity of the light scattered. C2: 2 ppm, C20: 20 ppm, C200: 200 ppm, C800:
800 ppm.
114
5.4.3. Suspension tests under different conditions
5.4.3.I. Sonication treatment
Sonication treatment did not kill the bacteriophage. However, a significant 
increase in number was observed (t-test, P>0.05) (Table 5-2). These results 
can be explained by the presence of small number o f aggregates in the 
phage suspension prior to the treatment, which were then broken up by the 
sonication. These revised baselines were taken in account when reduction 
factors were calculated.
fable 5-2 Effect o f sonication on phage survival without biocide.
Phage numbers (Logio PFU/ml)
Pre-sonication Post-sonication RF
10°C 9.38 ± 0 .32 9.80 ± 0 .5 7  0.42 ± 0 .1 6
30740°C 9.51 ± 0 .1 4  1Q .09± 0 .10  0.58 ± 0.08
Son 30740°C= constant sonication, sample temperature ranged from 30° to 40°C.
RF: Logio reduction after 30 min exposure.
Sonication was performed at two different temperatures 10°C and 
30°C/40°C [see Material and Methods] and affected the virucidal activity of 
the compounds. At 10°C, PHMB activity was still low (1-2 Logio). 
However, after 30 min o f exposure, VANTOCIL™ TG was more effective 
than the treatment without sonication, increasing significantly the reduction 
o f MS2 (ANOVA, F,.8=35.8, P>0.05) (Table 5-3). When the vessel was 
kept at room temperature, the sample temperature ranged from 30° to 40°C. 
The activity approximated 3 Logio reduction after 10 min o f exposure with 
both biocides, VANTOCIL™ TG and COSMOCIL™ CQ (Table 5-3), and 
contact time enhanced significantly the virucidal activity (VANTOCIL™
I G ANOVA F,,8=399.1, P<0.05; COSMOCIL™ CQ ANOVA F 18=219.7, 
P< 0.05).
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Table 5-3 Suspension tests o f VANTOCIL™ TG and COSMOCIL™ CQ at 
800 ppm with sonication.
RF
T(°C)
1
Contact time (min) 
5 10 30
VANTOCIL™ TG 10 0.37 ±0.24 0.36 ±0.20 0.58 ± 0.05 1.89 ±0.28
30/40* 0.82 ± 0.06 1.43 ±0.12 3.43 ±0.21 5.20 ±0.98
COSMOCIL™ CQ 10 0¥ 0¥ 0.93 ± 0.30 0.55 ±0.13
30/40 0.22 ±0.15 1.22 ± 0.11 2.74 ± 0.49 5.42 ±0.08
*temperature increased with duration of sonication: 30°C (1-5 min) and 40°C (10- 
30 min)
¥N o red u c tio n  o b se rv e d .
RF: Logio reduction factor. Values are the mean of three replicates.
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5.4.3.2. Temperature effect
The effect of temperature on coliphage survival was tested. No significant 
viral viability reduction was found; however at some temperatures, 
specifically 30°C and 40°C, significant increases in MS2 number was 
observed (Table 5-4). This can be explained by the presence o f some 
aggregates prior to the treatment which were eventually broken up by higher 
temperatures. In fact, at higher temperatures, the increased kinetic energy in 
the system can break electrostatic and hydrophobic bonds, responsible for 
the formation of the viral aggregates (Haynie, 2001).
Table 5-4. Effect o f temperature on phage survival without biocide.
Phage numbers (LogioPFU/ml) 
Pre-temperature Post- temperature
 treatment__________ treatment___________________
10°C 11.13 ± 0 .02  11.02 ±0.01 0.12 ±0 .02
20°C 10.80 ±0.01 10.60 ± 0.01 0.21 ± 0.01
30°C 9.86 ± 1 .0 9  10.11 ± 1.15 0.24 ± 0.24*
40°C 10.04 ± 0.38 10.33 ±0.52 0.29 ± 0.02*
50°C 10.98 ± 0 .03  10.51 ±0.01 0.47 ± 0 .04
* indicate a significant increase in MS2 concentration.
RF: Logio reduction after 30 min exposure.
Values are the mean of three replicates.
The virucidal activity o f VANTOCIL™ TG and COSMOCIL™ CQ at 800 
ppm was notably influenced by the temperature. Generally, an increase of 
activity was associated with a rise in temperature. At 20°C, 0.52 Logio 
reduction was achieved after 5 min contact time by VANTOCIL1 M TG, 
whereas at 30°C the reduction factor increased by 1 Logio (Table 5-5). 
Higher reductions in number were observed at 40°C, with 4 Logio after 10 
min for both PHMB biocides (Table 5-5).
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The efficacy of VANTOCIL™ TG virucidal activity increased significantly 
with time of exposure only at temperatures over 30°C (30°C ANOVA, 
F , .8 = 6 5 .9 , P<0.05; 40°C ANOVA, F u =199.8, P<0.05; 50°C ANOVA, 
F,.8=122.7, P<0.05).
The same result was found with COSMOCIL™ CQ, only at 30°C, 40°C and 
50°C There was a significant relationship between reductions and contact 
time (30°C ANOVA, F,.8=93.9, P<0.05; 40°C ANOVA, F,.8=24.4, P<0.05; 
50°C ANOVA, Fi.g=50.9, P<0.05). The activity o f the two PHMB-based 
biocides did not differ significantly (t-test, P>0.05).
Table 5-5. Suspension tests o f VANTOCIL™ TG and COSMOCIL™ CQ at 
800 ppm against MS2 at different temperatures.
RF
T(°C)
1
Contact time (min) 
5 10 30
VANTOCIL™
TG 10 0.43 ± 0.54 0.45 ± 0.28 0.50 ±0 .08 0.56 ±0.36
20 0.43 ± 0.34 0.52 ± 0.05 0.88 ± 0 .17 0.50 ± 0.02
30* 0.64 ± 0.09 1.39 ±0.09 1.46 ± 0 .10 2.76 ±0.34
40* 1.49 ±0.05 2.39 ±0.30 4.10 ± 0 .02 5.19 ± 0.30
50* 2.49 ±0.15 5.30 ±0.42 5.79 ± 0 .38 5.36 ±0.28
COSMOCIL™
CQ
10 0.40 ± 0.54 0.42 ± 0.26 0.12 ± 0.12 0.50 ± 0.24
20 0.54 ±0.36 0.76 ± 0.45 0.77 ± 0.40 1.07 ±0.30
30* 0.61 ± 0.05 1.75 ±0.31 2.39 ± 0.03 2.60 ± 0.03
40* 2.26 ± 0.29 3.04 ±0.63 3.56 ± 0 .24 4.79 ±0.09
50* 2.46 ±0.19 3.05 ±0 .37 3.92 ±0.41 5.33 ±0.16
* Significant relation between reduction factors and contact time. 
RF: Logio reduction factor. Values are the mean of three replicates.
Qio is the factor which describes the rate by which a reaction increases for 
every 10°C rise o f temperature. In disinfection practice, the rate represents 
the time to kill the same number of microorganisms at Ti and T]±10°C. Qio
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thus describes the biocide activity dependency on temperature. In these 
studies it was calculated with reference to the time needed to kill 4 Logio as 
predicted from the fit between reduction factor and contact time [see 
Material and Methods, Statistical analysis].
Qio values demonstrated the high influence o f temperature on 
VANTOCIL™ TG activity mostly between 20°C and 30°C (Table 5-6). 
COSMOCIL™ CQ activity was affected by temperature similarly, however 
a higher Qio was found between 10°C and 20°C rise. The highest value 
occurred again when the temperature rose from 20°C to 30°C (Table 5-6).
Table 5-6. Q ,0 o f VANTOCIL ™ TG and COSMOCIL™ CQ.
Qio
10°C/ 20°C/ 30°C/ 40°C/
20°C 30°C 40°C 50°C
VANTOCIL™ TG 1.1 3.9 2.0 1.2
COSMOCIL™ CQ 2.3 2.5 1.8 1.1
5.4.3.3. Formulations
Formulations are based on VANTOCIL™ TG combined with different 
surfactants [see Materials and Methods]. Their virucidal activity against 
MS2 was low, even after a long time of exposure (Table 5-7).
Table 5-7 Suspension test o f three formulations.
V A N T O C I L T G  
800ppm
RF
T(°C)
1
Contact time (min) 
5 10 30
FI 20 0.39 ±0.14 0.99 ±0.25 0.51 ±0.11 0.27 ±0.58
F2 20 0.10 ±0.08 0.00 ±0.15 0.87 ± 0 .17 0.88 ± 0.06
F3
' L ,
20 0¥ 0¥ 0.02 ± 0.29 0¥
RF: Logio reduction factor. Values are the mean of three replicates.
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5.4.3.4. Inactivation kinetic
Inactivation kinetic curves plot the survival ratio (Nj/No), where Ni is the 
viable count at time t and No is the viable count at time 0, against contact 
time. Efficient phage inactivation would ideally show a significant linear 
relationship for the full time course (first-order kinetics).
VANTOCIL™ TG achieved significant linearity at 30°C (r=-0.93, Z^O.OS), 
40°C (r=-0.88, P<0.05), and when sonication was used at 10°C: (r=-0.98, 
P<0.05) and at 30/40°C (r=-0.95, P<0.05) (Figure 5-9).
A linear relation was observed only during the treatment with sonication at 
room temperature when COSMOCIL™ CQ was used (r=-0.98, P<0.05) 
(Figure 5-10).
Figure 5-9. The efficacy o f VANTOCIL™ TG at 800 ppm against MS2 
established by suspension test.
0 5 10 15 20 25 30
0.0
- 2.0
■4.0
o
z
z
c
- 10.0
- 12.0
-14.0
-16.0
contact time-min
* significant Pearson coefficient.
Values are the mean of three replicates. Bars represent standard deviation.
Grey lines represent treatments with sonication while coloured lines represent 
treatment without sonication at different temperatures (from 10°C to 50°C).
V800T10 
V800 T20 
V800 T30*
V800 T40*
V800 T50 
V800 T10 son* 
V800 T30-40 son*
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Figure 5-10 The efficacy o f COSMOCIL1M CQ at 800 ppm against MS2 
established by suspension test.
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- 12.0
-14.0
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co n ta ct time - min
* significant Pearson coefficient.
Values are the mean of three replicates. Bars represent standard deviation.
Grey lines represent treatments with sonication while coloured lines represent 
treatment without sonication at different temperatures (from 10°C to 50°C).
5.4.3.5. Suspension test -  Purified MS2
TW
A further investigation on the virucidal activity of VANTOCIL TG and 
COSMOCIL™ CQ was performed using the purified MS2 as phage 
suspension. This preparation has been used in other assessments (SDS- 
PAGE, dynamic light scattering) and an analysis was needed in order to 
assess if any changes in activity occurred when the phage was purified from 
bacterial debris.
Using the purified phage suspension only had a minor effect on 
VANTOCIL™ TG (ANOVA, FM=25.98, P<0.05) and no effect on 
COSMOCIL™ CQ (ANOVA, F M=0.42, P>0.05) (Table 5-8).
C800T10 
C800 T20 
C800 T30 
C800 T40 
C800 T50 
C800T10son 
C800 T30-40 son *
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Table 5-8. Suspension tests results of purified MS2 treated with 
VANTOCIL™ TG and COSMOCIL™ CQ at 800 ppm.
T(°C) Purified MS2 RF
Un-purified MS2 
RF
VANTOCIL™ TG 20 1.20 ±0.24* 0.50 ±0.02*
COSMOCIL™ CQ 20 0.95 ± 0.06 1.07 ±0.30
* s ig n ific an tly  d iffe ren t.
T im e  o f  e x p o su re  w as  3 0  m in .
R F: red u c tio n  fac to r  e x p re s s e d  in L o g i0.
R e su lts  from  su sp e n s io n  te s ts  w ith  th e  u n -p u rifie d  p h ag e  a re  ta k en  f ro m  C h a p te r  2.
5.4.4. Protein analysis
The treatment with PHMBs at 40°C had an effect on the protein profile of 
MS2 (Figure 5-11); a new band o f approximately 40 KDa was visible after 
the treatment at both PHMB concentrations (200 and 800 ppm). In addition, 
a loss o f intensity of the coat protein band occurred.
The gel stained with Eosin Y was performed at both 20°C and 40°C. Results 
showed the presence o f PHMB on the phage capsid protein and the intensity 
increased with the concentration (Figure 5-12). At 20°C brighter pink bands 
were observed.
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Figure 5-11. SDS-PAGE gels o f MS2 phages treated with VANTOCILTM
TG and COSMOCIL™ CQ at 40°C.
/  * V 200 C200
C ontrol V 800 C800*
M arker fai _
, 6 6 ^ .  
145^ . 
!36 T ?
29 —  
24 ^
j20__
14.2 ^
x
\
/
w  '!
T h e  b lack  arrow s ind ica te  th e  tw o  p ro te in s  w hich  fo rm ed  M S 2 , c o a t p ro te in  
(1 3 .7 K D a) and  A  p ro te in  (4 4 K D a ), th e  red  arrow  in d ica te  the  n ew  b an d  (4 0 K D a). 
P ro te in s  s izes are in K D a.
Figure 5-12. Eosin Y stained SDS-PAGE gels of MS2 phages treated with 
VANTOCIL™ TG and COSMOCIL™ CQ.
MS2
C800 C200 V800 V200 control
C200 V200
C800 V800 Control
A B
T h e  p ink  bands rep rese n t th e  band  P H M B . A : trea tm e n t a t 20°C . B: trea tm e n t at 
40°C .
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5.5. Discussion
This chapter examines the possible importance of aggregation in reducing 
the virucidal activity o f the PHMB-based biocides, VANTOCIL™ TG and 
COSMOCIL™ CQ, against a non-enveloped virus. By testing the biocide in 
combination with temperature, sonication or surfactants, aggregation could 
be shown to be a relevant factor affecting the efficacy of the biocide. The 
role of aggregation in preventing virucidal activities is controversial. Some 
authors reported the role o f aggregation as a viral resistance mechanism to 
chemical biocides, such as bromine against reovirus (Sharp et al., 1975), 
and to physical agents, such as UV light against vaccinia virus (Sharp & 
Kim, 1966). Conversely, other authors concluded that aggregation did not 
influence the inactivation o f poliovirus I by chlorine (Sharp & Leong, 
1980) Some additional reasoning has been based on the use o f disinfection 
kinetics, which has been described to be analogous to a chemical reaction 
(Chick, 1913). Thus it has been postulated that to achieve an efficient 
inactivation of viruses the reaction should follow a first order kinetic. 
Differences in viral structure, biocides and environmental conditions will 
cause a deviation from first order kinetics. Observing the kinetic curves, a 
“tailing o f f ’ effect was visible mostly after treatment at 10°C, 20°C and 
50°C for VANTOCIL™ TG, and at all treatments except with sonication at 
room temperature for COSMOCIL™ CQ. The “tailing o ff’ shape is usually 
explained by biocide depletion or by the presence of a more resistant viral 
subpopulation due to aggregation, conformational change of the viral capsid 
or genetic variation (Hoff & Akin, 1986).
In this study, one o f the factors responsible for the departure from first-order 
kinetics in the case o f VANTOCIL™ TG inactivation against MS2 at 20°C 
appeared to be aggregation. A significant linear relationship was found after 
treatments at 30°C and 40°C and when clump sizes were measured to be at a 
maximum of 155 ± 11.5 nm. Presumed clump sizes were much smaller at 
higher temperatures than the ones measured at 10°C and at 20°C, where 
clumps were more than 1000 nm in size. PHMB treatment at 50°C did not 
produce a first order inactivation kinetic. However, it can be noted that the
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activity was fast and Logio reduction observed at this temperature was at the 
limit of detection o f the assay. Temperature also influenced also the activity 
o f COSMOCIL™ CQ, leading to a reduction in the aggregate size as 
temperature rose. However, a significant linear relationship was not 
observed.
Qio values for disinfectants, which describe the temperature effect, vary 
widely (4 for phenol, 45 for ethanol, 300 for ethylene glycol monoethyl 
ether) (Smith, 2004). VANTOCIL™ TG and COSMOCIL™ CQ exhibited 
temperature coefficients from 1.5 to 4, similar to those measured for PHMB 
bactericidal activity against E. coli (Broxton et al., 1983). The highest value 
was achieved at the temperature step o f 20°C/30°C for both biocides. 
VANTOCIL™ TG was the most affected by temperature, its activity 
increasing by a factor o f 4 from 20°c to 30°C. Modest variation in Qio over 
defined temperature ranges should be treated with caution given the wide 
range observed in different biocide classes. It appears likely that the 
temperature depending o f MS2 interaction is similar for both PHMBs. 
Sonication enhanced significantly the reduction o f phage number only at 
10°C over an exposure time o f 30 min with VANTOCIL™ TG, and after 10 
min with COSMOCIL™ CQ. Furthermore, significant first-order kinetics 
occurred when the biocides were tested in combination with sonication, 
which was used to enhance biocide efficacy presumably because o f its 
capacity for breaking up clumps (Burleson et al., 1975).
Formulations are often used to enhance the efficacy o f disinfection. The 
concept is based on a potentiating action, where the activity o f the 
compounds enhance each other (Jimenez & Chiang, 2006). Among 
surfactant properties, solubilisation ability is important, as well as their 
ability to break up microbial clumps. Here, the three surfactant-containing 
formulations did not increase the virucidal activity o f VANTOCIL™ TG. 
No evaluation was undertaken to see if  the added surfactants had any 
inhibitory effect on PHMB activity.
Temperature had a profound affect on the activity o f PHMB against a non­
enveloped virus. In addition to dispersing the viruses uniformly due to the 
thermal energy, temperature may also have altered the stability o f viral 
capsid. Such properties have been extensively studied for drug design,
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inactivation strategies for vaccine development, and for enhancement of 
antiviral activity (Newman et al., 2003; Ausar et a l , 2006; Hilmer et al., 
2008; Nelson et al., 2008a). For instance, temperature-induced changes 
occurred in the quaternary structure of Norwalk virus capsid, which were 
characterised by a loss o f continuity in the icosahedral geometry (Ausar et 
al., 2006). Canine parvovirus capsid responded to increased temperature by 
higher DNA exposure and by an increased permeability to negative stain 
(Nelson et al., 2008a). In this study raised temperature did not affect phage 
survival. However, it is possible that an increase in capsid permeability 
enhanced the penetration o f PHMB and thus increased and its virucidal 
activity in a temperature-dependent manner. Notably the Eosin Y stained gel 
showed a lower amount o f PHMB on the capsid after the treatment at 40°C, 
meaning that a possible penetration of VANTOCILIM TG and 
COSMOCIL™ CQ inside MS2 could have occurred.
In conclusion, aggregation appeared to account, at least in part, for the low 
virucidal activity of PHMB at 20°C. Raising the temperature o f disinfection 
had a significant role in enhancing the efficacy of the PHMB biocides, 
helping virion dispersion, as shown by light scattering, and possibly 
increasing virus susceptibility due to protein conformational changes.
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6. MAMMALIAN VIRUSES AND PHMBs
6.1. Introduction
Adenovirus was first isolated from adenoids of infected patients in 1953; 
since then more than 100 different species have been identified from 
reptiles, birds and mammals. Human adenoviruses are classified in 51 
serotypes (Russell, 2009) and cause respiratory infection, conjunctivitis and 
severe gastro-enteric dysentery. Adenovirus type 2 and 5 (group C) are the 
most studied and present all over the world (Rux & Burnett, 2004).
Control of viral contamination is important to prevent the spread of 
infections, especially in the hospital environment (Eterpi et al., 2009). 
Adenoviruses were found responsible for several nosocomial infections and 
outbreaks (Bruckova et al., 1980; Alpert et al., 1986; Hong et al., 2001). 
Furthermore, in recent years they have been considered relevant viral 
pathogens of immunocompromised patients. Adenoviruses groups A, B and 
C have been isolated from bone marrow and haematopoietic stem cell 
transplant recipients, and the serotype 5 was found to be often associated 
with respiratory manifestations and hepatitis (Echavarria, 2008).
For over 50 years adenoviruses have been used as models o f virus-cell 
interaction; currently their application is focused on gene therapy (cancer 
treatment, genetic disease, and vaccination) because o f their ability to infect 
a variety of non-dividing cells (Cusack, 2005). In addition, their use in 
studies on the virucidal properties of biocides against human virus has been 
widely recognized (Gaustad et al., 1974; Wichelhaus et al., 2006; Raffo et 
a l,  2007; Garcia-De-Lomas et al., 2008; Vieira et al., 2008). Specifically, 
adenovirus type 5 is considered as a reference virus (Sauerbrei et al., 2004b; 
Sauerbrei et al., 2007; Eterpi et al., 2009), since it has a higher resistance to 
biocides compared to other adenovirus strains of the groups C and D 
(Sauerbrei et a l,  2004a). In Europe it has also been recommended as a 
surrogate organism for testing disinfectants against human pathogenic 
viruses (German Association for the Control o f Virus Diseases, 1990; 
European Committee for Standardization, 1996; Fachausschuss 
"Virusdesinfektion" der Deutschen Vereinigung zur Bekampfung der 
Viruskrankheiten und des Robert Koch-Instituts, 2003). A detailed
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knowledge of its structure and infection cycle is available in the literature 
(Rexroad et a l 2003; Maheshwari et a l 2004; Rexroad et al., 2006; 
Russell, 2009), helping the mechanistic interpretation of the results. 
Investigations on the virucidal activity of PHMB-based biocides are very 
few. Recognising their reactivity with lipidic membranes, PHMBs are likely 
to interact with the viral cell membrane component. Indeed, it was found 
active against enveloped viruses, such as HIV (Krebs et al., 2005; Thakkar 
et al., 2009) and Herpes simplex virus (Valluri et al., 1997). Some 
substituted biguanides have antiviral properties against influenza virus 
grown in chick embryo (Pilcher et al., 1961). So far, however, their efficacy 
against non-enveloped viruses has not been tested.
This study was based on previous findings with the coliphage MS2 treated 
with PHMB-based biocides [Chapters 3 to 5], Ad5 was chosen as a 
reference virus, since its high resistance and its relevance among the 
clinically important viruses.
6.2. Aims
The chapter aims to investigate the virucidal activity o f VANTOCIL™ TG 
and COSMOCIL™ CQ against human Adenovirus type 5.
Specifically:
• To assess the virucidal activity of two PHMB-based biocides,
VANTOCIL™ TG and COSMOCIL™ CQ against the human 
adenovirus type 5 (Ad5);
• To investigate the structural damage of Ad5 caused by the PHMBs;
• To investigate the interactions between PHMBs and the Ad5 viral
particles.
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6.3. Materials and methods
6.3.1. Cell culture
6.3.1.1. Establishing 293T from frozen stock
293T cell stocks were kindly supplied by Dr. Carol Rickards, 
Cytomegalovirus and Adenovirus Research group, Cardiff University. Cells 
were rapidly thawed by briefly immersing the vial in a 37°C water bath (2-3 
min constant agitation). Upon thawing, the outside of the vial was 
immediately wiped with 70% ethanol, and after transferring the contents 
into a centrifuge tube (50 ml), 10 ml of complete growth medium (DMEM, 
10% v/v heat inactivated foetal bovine serum, 50 units/ml penicillin, 0.05 
mg/ml streptomycin and 0.1 mg/ml neomycin) was added gently (drop by 
drop, so as not to shock the cells). The mixture was centrifuged at 153 xg  
(Avanti J-14, Beckman Coulter, Fullerton, USA) for 10 min at 20°C. The 
supernatant was discarded and gently 20 ml o f complete medium was 
added. The content was then transferred to the flask. The culture was 
incubated in a 5% CO2 humidified incubator at 37°C.
Cell density was monitored daily. Cells were fed twice a week and usually 
split once a week when 50-60% confluent growth was reached.
6.3.I.2. 293T passaging
Cells were passaged when the monolayer reached 50% confluence. All 
media were pre-warmed to 37°C in a water bath. Growth medium was 
removed from the T75 flask (Coming Incorporated, NY, USA) and the cells 
were washed twice with 5 ml of PBS. Three ml o f trypsin-EDTA (0.53 mM 
EDTA, 0.05% w/v trypsin) was added and after a short shake, it was 
withdrawn immediately. The flask was then incubated in a 5% CO2 
incubator at 37°C for 1-2 min. After checking under the microscope (Leica 
inverse microscope, objective 10X) if the cells were sloughed off, 10 ml of 
new complete medium was poured into the flask to stop the trypsinization. 
The cell suspension was then transferred in a new T75 flask following the
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dilutions described in Table. 6-1. Cells were then placed in a 5% CO2 
incubator at 37°C and checked daily. The next passage occurred when cells 
reached 50% confluence.
Table. 6-1 Dilution factors and volumes used during cell 293T passage.
Dilution Media in 
fresh T75 
flask
Resuspension
media
Cell
suspension
aliquot
Total 
volume in 
T75 flask
1:2 15 10 5 20
1:4 17 10 3 20
1:8 18 10 2 20
1:10 18.4 10 1.6 20
V o lu m e s  are  in m l.
6.3.1.3. Frozen 293T cell preparation
After trypsinization [see section 6.3.1.2], cell suspensions were transferred 
in a centrifuge tube (50 ml). The cell were counted with an haemocytometer 
to DIN/ISO regulations double net ruling (Fisher Scientific, Leicestershire, 
UK) and then centrifuged at 153 xg  for 10 min at 20°C. The pellet was re­
suspended with the “freezing” medium (DMEM, 10% v/v heat inactivated 
foetal bovine serum, 50 units/ml penicillin, 0.05 mg/ml streptomycin and 
0.1 mg/ml neomycin, 10% v/v dimethyl sulfoxide) in order to get 2-5 x 106 
cells/ml. One ml was transferred into cryogenic vials (Coming, NY, USA) 
which were placed upright in a styrofoam box full o f cotton wool. The box 
was transferred to a -80°C freezer for 24 h and then vials were placed in a 
liquid nitrogen container.
6.3.2. Adenovirus type 5
6.3.2.1. Propagation
Adenovirus type 5 (Ad5) stocks were kindly supplied by Dr. Carol 
Rickards, Cytomegalovirus and Adenovirus Research group, Cardiff 
University.
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The growth medium was removed from the flask and 5 ml of pre-warmed 
serum-free medium was added. Cells were infected with 0.1 ml of the 
virus/cell suspension (multiplicity of infection 1-10 PFU/ml). The infected 
cells were incubated for lh  at 37°C to let the virus bind to the cells. Fifteen 
ml of complete growth medium was then added and incubation undertaken 
at 37°C under 5% CO2 until cytopathic effects were visible (usually 2-3 
days).
6.3.2.2. Viral extraction from infected cells
Infected cells were removed from the bottom of the flask with a scraper. 
The contents of the flask were withdrawn and transferred into a 50 ml 
centrifuge tube. A centrifugation step was performed at 345 xg for 5 
minutes at 20°C (Avanti J-14, Beckman Coulter, Fullerton, USA). After 
discarding the supernatant, the pellet was washed with PBS. All pellets were 
pooled into one tube and centrifuged again at 345 xg for 5 min.
The pellet was re-suspended in 1 ml per flask of PBS and an equal amount 
o f tetrachloroethylene was added. The mixture was then shaken vigorously 
in order to break up the cells to release the virus. A last centrifugation step 
at 345 xg for 5 min was performed to separate the 2 layers, the lower layer 
with the cell debris and the top one with the virus. The top layer was then 
removed and aliquots o f 1 ml were stored at -80°C in PBS.
6.3.2.3. Titration
Immunostaining was used to titrate Ad5. The protocol is based on Bewig & 
Schmidt (2000).
24 well-plates (Coming Incorporated, NY, USA) were seeded with 5x105 
cells/well in 2 ml o f complete growth medium and cells were allowed to 
adhere overnight. The complete medium was substituted by 0.5 ml of 
serum-free medium and 100 pi o f the diluted viral suspension (approx. from 
102 to 104 PFU/ml) was inoculated onto the well in duplicate. After 1 h of
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incubation at 37°C under 5% CO2 , 1 ml of complete medium was added to 
the wells. The plates were incubated for 48 h at 37°C in 5% CO2 .
When cytopathic effects were visible (after 48 h) the medium was aspirated 
and the wells were air dried. Gently 1 ml of ice cold 50/50 acetone/methanol 
was added and incubated at -20°C for 10 min. The acetone/methanol was 
aspirated and a wash step in 0.5 ml of PBS with 1% w/v BSA was repeated 
3 times.
The goat anti-adenovirus primary antibody (Millipore AB1056) was diluted 
1 in 5000 in PBS + 1% BSA and 0.5 ml was added to each well. The 24 
well-plates were incubated at 37°C in 5% CO2 for lh. The primary antibody 
was removed aspiring with the pipette and the cells were washed 3 times 
with 0.5 ml of PBS+1%BSA.
The secondary antibody (anti-goat hrp) (donkey anti goat/sheep IGG HRP, 
Millipore AB324P) was diluted 1 in 1000 in PBS + 1 %  BSA. 0.5 ml was 
inoculated into each well and then incubated at 37°C in 5% CO2 for lh. 
After removing with the pipette the secondary antibody, a further wash step 
in 0.5 ml o f PBS + 1%BSA repeated 3 times was performed.
The metal enhanced DAB (3,3' diaminobenzidine) substrate (PIERCE 
34065) was made up by diluting 10-fold the DAB/Metal concentrate by 
adding the peroxide buffer supplied with the kit. The 1X substrate solution 
was stable for several hours at 4°C.
500 pi of DAB substrate was added to each well and incubated for 10 min at 
room temperature (20°C). The DAB substrate was then removed and 0.5 ml 
of PBS was pipetted into the wells.
Using the inverse microscope (Leica, objective 10X and 20X) the number of 
infected cells (coloured purple/brown) were counted in 5 fields of view 
using an objective and a dilution that gave 5-50 positive cells (infected 
cells).
The PFU/ml was calculated as: [(infected cells per field) x (fields per well)] 
/ [volume virus (ml) x dilution factor]. The number o f fields per well was 
determined from Table 6-2. Objective 20x was usually used when 24-well 
plates were used.
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Table 6-2. N um ber o f  fields per well.
  Fields per well______
Objective 12-well 24-well 96-well
lenses plate plates plates
4x 19 10 1.6
5x 30 16 2.6
lOx 150 79 12.6
20x 594 313 50
6.3.3. Concentration and purification of adenovirus
6.3.3.I.a.Concentration of adenovirus type 5
The modified protocol previously described by Sambrock & Russel (2001) 
was applied to mammalian viruses. The viral solution prepared from a 
minimum of 8 flasks T162 (162 cm2) was mixed with 10% w/v of PEG 
8000 and NaCl (final concentration of 1M). The mixture was stirred and 
held at 4°C overnight. It was then centrifuged at 11000 xg for 30 min at 4°C 
(JA25-50 rotor, Avanti J-25 centrifuge, Beckman Coulter, Fullerton, USA). 
The precipitate was dissolved 1:10 in the initial volume of PBS and an equal 
volume o f chloroform was added to extract PEG and cell debris. A vortex 
step of 30 seconds was performed and then the mixture was centrifuged at 
3000 xg for 15 min at 4°C to separate the aqueous from the organic phase. 
The aqueous phase was recovered and used for isopycnic separation.
6.3.3.2. Isopycnic separation
0.5 g o f CsCl per ml of viral suspension was added. The different densities 
of CsCl were prepared using PBS as diluent.
Table 2-1 showed the characteristics of the CsCl solutions used. According 
to Ad5 buoyant density in CsCl, between 1.32 and 1.34 g m l'1 (International 
Committee on Taxonomy of Viruses, 2002), a 13.5 ml polyallomer 
centrifuge tube (Beckman Coulter, Fullerton, USA) was filled with 2.6 ml 
of the following densities of CsCl, p = 1.32 g m l'1, p = 1.45 g m l'1, p = 1.70 
g ml"1. A line was drawn outside the tube at the interface between p = 1.32 g 
m l'1 and p = 1.45 g m l'1.
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Table 6-3. Densities and respective concentrations of CsCl solutions 
prepared in 10ml o f SM buffer used during the experiments.
Density p (g/ml) M (g-mole/L) CsCl (g) PBS (ml)
1.32 2.49 4.20 8.93
1.45 3.60 6.00 8.50
1.70 5.65 9.50 7.50
F rom  S am b ro ck  &  R u sse l (2 0 0 1 ).
The virus suspension (5.2 ml) was layered on top of the gradient and then 
centrifuged at 200000 xg  for 8 h at 20°C (Vti 65 rotor, Optima LE-80K 
Ultracentrifuge, Beckman Coulter, Fullerton, USA). The band 
corresponding to the virus (in the p = 1.32 g m l'1 zone) was harvested by 
gently inserting a sterile needle to remove it. The infectivity was checked as 
described in section 6.3.2.3.
The purified virus was dialysed overnight (Spectra/Por Float-A-Lyzer, 
MWCO 3500 Da) against PBS and then filtered through 0.22 pm filter 
(Millipore, Cork, Ireland). Purified adenovirus was stored in aliquots o f 1 
ml at -80°C.
6.3.4. Preliminary cytotoxicity tests
The toxicity of PHMB molecules was tested against 293T cells. Various 
methods were tested to neutralize any cytopathic effects: i) use o f neutraliser 
A (6% Tween 80, 0.45% Lecithin and 0.1% L-Histidine); ii) use of 
neutraliser B (2% Tween 80, 0.45% Lecithin and 0.1% L-Histidine); iii) use 
of neutraliser C (6% Tween 80, 0.45% Lecithin and 0.1% L-Histidine in 
DMEM); iv) use o f AMICON ULTRA 0.5 10 KDa (Millipore, Billerica, 
USA).
The test with the various neutralisers consisted o f mixing 1 ml of growth 
medium with 9 ml o f VANTOCIL™ TG and COSMOCIL™ CQ at 200 and 
800 ppm for 5 min. Sterile water was used as the control. One ml of the 
mixture was mixed with 9 ml of neutraliser and after 2 min, a 10-fold 
dilution step was performed. Four dilutions were plated (1, 10, 10'2, 10'3) on
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cells seeded a day before on a 24-well plate. Specifically, the growth 
medium of the cells was replaced with 0.5 ml o f serum-free medium. A 
sample (diluted neutralised biocide) volume of 0.1 ml was inoculated into 
medium and after lh  incubation at 37°C under 5% CO2 , 1 ml of complete 
medium was added. Each dilution was plated in triplicate. Cytopathic 
effects were checked after 24 h, 48 h, and 72 h.
The experiment performed with the device AMICON ULTRA 0.5 10 KDa 
was carried out with and without the use of the neutraliser (6% Tween 80, 
0.45% Lecithin and 0.1% L-Histidine). One ml of growth medium was 
mixed with 9 ml of PHMB biocides at 800 ppm or water as control. After 5 
min, 1 ml of the mixture was mixed with 9 ml of neutraliser, when the 
neutralization step was included in the experiment. 0.5 ml was then loaded 
into the AMICON ULTRA 0.5 10 KDa in duplicate and a centrifugation 
step of 5 and 10 min at 14000 xg at 20°C was performed. The filter device 
was removed and placed upside down in a clean centrifuge tube and spun 
for 2 min at 1000 xg to recover the ultrafiltrate. The growth medium was 
removed from the wells with 5 x l0 5 cells seeded for 24 h the previous day 
and replaced with 0.5 ml o f serum-free medium. Cells were inoculated with 
0.1 ml o f the ultrafiltrate (undiluted and 10-folder diluted) in duplicate for 1 
h at 37°C in 5% CO2 . Then 1 ml of complete medium was added and 
cytopathic effects were checked after 24 h, 48 h, and 72 h.
6.3.5. Sephadex™ column system
In order to overcome the cytotoxicity of PHMB on 293T cells, a gel 
filtration methods using SephadexIM were also used (Geller et al., 2009). 
Gel filtration separates molecules according to their size through a gel 
packed in a column.
6.3.5.1. Preparation of Sephadex1M media
Sephadex™ G-25 comes in powder. It was re-suspended in 20 ml g"1 of 
PBS for at least 3 hours. The swelled gel was autoclaved. The volume
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achieved after swelling was 6 ml per g o f Sephadex™. After decanting the 
supernatant, the excess o f buffer was removed to obtain a suspension with a 
volume ratio of Sephadex™ G-25/PBS of 1/1. It was stored at 4°C.
6.3.5.2. Preparation of Sephadex™ columns
Columns were prepared with a 1 ml syringe packed with sterile (UV) cotton 
wool attached to a drilled 1.5 ml centrifuge tube. The syringe was filled with 
1 ml of sterile Sephadex™. The whole system was placed in a 50 ml 
centrifuge tube and centrifuged at 4500 xg  for 1 min. The centrifugation 
step was necessary to pack the column in the syringe and to eliminate the 
excess of PBS. After replacing the 1.5 ml centrifuge tube with the released 
buffer, the Sephadex™ column was ready to use.
6.3.5.3. Control experiments
Three different controls were performed:
- elimination of cytotoxicity against 293T cells;
- non-retention of Ad5 in the Sephadex™ column after filtration;
- neutralization of the potential virucidal activity o f PHMB.
Cytotoxicity tests were performed by mimicking the suspension test 
experiment without the use o f Ad5. 293T cells were seeded in a 24-well 
plate. After incubation at 37°C in 5% CO2 overnight, the medium was 
replaced with 0.5 ml o f serum-free medium and 0.1 ml o f the undiluted and 
10-fold diluted biocide solution filtered through the column [see section 
6.3.6]. Cells were incubated for lh  and then 1 ml of complete medium was 
added. The presence o f cytopathic effect was monitored at 24 h, 48 h and 72 
h.
The retention of virus in the column was assessed mixing 0.5 ml o f the viral 
suspension with sterile water for the defined contact time, and then filtered 
through the Sephadex™ column and titrated with the most probable number 
(MPN) assay explained in section 6.3.6. The reduction factor was calculated 
as Logio(MPN/ml before filtration) -  Logio(MPN/ml after filtration).
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The efficiency of neutralization of possible PHMB virucidal activity by the 
Sephadex™ column system was tested. 0.5 ml of the biocide solution at 800 
ppm or sterile water (control) was filtered through the column before mixing 
0.45 ml of these solutions with 50 pi of the viral suspension (104 PFU/ml). 
After 10 min contact time, viral titer was obtained as described in 6.3.2.3. 
The reduction factor was calculated as Logio(PFU/ml control) -  
Logio(PFU/ml after treatment). The reduction factor should not excess 0.5 
Logio as recommended by EN 14476+A1 (CEN, 2002b) to be considered 
effective.
6.3.6. Suspension test
The suspension test was performed at 20°C and 40°C, and repeated three 
times.
24 well-plates were seeded with 5x l05 cells/well in 2 ml of complete growth
'  n
medium and allowed to adhere overnight. 0.5 ml of Ad5 suspension (10 - 
108 PFU/ml) was mixed with 4.5 ml o f VANTOCIL™ TG and 
COSMOCIL™ CQ at 200 and 800 ppm. After the appropriate contact time 
(1, 5, 10 and 30 min), 0.5 ml o f the mixture was placed in the Sephadex™ 
column and centrifuged at 400 xg  for 1 min to separate the virus from the 
biocides. The mixture was further diluted 2 and 8 times after the treatment 
respectively at 200 and 800 ppm, in order to eliminate the cytotoxicity of 
PHMB on the 293T cells. The viral titer in the filtrate was then evaluated 
with the most probable number (MPN) assay. Specifically, the cell medium 
was replaced by 0.5 ml o f serum-free medium, and 0.1 ml o f the filtrate was 
inoculated. After an incubation period of lh  at 37°C under 5% CO2 , 1 ml of 
complete medium was added. Three 10-fold dilutions in 4 replicates were 
plated. Positive and negative wells for cytopathic effects were checked after 
48h and 72h. The number o f positive wells for each dilution factor was used 
to determine the most probable number o f organisms (causing the positive 
results) per unit volume. The software utilised for the MPN calculation was 
MPN Calculator VB6 version (Curiale, 2004). Reduction factors were 
calculated as MPN/ml control -  MPN/ml after treatment.
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6.3.7. Hydrophobicity test
6.3.7.1. MATH
The same protocol used with MS2 [see Chapter 5] was applied for Ad5. 
Hexadecane was utilised in this experiment. The biocide concentrations 
tested were 2 ppm, 20 ppm, 200 ppm, and 800 ppm.
0.5 ml of Ad5 suspension (108 PFU/ml) was mixed with 4.5 ml o f PHMB 
biocides or deionised water (control) for 5 min. Then 1 ml o f the mixture 
was mixed with 0.2 ml o f  hexadecane and hold at room temperature for 10 
min. After 60 sec o f vortexing, the two phases were allowed to separate at 
room temperature for 10 min. The amount of Ad5 in the aqueous phase was 
titrated with the immunostaining technique [see section 6.3.2.3]. The 
experiment was repeated three times in duplicate.
The percentage of Ad5 partitioned was calculated as: [(PFU/ml adsorbed to 
the hexadecane in the control / PFU/ml adsorbed to the hexadecane after the 
biocide treatment) x 100].
6.3.7.2. Cholesterol test
The experiment followed the same procedure o f that performed with the 
phage MS2 [see Chapter 5].
A 5% w/v cholesterol emulsion was prepared adding 0.01% v/v o f Tween 
80 to increase the lipid solubility. The suspension was kept at 4°C and used 
at room temperature during the experiments.
The biocide concentrations tested were 2 ppm, 20 ppm, 200 ppm, and 800
o
ppm. A volume o f adenovirus suspension (0.5 ml, 10 PFU/ml) was mixed 
with 4.5 ml of PHMB biocide or deionised water (control). After 5 min o f 
contact time, 1 ml was mixed with 4 ml o f the cholesterol emulsion. The 
mixture was constantly agitated at 150 RPM for 30 min at room temperature 
and then centrifuged twice for 30 min at 5000 xg  at 20°C (Mistral 1000, 
MSE, London, UK), in order to separate the lipidic phase from the aqueous 
phase. The resultant quantity o f virus in the supernatant was titrated through
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the immunostaining technique [see section6.3.2.3]. The experiment was 
repeated three times in duplicate.
The percentage o f Ad5 partitioned was calculated as: [(PFU/ml adsorbed to 
the cholesterol in the control/ PFU/ml adsorbed to the cholesterol 
suspension after the biocide treatment) x 100].
6.3.8. Dynamic light scattering
Dynamic light scattering (N4plus, Beckman Coulter, Fullerton, USA) was 
used to measure the size of the aggregates o f the virus before and after the 
treatment with the PHMB-based biocides [see Chapter 5]. The purified virus 
suspension [see section 6.3.3] was dialysed overnight against PBS and then 
filtered through 0.22 pm filter. Four different concentrations o f PHMBs 
were tested, 2, 20, 200 and 800 ppm at 10°C, 20°C and 40°C.
Dynamic light scattering measurement were run for 200 sec, repeated 3 
times using a laser angle of 90°. The mean o f the 3 measurements was used 
to categorise the size of aggregates. In order to simplify the reading, 
arbitrary size categories have been chosen. The threshold o f the smaller 
category size was selected according to the theory o f “the 16 particle 
aggregate”. This theory established that an aggregate formed o f 16 particles 
of identical diameter is needed to protect one particle, giving complete 
protection from the medium around (Thurman & Gerba, 1988a). In the case 
o f Ad5 (diameter 100 nm) the threshold calculated was 250 nm, with the 
assumption that aggregates are globular.
6.3.9. Protein analysis
The PhastSystem (Amersham Pharmacia Biotech AB, Buckinghamshire, 
UK) was used. The protocol used for MS2 [see Chapter 4, section 4.3.2] 
was applied to Ad5. Titration o f proteins was performed by the Lowry 
method [see Chapter 4, section 4.3.2.1]
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6.3.9.1. Sample preparation
The purified Ad5 in PBS [see section 6.3.3] was used to perform SDS- 
PAGE. A volume o f the viral suspension (0.375 ml) (107 PFU/ml) was 
mixed with 0.125 ml o f the PHMB biocide to get a total volume of 0.5 ml. 
The concentrations o f biocide tested were 200 and 800 ppm. The control 
was treated with deionised water instead of biocide.
After 5 min contact time, 0.2 ml was withdrawn to perform the Lowry 
titration and 0.3 ml was used for the ongoing experiment. Four volumes of 
cold acetone (-20°C) (1.2 ml) were added to the 0.3 ml of sample and then 
incubated overnight at -20°C to precipitate the proteins and to eliminate any 
acetone soluble interferences. After a centrifugation at 19000 xg for 15 min 
at 4°C, the supernatant was discharged and the sample was air dried. The 
pellet was re-suspended in 20 pi of 2x sample buffer, and boiled for 5 min. 
In order to precipitate any insoluble materials, a quick centrifugation (10 
sec) was performed before loading 10 pi of sample on the gel. Low range 
(MW 6500-66000) and a wide range (MW 6500-205000) molecular weight 
markers were used (Sigma, St. Louis, MO, USA). Five pi was directly 
loaded on the gel.
6.3.9.2. Gel preparation
SDS-Polyacrylamide 20% homogeneous gel (GE Healthcare Bio-Sciences 
AB, Uppsale, Sweden) was used, following the separation technique file 
No. 110 (Anonymous, 1986a). Silver staining development technique file 
No. 210 was used (Anonymous, 1986b).
6.3.9.3. Eosin Y staining
Attachment of PHMB to viral proteins was measured qualitatively with the 
colourimetric assay Eosin Y (Gilbert & Moore, 2005) which was used for 
MS2 [see Chapter 5, section 5.3.6.1]. The same sample which was used for 
the silver stained SDS-PAGE gel was processed through the Eosin Y 
procedure.
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6.3.10. Electron microscopy
A transmission electron microscope was used to investigate structural 
damage on the virus capsid caused by the PHMBs. Twenty pi of 
concentrated virus stock (1010 PFU ml"1) was treated with 20 pi of biocide to 
achieve a final concentration o f 200 and 800 ppm. The treatment was 
performed at 20°C. After 10 min exposure, the sample was mixed with 40 pi 
o f 2% methylamine tungstate for 15 min. Ten pi o f the negatively stained 
virus mix was placed on a nickel- or copper-coated grid and left drying for 
20 min. The excess liquid was removed with filter paper. The grid was 
examined in a Philips EM 400T electron microscope operating at 80 kV 
accelerating voltage at magnification o f X28000-44000. Control consisted 
o f Ad5 treated with deionised water instead o f PHMBs.
6.3.11. Statistical analysis
Suspension tests, hydrophobicity tests and the SDS-PAGE were repeated 
three times, whereas dynamic light scattering was performed twice. The 
electron microscopy was carried out on one sample, and 15 different fields 
were considered.
Statistical analysis was performed using Statistica 7.0 software (StatSoft 
Inc, Tulsa, USA). Statistical differences were tested through the analysis of 
variance (one-way ANOVA), and Tukey test was used as a post-hoc test. 
Light scattering results were analyzed by non parametric tests, y2 test. 
Pearson correlation coefficient was calculated for the inactivation kinetic 
curves.
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6.4. Results
6.4.1. Preliminary cytotoxicity tests
The use of three different neutralisers did not remove the toxicity of the 
PHMB compounds. In addition, the neutralisers were found to be toxic to 
the cells as well. Cytopathic effects were visible after 24h incubation (Table 
6-4).
The Amicon Ultra 0.5 10 KDa centrifugal filter devices provide fast 
ultrafiltration with a cut-off o f 10 KDa, enough to release PHMB molecules 
(2.5 to 3.1 KDa) but retain the virus (150-180 x 103 KDa). When the PHMB 
solution was inoculated on the cells after being filtrated through the device, 
the presence of cytotoxicity was observed after 24 h incubation. The same 
results were achieved with and without the use o f the neutraliser (Table 
6-4).
Table 6-4. Preliminary cytotoxicity tests results.
_____________ % cytopathic effects____________
24 h
VANTOCIL TG 
COSMOCIL™ CQ
V alu e s  a re  %  o f  w e lls  p re se n tin g  c y to p a th ic  e ffe c ts . R e su lts  re la tiv e  to  th e
u n d ilu ted  filtra te .
6.4.2. Sephadex™ column system
A further method was considered in order to eliminate the cytotoxicity of 
molecules tested. The method was based on SephadexIM column suggested 
by Geller et al (2009). SephadexrM is usually used in gel filtration. It is a 
bead-formed gel prepared by cross-linking dextran with epichlorohydrin. 
There are several types of Sephadex™ and the degree of cross-linking 
influences the extent to which macromolecules pass through. Sephadex™
Neutraliser Neutraliser Neutraliser
A B C  U, t r a_____________________     0.5
100__________100________ 100_______ 100
100 100 100 100
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G-25 has a fractionation range for globular proteins of 1000-5000 
molecular weight (GE Healthcare, 2009).
6.4.2.I. Controls
Three controls were undertaken prior to performing the actual suspension 
test: elimination o f the cytotoxicity o f PHMB molecules, the non-retention 
o f viral particles in the Sephadex1 M column and the neutralization efficacy 
of the Sephadex rM column.
PHMB molecules appear to be highly cytotoxic to the 293T cell line used to 
grow the Ad5 [see section 6.4.1]. Therefore the elimination of the 
cytotoxicity was essential in order to assess any virucidal activity of two 
PHMB-based biocides. The assessment was performed using 
VANTOCIL™ TG and COSMOCIL™ CQ at 100, 200 and 800 ppm. Only 
with the lowest concentration, 100 ppm, did the Sephadex1 column 
eliminated cytotoxicity, since no effects on the cells were visible after 72 h 
o f incubation (Table 6-5). Results were consistent along the experiments
(n=3).
Table 6-5. Cytotoxicity test results after filtration through SephadexrM 
columns.
___________ %  cytopathic effects___________
VANTOCIL™ TG COSMOCIL™ CQ
100
ppm
200
ppm
800
ppm
100
ppm
200
ppm
800
ppm
24h 0 100 100 0 25 100
48h 0 100 100 0 50 100
72h 0 100 100 0 100 100
V alu e s  in d ica te  th e  %  o f  w e lls  p re se n tin g  cy to p a th ic  e ffe c ts . R e su lts  re la tiv e  to  th e  
u n d ilu ted  filtra te .
The retention of Ad5 in the column was measured. The initial viral titre was
8 •approximately 10 PFU/ml. Reduction factors were calculated as the
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difference between the viral titre before and after the filtration through the 
Sephadex™ column. Reductions o f 0.37 ± 0.17, 0.15 ± 0.30, 0.05 ± 0.35, 
0.00 ± 0.28 for time of exposure o f 1, 5, 10 and 30 min were measured 
(Table 6-6). The contact time did not affect the retention of the virus in the 
column (ANOVA, Fi,8=0.72, P>0.05). Concluding, reductions of viral titre 
after filtering though the Sephadex™ column were not significant, even if 
aggregates were present. In fact, Sephadex™ column is based on gel 
filtration chromatography, therefore only molecules smaller than the pore 
size of the bead-formed gel (1000-5000 Da) are trapped inside the column. 
So viral aggregates (>100 KDa) leave the column even faster than 
individual particles.
Table 6-6. Non-retention test o f Ad5 by the Sephadex1 M column.
Contact Pre - Post - RFtime (min) MPN/ml MPN/ml
1 7.23 ±0.15 6.85 ±0.17 0.37 ± 0 .17
5 7.23 ±0.15 7.08 ± 0.29 0.15 ±0 .30
10 7.23 ±0.15 7.18 ±0.35 0.05 ± 0.35
30 7.23 ±0.15 7.23 ± 0.29 0.00 ±0.28
R F: red u c tio n  fac to rs  e x p re sse d  in  Logio 
V a lu e s  a re  th e  m e an  o f  th re e  re p lic a te s .
The last control performed was on the efficacy of the Sephadex™ column 
system to neutralise the activity o f PHMB. A 0.5 Logio difference between 
the viral titre before and after the treatment was considered the maximum 
value to accept the validity o f the system (EN 14476+A1, CEN, 2002b).
The reduction factors o f VANTOCIL™ TG and COSMOCIL™ CQ were 
0.13 ± 0.14 and 0.12 ± 0.13, respectively. Controls consisted o f mixing the 
Ad5 and the filtrate from previous filtrations containing only distilled water, 
instead of the biocides. The PFU/ml of control did not differ significantly 
from the PFU/ml o f the mixture of Ad5±filtrate from previous filtrations 
containing the PHMBs (t-test P>0.05). The reduction factors were less than 
0.5 Logio (Table 6-7), therefore the neutralization was considered valid.
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Table 6-7. Ad5 neu tralisation  efficacy test.
PFU/ml
control
PFU/ml
after RF
VANTOCIL1*1 TG 
COSMOCIL™ CQ
7.81 ± 0 .17
7.81 ± 0 .17
7.62 ±0.12 
7.69 ±0.12
0.09 ±0.12 
0.10 ± 0.12
T h e  b io c id es  c o n c en tra tio n  te s te d  w a s  8 0 0  ppm .
R F is reduc tion  fac to r. V a lu e s  a re  e x p re s se d  in Logio  an d  a re  th e  m ean  o f  th ree  
rep lica tes .
6.4.3. Virucidal activity -  suspension test
VANTOCIL™ TG and COSMOCIL™ CQ were tested at 200 and 800 ppm. 
The cytotoxicity tests showed that at 100 ppm PHMB toxicity against cells 
was not present. Such a concentration was not considered in the suspension 
tests for two reasons: 200 and 800 ppm are the manufacturer’s 
recommended concentrations and compare directly the results o f the human 
virus with the phage MS2. The treatment was also performed at 40°C as 
well as 20°C, since the higher virucidal activity observed with MS2 at raised 
temperatures [see Chapter 5]. In order to test the biocides at 200 and 800 
ppm without having cytotoxic effects, samples were diluted before 
inoculating 293 T cells to get a final PHMB concentration o f 100 ppm. 
Furthermore, as the Sephadex™ column system did not retain any viral 
particles [see 6.4.2.1], the reductions observed were considered result only 
o f the activity o f the two biocides.
VANTOCIL™ TG tested at 200 ppm at 20°C reduced the Ad5 titre by 
factors ranging from 0.41 to 1.06 Logio (Table 6-8) The contact time 
significantly influenced the activity (ANOVA, Fi,8=4.74, .P<0.05), 
specifically the efficacy at 5 min differed from 30 min (Tukey test, P<0.05). 
At 800 ppm, reductions of 1 Logio (90%) were achieved after 5, 10 and 30 
min contact. These reductions in viral concentration were significantly 
higher than following 1 min exposure (ANOVA, Fi^= 16.84, P<0.05) where 
no reduction was found (Table 6-8). Comparing 200 and 800 ppm results, 
the highest concentration significantly enhanced the virucidal activity only 
at the 10 min time exposure (t-test, F<0.05), whereas a significantly lower
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reduction was found after 1 min (t-test, P<0.05). Times of exposure of five 
and thirty min did not differ in activity (t-test, T>0.05).
COSMOCIL™ CQ was tested only at 30 min contact time. Reductions of 
0.03 ± 0.27 Logio and 1.33 ± 0.17 Logio were found respectively at 200 and 
800 ppm (Table 6-8). Comparing with VANTOCIL™ TG, a significant 
difference only occurred at 200 ppm (t-test, f<0.05). No further 
investigation on COSMOCIL™ CQ activity was considered, as it showed 
lack of activity at 200 ppm and an efficacy similar to VANTOCIL™ TG at 
800 ppm.
VANTOCIL™ TG was also tested at 40°C. Reductions of up to 1.74 Logio 
were observed (Table 6-8), and contact time did not affect the virucidal 
activity (ANOVA, Fi,8=2.69, P>0.05). A comparison o f the activity at 20°C 
showed that the higher temperature significantly enhanced the ability to kill 
Ad5 after 1 and 30 min of exposure (t-test, P<0.05) (Table 6-8).
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Table 6-8. Suspension test. A ctivity o f  V A N TO C IL™  TG and C O S M O C IL IM CQ against Ad5.
RF
VANTOCIL™ TG
T°C
20
40
Concentratio 
n (ppm)
200*
800¥
800
1
Contact time (min) 
5 10
0.41 ±0.14
0.09 ±0.14 
0.75 ±0.33
0.32 ± 0.47
1.06 ±0.20 
1.74 ±0.56
0.67 ±0.12
1.24 ±0.16 
1.09 ±0.60
30
1.06 ± 0.16
0.77 ±0.32 
1.42 ±0.22
COSMOCIL™ CQ 20 200
800
NT
NT
NT
NT
NT
NT
0.03 ±0.27 
1.33 ± 0.17
* S ig n if ica n t d iffe re n c e  b e tw e en  5 and  30  m in  co n ta c t tim e.
¥ S ig n if ica n t d iffe ren ce  b e tw e en  1 and  all o th e r  te s te d  c o n ta c t tim es.
R F: re d u c tio n  fac to r. V a lu e s  a re  ex p re ss  as Logio an d  are  th e  m ean  o f  th ree  rep lica tes . 
N T : n o t te s ted .
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C hapter 6 M am m alian virus and PHM Bs
Figure 6-1 shows the inactivation kinetics o f VANTOCIL™ TG tested at 
200 and 800 ppm and at two different temperatures, 20°C and 40°C.
Only the treatment at 20°C with a concentration o f 200 ppm achieved 
significant linearity (r=-0.91, P<0.05). No linear relationship was detected 
during the other two treatments. Furthermore, a high variability was 
observed at 40°C (Figure 6-1).
Figure 6-1. Inactivation kinetics for VANTOCIL™ TG at 200 and 800 ppm 
against Ad5 tested at 20°C and 40°C by suspension test.
2
1
0
20 251
-4
5 V200 T20*
• V800 720-6
• V800 T40■7
contact time - min
* s ig n ific an t P earson  co e ffic ien t.
V 200  T 20: 200  ppm  a t 20°C . V 8 0 0  T 20: 800 ppm  a t 20°C . V 8 0 0  T 40 : 800  ppm  at 
40°C.
V alu es are  the  m ean  o f  th ree  rep lica tes . B ars rep re se n t s ta n d a rd  d ev ia tio n .
6.4.4. Hydrophobicity test
6.4.4.I. MATH
Ad5 surface properties were altered by the presence o f the two biocides. The 
virus become more hydrophobic as the concentration of the PHMB 
increased (Figure 6-2). Regarding VANTOCIL ™ TG, at 200 and 800 ppm
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90% of the virus was found in the hydrocarbon phase, a significantly higher 
proportion compared to 2 and 20 ppm (ANOVA, F i?8=24.9, P<0.05). 
COSMOCIL™ CQ, instead, significantly changed the hydrophobicity of 
Ad5 after the treatment at 20 ppm (ANOVA, Fi 8=32.9, P<0.05).
Figure 6-2 MATH test of Ad5 treated with VANTOCIL™ TG and 
COSMOCIL™ CQ.
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80 
70
"S 60 
I  50
t= 40
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Q- 30 
■o 2 0
s o  1 0  
0 
-10 
-20 
-30
PHMB con cen tration  (ppm )
P ercen tag e  o f  A d5 p a rtitio n ed  in th e  h y d ro ca rb o n  phase .
V a lu es a re  the  m ean  o f  th ree  rep lica tes . B ars a re  s ta n d a rd  d ev ia tio n .
6.4.4.2. Cholesterol test
The cholesterol test confirmed what was already found with the MATH test. 
The hydrophobicity of the Ad5 surface increased significantly with the 
increasing PHMB concentration of VANTOCILIM TG (ANOVA, 
F,,8=103.8, /><0.05) and of COSMOCIL™ CQ (ANOVA, F,,8=9427.7, 
.P<0.05). The percentage of virus partitioned in the lipid phase was around 
100% following the treatment at 20 ppm (Figure 6-3).
93 9286
90
VANTOCIL TG 
COSMOCIL CQ
-13
200 800
-21
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Figure 6-3. Cholesterol test o f Ad5 treated with VANTOCIL™ TG and 
COSMOCIL™ CQ.
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P ercen tage o f  A d5 p artitio n ed  in th e  lip id ic ph ase  (c h o le s te ro l) . 
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6.4.5. Dynamic light scattering
Results of the dynamic light scattering showed an overall increase in the 
number of aggregates as the concentration of the PHMB increased. 
Controls, which described the distribution of adenovirus before the biocide 
treatment, consisted mostly of single particles (from Figure 5-3 to Figure 
6-9).
At the three different temperatures (10°C, 20°C, 40°C), the increasing 
VANTOCIL™ TG concentration increased significantly the number of 
clumps, comparing with the control (x2 test, Z^O.Ol). Interestingly, at 200 
ppm the aggregates size measured over a micrometer at all temperatures, 
decreasing at 800 ppm to 430 ± 94 nm at 10°C and 779 ± 25 nm at 20°C. At 
40°C, instead the clump size remained above one micrometer.
COSMOCIL™ CQ concentration also enhanced the size of aggregates at 
10°C, 20°C and 40°C (x2 test, P^O.Ol). Measurements up to a micrometer 
occurred at 2 and 20 ppm at 10°C, at 800 ppm at 20°C and at 20 ppm at 
40°C (Figure 6-7, Figure 6-8, Figure 6-9).
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Figure 6-4 Dynamic light scattering. Ad5 treated with VANTOCIL™ TG at 
10°C.
■ Control 
□ V20
■ V800
<250 nm 251-900 nm >1000 nm
size categories
D istribu tion  o f  th ree  size  g ro u p s  o f  A d5  ag g re g a te s  a s  a  fu n c tio n  o f  th e  percen tag e  
in tensity  o f  the light scattered . T h e  m a g n itu d e  o f  e a ch  h is to g ra m  is p ro p o rtio n a l to  
th e  percen tage o f  the  to ta l sc a tte red  in te n s ity  c a u se d  by  th e  p a rtic le s  o f  the  
co rresp o n d in g  g roup  size.
V 2: 2 ppm , V 20: 20 ppm , V 200 : 2 0 0  p pm , V 800 : 800  ppm .
Figure 6-5. Dynamic light scattering. Ad5 treated with VANTOCIL™ TG 
at 20°C.
■ Control □ V2
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size categories
D istribu tion  o f  th ree  s ize  g ro u p s  o f  A d5 ag g re g a te s  as a  fu n ctio n  o f  th e  percen tage  
in tensity  o f  the light sc a tte red . T h e  m a g n itu d e  o f  each  h is to g ram  is p ro p o rtio n a l to  
th e  p ercen tage o f  th e  to ta l sc a tte red  in ten sity  cau sed  by th e  p a rtic le s  o f  the 
c o rresp o n d in g  g roup  size.
V 2: 2 ppm , V 20: 20 ppm , V 200 : 2 0 0  p pm , V 800 : 800  ppm .
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Figure 6-6 Dynamic light scattering. Ad5 treated with VANTOCIL™ TG at 
40°C.
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D istrib u tio n  o f  th ree  s ize  g ro u p s  o f  A d5  a g g re g a te s  a s  a fu n c tio n  o f  th e  p e rc en ta g e  
in tensity  o f  th e  ligh t sca tte red . T h e  m a g n itu d e  o f  ea ch  h is to g ra m  is p ro p o rtio n a l to  
the  p ercen tag e  o f  th e  to ta l sc a tte red  in te n s ity  c a u se d  by  th e  p a r tic le s  o f  th e  
c o rre sp o n d in g  g ro u p  size.
V 2: 2 ppm , V 20: 20  pp m , V 200 : 2 0 0  ppm , V 8 0 0 : 8 0 0  ppm .
Figure 6-7. Dynamic light scattering. Ad5 treated with COSMOCIL™ CQ 
at 10°C.
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size categories
D istrib u tio n  o f  th ree  size g ro u p s  o f  A d 5  a g g re g a te s  as  a  fu n c tio n  o f  th e  p ercen tag e  
in ten sity  o f  the  ligh t scattered . T h e  m a g n itu d e  o f  each  h is to g ram  is p ro p o rtio n a l to 
the  p e rcen tag e  o f  the  to ta l sc a tte re d  in te n s ity  ca u se d  by th e  p a rtic le s  o f  the  
co rre sp o n d in g  g ro u p  size.
C 2: 2 ppm , C 20 : 20  ppm , C 200 : 2 0 0  p pm , C 800 : 800  ppm
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Figure 6-8 Dynamic light scattering. Ad5 treated with COSMOCIL™ CQ at 
20°C.
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D istribu tion  o f  th ree  s ize  g ro u p s  o f  A d5  a g g re g a te s  as  a  fu n c tio n  o f  th e  p e rc en ta g e  
in tensity  o f  the ligh t sca tte red . T h e  m a g n itu d e  o f  ea ch  h is to g ra m  is p ro p o rtio n a l to  
th e  pe rcen tag e  o f  th e  to ta l sc a tte red  in te n s ity  c a u se d  by  th e  p a r tic le s  o f  th e  
co rre sp o n d in g  g ro u p  size.
C 2: 2 ppm , C 20: 20  ppm , C 20 0 : 2 0 0  p p m , C 8 0 0 : 8 0 0  ppm
Figure 6-9 Dynamic light scattering. Ad5 treated with COSMOCIL™ CQ at 
40°C.
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D istrib u tio n  o f  th ree  s ize  g ro u p s  o f  A d5  ag g re g a te s  as  a  fu n c tio n  o f  th e  p ercen tag e  
in ten s ity  o f  the light sca tte red . T h e  m a g n itu d e  o f  each  h is to g ram  is p ro p o rtio n a l to  
th e  p e rc en ta g e  o f  th e  to ta l s c a tte re d  in te n s ity  ca u se d  by th e  p a rtic le s  o f  the  
c o rre sp o n d in g  g roup  size.
C 2: 2 p pm , C 20: 20  ppm , C 2 0 0 : 2 0 0  p pm , C 8 0 0 : 800  ppm
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6.4.6. Protein analysis
The SDS-PAGE analysis was performed after treatment at 20°C and 40°C. 
The Ad5 protein pattern was consistent during the replicates (n=3) at both 
temperatures. The amount o f proteins in the samples was in the range of 
0.07 to 0.2 mg/ml.
Fourteen bands were present in the control. After contact with 
VANTOCILIM TG at 200 ppm, the two lowest molecular weight bands 
disappeared. According to the Ad5 proteins profile, the band of 22 KDa 
corresponds to the minor coat protein VI (Rux & Burnett, 2004). whereas 
the one at 19KDa correspond to the core protein VII (Chatterjee et al. , 
1985). This profile was enhanced by treatment at a higher concentration, 
800 ppm. No differences were observed in the protein pattern between 20°C 
and 40°C (Figure 6-10).
The gel stained with the Eosin Y showed the PHMB attached to the viral 
capsid. The amount of PHMB on the capsid is higher when treated at 20°C 
(brighter pink bands). The intensity of the stain increased with the 
concentration of the active compound (Figure 6-11).
154
Chapter 6 M am m alian virus and PHMBs
Figure 6-10 SDS-PAGE of Ad5 treated with VANTOCIL™ TG and 
COSMOCIL™ CQ at 200 and 800 ppm. A. treatment at 20°C. B. treatment 
at 40°C.
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Figure 6-11. Eosin Y stained SDS-PAGE gels of Ad5 treated with 
VANTOCIL™ TG and COSMOCIL™ CQ at 200 and 800 ppm. A. 
treatment at 20°C. B. treatment at 40°C.
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6.4.7. Transmission electron microscopy
The electron microscopy investigation revealed a variety o f damage to the 
Ad5 capsid (Figure 6-12 and Figure 6-13).
Representative samples of 120-150 viruses were observed in 15 separate 
fields for each treatment. Each observed virus was placed into two 
categories, intact and broken. The un-treated sample was composed mainly 
of intact Ad5 (94%), whereas the PHMB treated samples showed 
significantly higher amount o f damaged particles (x test, .P<0.01) (Table 
6-9). 36% and 56% of broken capsid were observed after contact with 
VANTOCILIM TG at respectively 200 and 800 ppm. Similar results were 
obtained for COSMOCILrM CQ, 28% and 61% o f damaged viruses after 
treatement with 200 and 800 ppm of the biocide.
Various types of damages were observed in the micrographs. After PHMB 
treatment at 200 ppm broken capsid was the main damage visible (Figure 
6-12 C-D). Increasing the concentration of the active compound to 800 ppm, 
led to a collapsed head (
Figure 6-13 A-B) and precise breakage of the capsid (arrows in Figure 6-13 
A). Furthermore, genetic material outside the viral particle was observed 
(circles in Figure 6-13 B-C).
Table 6-9. Electron microscopy investigations with Ad5 treated with 
VANTOCIL™ TG and COSMOCIL™ CQ at 200 and 800 ppm.
Intact Broken
Control 94 6
V200 64 36
V800 44 56
C200 72 28
C800 39 61
Proportion are in percentage taken from 128 control viruses, 148 VANTOCIL™ 
TG 200 ppm treated viruses, 148 VANTOCIL™ TG 800 ppm treated viruses, 137 
COSMOCIL™ CQ 200 ppm treated viruses, 110 COSMOCIL™ CQ 800 ppm 
treated viruses.
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Figure 6-12. M icrographs o f  A d5 treated  w ith PH M B s at 200 ppm.
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A-B) Ad5 untreated. C) Ad5 treated with VANTOCIL™ TG. D) Ad5 treated with 
COSMOCIL™ CQ. Arrows in figure C indicate damage capsid. These 
micrographs are representative of observations from 15 separate fields.
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Figure 6-13. Micrographs o f  Ad5 treated with PHMB at 800 ppm.
B C
A-B) Ad5 treated with VANTOCIL™ TG. C) Ad5 treated with COSMOCIL™ 
CQ. Arrows in figure A and C indicate precise damage of capsid, circles indicate 
collapsed capsid (A-B) and the released genetic materials (B-C) These micrographs 
are representative of observation from 15 separate fields.
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6.5. Discussion
This chapter investigated the virucidal activity of PHMB-based biocides 
against an human non-enveloped virus and their possible interactions.
One o f the major problems when testing the virucidal activity of a 
compound is to overcome the biocide-induced cytotoxicity on the cell line 
(Sattar et al., 2003). Various attempts have been made, such as the use of 
dilution (Wood & Payne, 1998) which required an initial high viral titre to 
be able to detect 4 Logio reduction. A washing step for the cells after the 
attachment of the virus to the host (Gordon et al., 1993), the use of 
neutralisers (Woolwine & Gerberding, 1995; Rutala et al., 2006) and the use 
o f foetal bovine serum or bovine serum albumine (Gordon et al., 1993) have 
been other possibilities. However, not all such methods assured the 
elimination of cytotoxicity and the biocide neutralization. PHMB was found 
to be cytotoxic against the 293T cell line. A dilution step and washing step 
were not applicable, since cytotoxicity was observed even after lh  and a 
high viral titre was required. After several failed attempts at neutralization, a 
Sephadex™ column system (Geller et al., 2009) resulted the efficient 
elimination o f cytotoxicity and neutralising the PHMB activity in 1 min.
The ability o f biocides to kill adenoviruses varied widely, according to the 
serotype and the biocides used. Previous studies with enteric adenoviruses 
(type 40 and 41) showed that free chlorine was effective at killing the two 
serotypes (Thurston-Enriquez et al., 2003a; Baxter et al., 2007), but type 40 
and 41 showed more resistance than other serotypes to UV treatment 
(Thurston-Enriquez et a l ,  2003b; Baxter et al., 2007). Adenovirus type 8, 
which is associated with epidemic keratoconjunctivitis, was inactivated (3 
Logio reduction) by 0.55% ortho-phtalaldehyde, 2.4% glutaraldehyde and 
1900 ppm chlorine after 1 and 5 min; whereas the biguanide chlorhexidine 
did not cause any reduction (< 1 Logio) (Rutala et al., 2006). Concerning 
Ad5, 2-butanone peroxide was able to reduce the titre by >4 Logio after 60 
min contact time. Other biocides, such ethanol, sodium hypochlorite, 
glutaraldehyde and peracetic acid based compounds resulted active against 
the serotype 5 even in the presence of blood and bovine serum albumin
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(Eterpi et al., 2009). However, chlorhexidine gluconate, which is a 
biguanide, appeared enable to remove the adenovirus from contaminated 
eyelid specula (Hutchinson et al., 2000). Such lack o f activity is partially in 
line with the findings from the two PHMB-based biocides tested here, 
VANTOCIL™ TG and COSMOCIL™ CQ. Low reductions (<1.5 Logio) 
occurred after up to 30 min contact time at 20°C. The concentration of the 
active compound did not influence the efficacy, whereas by increasing the 
temperature to 40°C, a slight but significant enhancement of the virucidal 
activity was observed. Such result might be explained by morphological 
alterations of the viral capsid at 40°C which might help the action of the 
PHMB. In fact, Rexroad et al. (2003) found that a capsid degradation and 
loss of penton capsomers occurred in adenovirus type 5 subjected to a 
temperature higher than 45°C.
The disinfection kinetic analysis generally showed a lack o f linear 
relationship between the inactivation rate and contact time. A “tailing o ff’ 
effect was visible instead, which is usually explained by biocide depletion 
or by the presence o f more a resistant viral subpopulation due to 
aggregation, conformational change o f the viral capsid or genetic variation 
(Hoff & Akin, 1986). Here, the formation of clumps might be the cause and 
was highlighted by the light scattering analysis, which showed aggregates 
up to a micrometer in size after the treatment with PHMB. Furthermore, 
Ad5 surface hydrophobicity increased after contact with VANTOCIL™ TG 
and COSMOCIL™ CQ. Since the pi values o f the adenovirus major capsid 
proteins are between 5 and 5.89 (Favier et al., 2004), the virus charge during 
the treatment (pH 7.5) is negative, thus attracting the positively charged 
PHMB molecules. Such electrostatic interaction will reduce the charge on 
the Ad5 capsid, so that viral particles may aggregate in a hydrophilic 
medium. This hypothesis is supported by previous work where aggregation 
was found responsible for preventing virucidal activities (Sharp & Kim, 
1966; Sharp et al., 1975; Siyikanchana et al., 2008).
Structural damage was visible during the electron microscopy investigation, 
especially the treatment with PHMB at 800 ppm which induced precise 
points of disruption on the capsid, often with the release o f the genome. 
Such damage was also confirmed by the SDS-PAGE gel, where the two
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proteins, the minor coat protein VI (22 KDa) and the core protein VII (19 
KDa), were altered. The coat protein is possibly associated with the protein 
Ilia and the penton base and mediates the disruption of the endosomal 
membrane to allow the transport o f the virus towards the nucleus (Russell, 
2009). Since the proteins Ilia and penton base appeared to be the weakest 
part o f the adenovirus capsid (Rexroad et a l ,  2003), the damage caused by 
the PHMB to the protein VI could explain the broken capsid. The additional 
damage to the core protein VII could support such an hypothesis, since its 
function is in viral assembly interacting with the viral DNA (Zhang & 
Arcos, 2005). Furthermore, the SDS-PAGE gel stained with the Eosin Y 
showed the presence o f PHMB on the virus at 20°C, confirming the 
attachment of the biocide to the adenovirus, possibly through electrostatic 
forces as explained by the change in viral surface hydrophobicity. At 40°C 
the intensity of the Eosin Y stained bands is decreased, indicating a lower 
amount of PHMB associated to the capsid. Higher capsid damage and 
therefore a higher penetration o f the biocide could explain such result, 
confirming also the enhancement o f the virucidal activity observed at 40°C.
Comparing Ad5 with the bacteriophage MS2, some similarities were 
observed. The reduction factors caused by PHMB at 20°C against the human 
virus were in agreement with the values obtained against the coliphage at 
the same temperature. Differences were visible as the temperature was 
increased. So, while the virucidal activity against Ad5 increased moderately, 
the MS2 titre was reduced up to 4-5 Logio- According to the results, the 
degree o f aggregation o f the two viruses appeared to be different. The 
temperature seemed to affect only the aggregate size o f MS2, although the 
surface properties o f both viruses were similar (both viruses negatively 
charged at pH 7); they both increased their hydrophobicity and PHMB 
molecules were found attached to both viral capsids. Further investigations 
are needed to understand the causes o f such a difference in sensitivity. It is 
possible that the strength of hydrophobic forces in the clumps might be 
different for the two viruses, with lower energy necessary to break up the 
MS2 aggregates. In addition, Ad5 has a more complex structure than the 
coliphage, with various proteins composing the capsid. Such complexity
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could increase the forces involved (hydrophobic, electrostatic and Van der 
Waals) in the formation of aggregates and in the viral particle itself. In a 
study o f the evaluation o f the effect o f temperature on the time-dependent 
MS2 inactivation, thermodynamic parameters were evaluated: an activation 
energy o f 50.5 kJ/mol was required to develop an MS2 transition state that 
resulted in loss of infectivity (Anders & Chrysikopoulos, 2006). Conversely, 
an activation energy o f 88 kJ/mol was required for breaking the capsid of 
adenovirus (Svensson & Persson, 1984). Another significantly difference 
between Ad5 and MS2 is in their genome. The RNA o f MS2 contains 
several coat protein-binding sites, supporting the hypothesis that the genome 
is closely bound to the phage capsid (Koning et al., 2003). Therefore, any 
breakage to the capsid caused by the PHMB could damage the MS2 nucleic 
acid, resulting in loss of infectivity. Additionally, Ad5 possesses a double­
stranded DNA genome, whereas the phage has a single-stranded RNA. The 
human virus with damaged genome is still able to infect host cells (Seth, 
1999), and because the genome is a double-stranded DNA, it can be 
processed by the DNA repair machine of the host cell (Eischeid et al., 
2009). This might explain further the low reductions achieved by the PHMB 
compared to the MS2.
In conclusion, PHMB was found to interact with the human adenovirus, 
altering the surface properties and damaging the capsid protein. Reductions 
lower than 2 Logio were achieved, possibly due to aggregation and to high 
infectivity of the genome. Some o f the characteristics o f interaction were 
shared with the phage MS2.
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7. FINAL DISCUSSION
7.1. Viruses and public health
There are thousands o f different viruses which infect animal, plant and 
bacteria. They are obligate parasites, presenting various compositions, 
shapes, sizes and complexity.
Human viral pathogens place a serious strain on health and healthcare 
systems. Infections outbreaks are often a result of viral infections (Butz et 
al., 1993; Aitken & Jeffries, 2001; Bont, 2009; Osbourn et al., 2009) with 
2322 cases registered from 1967 in the Outbreak Database (Hygiene and 
Environmental Medicine Charite -  University Medicine Berlin, 2008). The 
most clinically important viruses are summarised in Table 7-1.
Table 7-1. Summary o f the clinically most important virus families.
Family Important species Genome Envelopment
Herpesviridae
Epstein-barr virus, herpes 
simplex type 1, herpes simplex 
type 2, varicella-zoster virus
dsDNA Enveloped
Hepadnoviridae Hepatitis B dsDNA and ssDNA Enveloped
Flaviviridae Hepatitis C +ssRNA Enveloped
Picomaviridae Poliovirus, Hepatitis A, coxsackievirus +ssRNA Non-enveloped
Retroviridae HIV +ssRNA Enveloped
Adenoviridae Adenovirus 5, 2, 8, 40, 41 dsDNA Non-enveloped
Orthomyxoviridae Influenza virus -ssRNA Enveloped
Caliciviridae
Noroviruses, caliciviruses, 
astroviruses, and small round- 
structured viruses
+ssRNA Non-enveloped
Reoviridae Reoviruses and rotaviruses dsRNA Non-enveloped
ds, double-stranded; +ss, positive single-stranded; -ss, negative single stranded.
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Several viral characteristics are responsible for such high occurrence. First, 
viruses possess high infectivity, for instance one PFU (referring to viruses 
that form plaques) is required to cause the infection of 1% of an healthy 
adult population (Schiff et al., 1984). Secondly, viruses can survive at 
different pHs and temperatures (Duizer et al., 2004; Koopmans & Duizer, 
2004), and for long periods o f time on surfaces and fomites (Tiwari et a l,  
2006; Weber & Stilianakis, 2008). Finally, transmission can occur through 
many routes including: person-to-person droplets; person-to-person intimate 
contact; animal to insect to human; or animal to human and, during birth by 
transplacental infection.
Nowadays, the main strategy to control viral diseases is vaccination and the 
use o f antiviral drugs (Flint et al., 2004b). Such methods are quite effective; 
however, vaccines and drugs are not always available for human viral 
pathogens and judging the hazard of viral contamination can be difficult, 
since the infectious dose can vary significantly with the pathogenicity o f the 
organism and the immune status o f the host (Barker et al., 2001). Therefore 
good disinfection practices used for prevention are essential. Several types 
o f biocide are available on the market, and their efficacy in killing viruses 
differs widely. The type o f virus, the biocide used and the environmental 
conditions are features that influence the result o f the disinfection process. 
Viral susceptibility varies amongst species, but the presence o f an envelope, 
for instance, was found to be a relevant characteristic o f less resistance to 
the action of biocides. Antimicrobial used in routine disinfection in 
healthcare settings needs to have a broad spectrum of activity, inactivating 
bacteria, fungi and viruses and to be effective after a reasonable contact 
time. Therefore, understanding the mechanisms o f action o f a specific 
biocide is essential for improving disinfection quality.
PHMB is a compound with a wide range o f antimicrobial activity. It is 
active against Gram-positive and Gram-negative bacteria (Chawner & 
Gilbert, 1989a; Allen et al., 2006). Moreover, PHMB is commonly used in 
contact lens fluids and for treatment o f Acanthamoeba keratitis by 
damaging the plasma membrane (Khunkitti et a l ,  1997; Hsin-Chiung et al., 
2009). The activity o f PHMB against viruses has not been extensively
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studied. The few available studies focused on enveloped viruses (Valluri et 
al., 1997; Krebs et al., 2005; Thakkar et al., 2009), which appeared to be 
inactivated by the compound because of their lipidic membrane being the 
main target o f the biocide (Broxton et al., 1984; Chawner & Gilbert, 
1989b).
This project aimed at understanding the mechanisms of action of two 
PHMB-based biocides against non-enveloped viruses. The investigation was 
initially performed with two bacteriophages, MS2 and FI 16 used as model 
viruses. It was then restricted to the coliphage MS2 principally because of 
its physical structure and its similar resistance profile to the enteric viruses 
under unfavourable conditions and disinfection processes (Grabow, 2001). 
Subsequently, the human viral pathogen Adenovirus type 5 was considered 
in the investigation.
7.2. Virucidal activity of PHMB
Chlorhexidine is a biguanide compound commonly used as an antimicrobial 
(Figure 7-1), completely inhibiting herpes simplex virus and HIV after 30 
sec at 1200 and 2000 ppm (Baqui et al., 2001). HIV was also inactivated by 
a chlorhexidine-based formulation at 400 ppm after 15 sec o f exposure 
(Montefiori et al., 1990). However, no activity was observed against non- 
enveloped viruses (Springthorpe et al., 1986). Against bacteriophage, 1% 
chlorhexidine was able to reduce 90% of the MS2 titre after 20 min contact 
time in suspension tests (Maillard, 2001), whereas 5000 ppm inactivated the 
coliphage by 1 Logio in carrier tests (Woolwine & Gerberding, 1995). No 
activity was observed against phage FI 16 (Maillard, 2001).
PHMB is a polymeric biguanide (Figure 7-1) and it has been previously 
tested against enveloped viruses. It was found active in vitro against both 
cell-free and cell-associated HIV-1 (Krebs et al., 2005). Different results 
were observed with different strains o f the virus. Specifically, it completely 
inactivated cell-free HIV IIIB at 3200 ppm and cell-free HIV BaL at 600 
ppm after 10 min contact. PHMB at 100 ppm also appeared effective in 
vitro against herpes simplex virus (Valluri et al., 1997).
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Such reductions are higher than determined here against two bacteriophages 
and a non-enveloped mammalian virus (Table 7-2). In fact reductions o f 1 
Log 10 were achieved with both PHMB-based biocides at 800 ppm against 
MS2 and Adenovirus type 5 after 30 min at 20°C. In contrast, the biocides 
were more effective with the bacteriophage FI 16, reducing its titre o f 2.5 
Logio.
Figure 7-1. Biguanide structures. A) PHMB. B) Chlorhexidine.
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The main disinfection kinetic pattern observed for the phages and Ad5 was 
the “tailing o ff’ curve, which has been well characterised for water 
disinfection (Jensen et al., 1980). Two main mechanisms could explain such 
a pattern: a depletion o f the active compound in the solution, or the presence 
of resistant subpopulations arising from conformational character or 
aggregate formation. Since the quantity of both biocides was in excess, 
aggregation or/and conformational impediments might be the most plausible 
reasons. Different mechanisms for MS2 and Ad5 were explored by further 
detailed investigations. The efficacy against MS2 was greatly enhanced by 
increasing temperature (>4 Logio) (Table 7-2), which also brought about a 
reduction in the size o f aggregates. Therefore, aggregation was considered 
to have an influential effect on virucidal activity against MS2 at 20°C. In 
addition, temperature enhanced the efficacy o f the PHMB biocides, 
VANTOCIL™ TG and COSMOCIL™ CQ, possibly increasing virus 
susceptibility due to conformational changes. Conversely, even though 
aggregation was observed with Ad5 after the treatment, temperature did not 
affect the activity and the size o f clumps unlike with MS2 (Table 7-2). Clear 
structural damage was observed where the primary structure o f a coat 
protein and a core protein were altered. Two characteristics could explain
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the higher resistance o f Ad5 compared to the coliphage: the nature o f its 
genome and the higher complexity o f the human virus.
Table 7-2. Summary o f suspension test results for VANTOCIL™ TG and 
COSMOCIL™ CQ against FI 16, MS2 and Ad5.
T
(°C)
RF
Concentra 
tion (ppm) VANTOCIL™ TG COSMOCIL™ CQ
Contact time (min)
1 30 I 30
F116 20 200 0.05 ± 0.22 0 0.45 ± 0.45 0.85 ±0.88
800 2.17 ±0.43 2.56 ± 0 .54 1.73 ±0 .40 2.19 ±0.48
MS2 20 200 0.44 ± 0.67 1.02 ±0.43 0 0.60 ± 0.22
800 0.43 ± 0.34 0.50 ± 0.02 0.54 ± 0.36 1.07 ±0.30
40 800 1.49 ±0.05 5.19 ± 0.30 2.26 ± 0 .29 4.79 ± 0.09
Ad5 20 200 0.41 ±0.14 1.06 ±0 .16 NT 0.03 ± 0.27
800 0.09 ±0.14 0.77 ±0.32 NT 1.33 ±0.17
40 800 0.75 ± 0.33 1.42 ±0.22 NT NT
RF: reduction factor. Values are in Logio ± standard deviation. 
NT: not tested.
7.3. Mechanism of action of PHMBs against non-enveloped virus
The results suggested a possible mechanism of action for PHMBs against 
non-enveloped viruses (Figure 7-3).
PHMB molecules are polycationic compounds derived from repeated 
biguanide units separated by hydrophobic hydrocarbon chains o f variable 
length. MS2 (Vega et a l , 2005) and Ad5 (Favier et al., 2004) have pi of 3.9 
and between 5 and 5.89 respectively; therefore both viruses are negatively 
charged during the treatment at pH 7-8 (Figure 7-3, Phase I). As the PHMB 
and the viral particles interact, the opposite charges are attracted, and the net 
charge on viral capsid progressively decreases (Figure 7-3, Phase II). The 
PHMB hydrocarbon chains function as a bridge between particles, inducing 
viruses and biocide molecules to form aggregates (Figure 7-3, Phase III).
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Therefore after an initial electrostatic interaction, hydrophobic forces begin 
to dominate. At this stage, different actions arise between the two viruses. 
The MS2 inactivation is temperature-dependent; after aggregates are 
formed, slight conformational changes may have occurred (only quaternary 
and tertiary structure) and caused a small reduction in titre (Figure 7-3, 
Phase IV). As the temperature increases, the higher thermal energy (thus 
high kinetic energy) causes bacteriophages to disperse uniformly and helps 
the PHMB to interact with the individual viral particles, increasing the virus 
susceptibility due to conformational changes (Figure 7-3, Phase V and VI). 
A different mechanism was observed when PHMBs interact with the more 
complex Ad5 (Figure 7-2, Table 7-3). After the formation o f aggregates, 
PHMB interacts with the minor coat protein VI, causing a precise breakage 
of the capsid (Figure 7-3, Phase IV). The DNA is then released into the 
outer environment (Figure 7-3, Phase V). Temperature has only a small 
influence on this action, only slightly enhancing the viral inactivation. Two 
factors may contribute chiefly to such result: firstly, the structural 
complexity o f the human virus. As Figure 7-2 and Table 7-3 summarised, 
Ad5 has 11 structural proteins compared to the 2 o f the coliphage with its 
genome encoding 10 times more proteins than MS2. Such greater 
complexity could increase the forces involved (hydrophobic, electrostatic 
and Van der Waals) in the formation of aggregates and in the viral particle 
itself. Secondly the RNA o f MS2 contains several coat protein-binding sites, 
supporting the hypothesis that its genome is closely bound to the capsid 
(Koning et a l ,  2003). Therefore, any breakage to the capsid caused by the 
PHMB could damage the MS2 nucleic acid. In addition, even though 
PHMB does not cause major damage to the nucleic acid, as shown in the 
FI 16 DNA analysis [Chapter 4, section 4.4.4], it has to be considered that 
the Ad5 genome is known to be highly infective (Seth, 1999) and can be 
repaired by the DNA repair machinery of the host cell (Eischeid et a l ,  
2009).
Overall, electrostatic and then hydrophobic forces seem to have an 
important role in the attachment of PHMB molecules to the virus. Such 
association will lead to viral aggregate formation, which inhibits the action 
o f the active compound. PHMB is able to react with proteins to various
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extents, altering their structure. No relevant interactions were observed with 
the DNA.
Figure 7-2. Structure of the human adenovirus (A) and of the bacteriophage 
MS2(B).
A Protein
A B
CP: coat protein.
From ICTY (International Committee on Taxonomy of Viruses, 2002).
Table 7-3. Summary of MS2 and Ad5 features.
MW Size Shape Envelope Genome Proteincoding
Structural
proteins Pi
MS2 3.6x106 Da
25
nm Icosahedral no
ssRNA 
linear 
3569 bp
dsDNA
4¥ 2m 3.9
Ad5 150xl06Da
100
nm Icosahedral no
linear
35938
bp
45* !!♦♦ 5/5.9
♦(Cusack, 2005)
♦♦(Rux & Burnett, 2004) 
¥(van den Worm et al., 2006) 
^Kuzmanovic et al, 2006)
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Figure 7-3. Proposed mechanism of action of PHMB against adenovirus 
type 5 and MS2. Phase I to III are similar for the two viruses, then different 
mechanisms are involved for the bacteriophage and the human virus.
PHMB
Ad5
Temperature increases, 
high thermal energy in the 
system. Ad5 still in 
aggregates but a possible 
increase in broken capsids
Inactivation energy
Ad5 88 KJ/mol
DNA
Phase V
Phase I
PHMB positive charged and virus 
negative charged
Phase / /
PHMB attached to viruses through 
electrostatic forces
Phase III
PHMB and virus complex forms 
aggregates through hydrophobic forces
Phase IV
Aggregates present. 
Ad5 and MS2 with 
some broken capsids.
T<20°C
MS2 T>30°C
Phase V
Temperature increases, 
T>-r high thermal energy in 
the system.
Conformational changes 
in MS2 and dispersion 
of aggregates
Inactivation energy
MS2 50.5 KJ/mol
Phase VI 
IcjU Increase in PHMB 
U>ts damage to MS2 capsids.
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7.4. Public health implications and practical applications
PHMBs have been widely used as biocides and an antiseptic for the past 40 
years. PHMB has a broad spectrum activity, a low toxicity (skin irritancy 
and hypersensitivity), and it is stable for long-term storage. Such features 
have led to its use as a swimming pool sanitizer (Goeres et al., 2004), 
wound dressing (Salas Campos et al., 2006), antiseptic, and contact lens 
cleaning solution (Bruinsma et al., 2006). Currently, there is no evidence to 
suggest any PHMB resistance development by nosocomial pathogens 
(Gilbert & Moore, 2005). PHMBs are active against bacteria (Broxton et al., 
1983; Allen et al., 2006; Oule et al., 2008) and Acanthamoeba keratinitis 
(Khunkitti et al., 1998; Hsin-Chiung et al., 2009). Regarding viruses, there 
is some knowledge about the activity o f PHMBs against the enveloped ones, 
such HIV (Krebs et al., 2005) and herpes simplex virus (Valluri et al., 
1997), but nothing on non-enveloped viruses. The latter category comprises 
important human pathogens, causing, for instance, the common 
gastrointestinal and respiratory infections. Therefore the discovery of 
undocumented activity o f a biocide against non-enveloped viruses would be 
o f particular relevance. Here, results showed that PHMB attached to the 
virus and interacted with the capsid, causing viral inactivation to various 
extents. Therefore, PHMBs have the potential to be virucidal compounds. 
Clearly this is a starting point, and further investigations are needed to better 
understand the mechanisms o f action and to possibly improve the PHMB 
formulations already present.
Another important feature o f this project is the use o f phages as surrogate 
viruses.
Some human pathogens are difficult if not impossible to grow and 
dangerous to handle, therefore using surrogates in some instances is 
necessary. There are no officially recognized surrogates for testing biocides 
against viruses (Sattar et al., 2003), since the difficulty is to find a pattern of 
viral resistance in order to group in categories o f susceptibility different 
species or families. The only attempt was performed be Klein and Deforest 
(1965), who found that the presence o f the lipidic envelope was responsible 
for the lower resistance. Generally, similar morphology and comparable 
susceptibility to biocides are the factors used to choose the appropriate
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surrogate (Eterpi et al. , 2009). In this study, FI 16 proved to be more 
susceptible to the PHMB compound, thus not suitable as surrogate; whereas 
the coliphage MS2 acted in a manner similar to the human adenovirus after 
being in contact with the biocide and the reductions were comparable at 
20°C. Differences were observed when the treatment was performed at 
higher temperatures (>30°C), possibly due to the nature o f the genome and 
the higher Ad5 structural complexity. Therefore, results support the use of 
MS2 as a surrogate for human viruses for testing biocides used at 20°C. 
Considering the nature o f the genome, which apparently could influence the 
virucidal activity, it is considered more appropriate to use MS2 as a model 
virus specifically for RNA non-enveloped viruses, such as coxsackievirus, 
norovirus and astrovirus reinforcing what has been already suggested 
elsewhere (Havelaar et al., 1993; Dawson et a l ,  2005; Koivunen & 
Heinonen-Tanski, 2005). Another practical application o f MS2 emerged 
from this project. In addition to using the coliphage as a surrogate organism 
to test new compounds, MS2 could also be used to design and model the 
whole set o f experiments. Such experiments have been performed with the 
human virus Ad5. This use o f MS2 is extremely important, especially when 
working with unsafe and complex viruses. In fact, MS2 is easy to handle, 
cheap, grows quickly (20/24h) and is harmless. Therefore it can be 
considered an appropriate organism to design experiments which need to be 
developed or modified in order to work with human viruses.
7.5. General conclusions
This research project clarified the virucidal properties and the mechanisms 
of action o f two PHMB-based biocides, VANTOCIL™ TG and 
COSMOCIL™ CQ, against the two bacteriophages FI 16 and MS2, used as 
surrogates, and a non-enveloped human virus, adenovirus type 5 (Ad5). 
Suspension tests at 20°C showed that the PHMB at 800 ppm (0.08% v/v) 
reduced MS2 and Ad5 by 90%. Higher reductions were achieved against 
FI 16 (99%). Times of exposure did not affect the activity, and non-linear 
disinfection kinetics were observed. Temperature, instead, showed great 
influence on the ability to kill MS2; in fact at 30°C 99.99% of the
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bacteriophage was inactivated after 10 min exposure time. The activity 
against Ad5 was also enhanced, but to a minor extent (from 90% to 99% 
reduction). Aggregation seemed to have a key role in such low reductions, 
especially for MS2. Regarding the mechanisms of action, the binding of 
PHMB molecules to the MS2 and Ad5 capsid was observed to be highly 
cooperative (aggregate formation) and occurred through first electrostatic 
and then hydrophobic forces. Since damage to capsids was found, it is likely 
that this caused the viral inactivation. However, the hypothesis of domain 
formation by PHMB molecules and thus the inhibition of the virus-host cell 
receptor interaction could be considered.
Concluding, PHMB-based biocides have modest potential virucidal activity 
against non-enveloped viruses and warrant further investigations.
7.6. Limitations and future works
Results from this project could help improve PHMB-based biocides, but 
some limitations need to be acknowledged. The method used to test the 
efficacy o f the biocide was the suspension test. This test is known to be less 
challenging for microorganisms, often overestimating the inactivation 
factor. However, it is essential as a first screening o f the efficacy o f a new or 
untested biocide, such as PHMB against non-enveloped virus. Moreover, 
the project was mainly focused on understanding the mechanisms of 
virucidal actions o f the biocide so that only a simple assessment was 
sufficient to gain a basic knowledge regarding the ability to reduce the viral 
titre.
This three-year project is an essential starting point for future investigations 
aiming at improving the efficacy o f PHMB-based biocides not only against 
bacteria but also viruses.
The first stage in the mechanism of action was identified, but further 
clarification about the factors (physical, chemical and biological) involved 
in the attachment o f PHMB to the capsid will provide important information 
in order to apply appropriate changes to the biocide formulations. This
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could be achieved by testing the biocide in the absence of either electrostatic 
or hydrophobic forces, and the analysis of the virucidal activity and the 
aggregation state of the viruses. Working at pHs similar to the viral pi value 
would eliminate any surface charges, and therefore no electrostatic force 
will be involved. Moreover, mixing a surfactant with the virus suspension 
would exclude any hydrophobic interactions.
Another important research step would be testing the PHMB-based biocides 
in the presence o f organic load. This would better mimic realistic conditions 
o f contamination. Furthermore, factors such as organic load alter the surface 
properties of viruses, possibly affecting the initial interaction between 
PHMB and viral particles.
Studies on the permeability o f virus to the biocides might explain further the 
higher virucidal activity as the temperature increases. Transmission electron 
microscopy could be a useful method for such assessment (Nelson et al., 
2008a). In addition, testing whether the temperature influences the 
susceptibility of the viral capsid would be considered. A variety o f methods 
can be considered, such as susceptibility to proteolysis, dynamic light 
scattering, and accessibility to the genome (e.g. TOTO-1).
Main research questions might include a detailed understanding of the 
interaction of PHMB with the capsid, specifically:
1. Does the PHMB target a precise protein or amino acids?
2. Does PHMB inhibit the infection by blocking the virus-host cell 
receptor?
Analysis through SDS-PAGE, Western blot, immunochromatography, and 
viral infection inhibition assay would help to answer such questions.
The genome is the last possible biocide target. Here a difference in 
inactivation between a DNA and a RNA virus was noted. It would be 
interesting to understand how PHMBs interact with RNA to compare with 
that found for the DNA and to determine whether the genome is still 
infective after the inactivation.
Testing the PHMB biocides against human RNA viruses would be 
appropriate. In fact, comparing the activity and the mechanisms of action 
with what was observed with MS2, it should be possible to confirm the use
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of this coliphage as an appropriate surrogate and therefore to develop an 
appropriate testing method against viruses.
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A b strac t
Aims: This study reports the activity of two biguanides against MS2 bacterio­
phage used as a surrogate virus for nonenveloped mammalian viruses and 
provides an explanation as to their apparent limited efficacy.
Methods and Results: When tested in a standard suspension test, two poly­
hexamethylene biguanides (PHMB), VANTOCIL™ TG and COSMOCIL™ 
CQ, reduced the viability of MS2 by only 1-2 log10 PFU ml-1. Exposure time 
up to 30 min did not affect the activity of the biguanides, although both 
PHMB were shown to strongly interact with MS2 proteins.
Conclusions: Inactivation kinetics and change in virus hydrophobicity sug­
gested that PHMB induces the formation of viral aggregates. This hypothesis 
was supported using dynamic light scattering that showed an increase in viral 
aggregates sizes (up to 500 nm) in a concentration-dependent manner. 
Significance and Impact of the Study. It has been reported that viral aggrega­
tion is responsible for virus survival to the biocide exposure. Here, this might 
be the case, because the virucidal activity of the biguanides was modest and 
viral aggregation important. The formation of viral aggregates during virus 
exposure to PHMB was unlikely to overestimate the virucidal potential o f the 
biguanides.
Introduction
The use of biocides is crucial for the control of micro­
bial contamination and infection in the health care envi­
ronment (Maillard 2005). Although the number and use 
of products containing a biocide are increasing, there is 
generally a lack of understanding of their mechanisms of 
action. When viruses are concerned, the paucity of 
information deepened. A number o f biocides (e.g. qua­
ternary ammonium compounds, biguanides, phenolics) 
have been described to have a virucidal activity against 
enveloped viruses, but there is a general lack of efficacy 
against certain nonenveloped ones (Broxton et al. 1984; 
Krebs et al. 2005; Sauerbrei et al 2006). Empirically, the 
explanation for this difference in activity has been based 
on both the interaction of these agents against the enve­
lope of these viruses and their lack of activity against 
viral capsid proteins (Maillard 2001). Very few studies
have explored the development of viral resistance during 
or following treatment. One of the described forms of 
resistance is viral aggregation whereby viral particles 
within the aggregate are somewhat protected from the 
deleterious effect of biocides (Sharp et al. 1975; Jensen 
et al. 1980).
Polyhexamethylene biguanide (PHMB) is a cationic 
antimicrobials agent used over 40 years in the health care 
environment, food and water industries. Current applica­
tions include impregnation of fabrics to prevent microbial 
growth, water treatment and disinfection of various solid 
surfaces. Its composition is a mixtures of polymeric bigu­
anides of structure [-(CH2)6.NH.C(=NH).NH.C.NH-]„, 
where n can vary from 2 to 40, resulting in a molecular 
mass range of 400-8000. Its antibacterial activity is 
directly correlated with the number of polymers, inducing 
anionic phospholipids phase separation and causing lost 
of membrane function with precipitation of intracellular
© 2009  The Authors
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constituents in bacteria (Broxton et al. 1984; Allen et al. 
2006). VANTOCIL™ TG, which is a commercial bacteri­
cide for use in industrial, institutional and domestic 
applications, causes dom ain formation of the acidic phos­
pholipids of the cytoplasmic membrane, bringing perm e­
ability changes and altering enzymes function in bacteria 
(Chawner and Gilbert 1989). Although its interaction 
with viruses has not been described, PHMB has been 
found active against HIV-1 (Krebs et al. 2005), and other 
biguanide derivatives were shown to be effective against 
vaccinia and influenza viruses (Pilcher et al. 1961; Fara 
et al., 1974). Such inform ation indicates that the viral 
envelope is an im portant susceptible target site to  these 
biocides, providing a justification for their preferential 
activity against enveloped viruses.
This study presents findings on the virucidal activity o f 
PHMB against nonenveloped viruses and provides evi­
dence that the biocide-induced viral aggregation in a con­
centration-dependent manner.
Materials and methods
Bacteriophage MS2 suspension and enum eration
The bacteriophage MS2 (NCIMB 10108; ATCC 15597- 
Bl) was used as a surrogate for nonenveloped m am m a­
lian viruses and notably poliovirus (Jones 1995; Brion 
and Silverstein 1999; Koivunen and Heinonen-Tanski 
2005; Sickbert-Bennett et al. 2005). MS2 was propagated 
in Escherichia coli (NCIMB 9481) following the protocol 
described by Woolwine and Gerberding (1995).
MS2 stock suspension was obtained by pipetting 5 ml 
of SM buffer (5% v /v  1 mol I-1 Tris/H Cl pH 7-4, 0-2% 
w/v M gS04, and 0-5% w /v  gelatine) onto a plaque assay 
plate showing at least 50 plaques. The top agar layer was 
scraped and poured into a centrifuge tube and centri­
fuged for 15 min at 11 000 g  at 4°C. The supernatant 
containing phages was filtered through a 0 2 2 -p m  m em ­
brane filter and stored at 4-5°C until used. To enum erate 
the phage stock, a plaque assay was performed as 
described by Adams (1959).
Biocides and suspension test
PHMB-based biocides were VANTOCIL™ TG (MW 
2678; Arch Chemicals, Manchester, UK) and cosmocil™  
CQ (MW 3016; Arch Chemicals). Both PHMB were used 
at two concentrations, 200 and 800 ppm , which reflect 
the range o f concentrations used in commercial products. 
They were prepared m onthly in a sterile bottle using ster­
ile deionized water.
The suspension test used here was based on the Euro­
pean Standard prEN13610 (Anon 2001). The efficacy o f
the PHMB was tested at four different contact times (1, 
5, 10 and 30 min) at room temperature. Briefly, 1 ml of 
phage suspension adjusted to c. 1010 PFU ml-1 was added 
to 9 ml of PHMB. After the appropriate exposure time, 
1 ml of the test mixture was added to 9 ml of neutralizer 
(6% w /v Tween 80; 0*45% w /v lecithin and 0T% w/v 
L-histidine). After 2-min contact in the neutralizer, a 
sample was taken, serially diluted (tenfold) and surviving 
bacteriophages enumerated with the plaque assay (Adams 
1959). In the control, PHMB was replaced with sterile 
distilled deionized water. The toxicity of the neutralizer 
towards MS2, and its host was validated together with the 
efficacy of the neutralizer to quench the activity of the 
biocide as follows: one ml of the overnight host cell 
suspension (c. 109 CFU m l-1) was mixed with 9 ml of 
neutraliser. After 10-min exposure time, 1 ml of sample 
was serially diluted and plated using the Miles-Misra 
method (Miles and Misra 1938). After 24-h incubation at 
37°C, colonies were counted, and the reduction factor 
(RF) was calculated as logi0 (CFU ml-1 initial inocu­
lum) -  log10 (CFU ml-1 after exposure). The neutraliser 
toxicity test was similar with MS2. One millilitre of phage 
suspension (c. 109 PFU ml-1) and 9 ml of neutraliser 
were mixed together for 10 min. Then, 1 ml o f sample 
was withdrawn and serially diluted, and surviving bacte­
riophages enumerated with the plaque assay (Adams 
1959). The RF was calculated as logio (PFU ml-1 initial 
inoculum) -  logio (PFU ml-1 after exposure).
The efficacy of the neutraliser to quench effectively 
PHMB was performed with both the host bacteria and 
MS2. Two different ratios (1/1 and 2/1) between the bio­
cide and the neutraliser were tested, as different amounts 
o f disinfectant and neutraliser were used in this investiga­
tion. One millilitre o f the overnight host cell 
(c. 109 CFU ml-1) or phage suspension (c. 109 PFU ml-1) 
was added to a disinfectant/neutraliser mixture and left 
for 10 m in and serially diluted. Bacterial survival and 
phage survival following exposure were measured as 
described previously.
Precipitation and purification of MS2
The protocol to precipitate and purify the bacteriophage 
was based on Sambrook and Russell (2001) with the fol­
lowing modifications: PEG 8000 and NaCl were added to 
the MS2 suspension (c. 1010 PFU ml-1) simultaneously. 
The CsCl equilibrium gradient was prepared with the 
three densities p = 135 g cm-3, p  = 1-45 g cm-3, p = 170 
g cm-3 in a 13-5-ml centrifuge tube, layering 2-6 ml of 
the three steps gradient. The three densities were chosen 
because o f MS2 density o f 138 g cm-3 (Kuzmanovic et al. 
2003) The virus (5*2 ml) was layered on top of the gradient 
and then centrifuged at 363 000 g  (Beckman Coulter;
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Fullerton, CA, USA) for 8 h at 20°C. Purified bacterio­
phages were harvested, dialysed overnight against SM 
buffer and then filtered through 0-22-fxm filter.
Hydrophobicity tests
Two different tests were performed: the adsorption to 
lipid and the MATH tests. The biocide concentrations 
tested were 2, 20, 200 and 800 ppm.
Adsorption to cholesterol was based on a modified 
protocol for bacteriophages described by Klein and Defor­
est (1983). A 5% w /v cholesterol suspension was prepared 
adding 0-01% w /v of Tween 80 to increase the lipid solu­
bility. The suspension was kept at 4°C and used at room  
temperature during the experiments. One millilitre of 
MS2 suspension (1010 PFU ml-1) was mixed with 9 m l of 
PHMB biocide at different concentrations (2, 20, 200 and 
800 ppm). Deionized water was used instead o f PHMB as 
a control. After 5-min exposure time, 1 ml o f the text 
mixture was mixed with 4 ml o f the cholesterol solution. 
The mixture was constantly agitated at 150 rev m in-1 for 
30 min at room temperature and then centrifuged twice 
for 30 min at 5000 g  at 20°C. The num ber of phage pres­
ent in the aqueous supernatant was enumerated according 
to Adams (1959).
Adsorption to hexadecane (MATH method) was 
described by Denyer et al. (1993). One ml o f MS2 
suspension (1010 PFU ml-1) was mixed with 9 ml of 
PHMB biocide at different concentrations (2, 20, 200 and 
800 ppm). Deionized water was used instead o f PHMB as 
a control. After 5-min exposure time, 1 ml o f the text 
mixture was mixed with 0-2 ml o f hexadecane at room 
temperature for 10 min. After 60-s vortexing, the two 
phases were allowed to separate at room tem perature for 
7 min. The number of phages in the aqueous phase was 
measured as described earlier.
The percentage of MS2 partitioned to the 
lipidic-hydrocarbon phase was calculated as: 
(PFU ml-1 inoculated — PFU ml-1 in the aqueous 
phase)/PFU ml-1 inoculated x  100.
Dynamic light scattering
Dynamic light scattering measured with N4plus (Beckman 
Coulter) was used to measure the size o f the aggregates of 
MS2 before and after the treatm ent with PHMB. Purified 
virus suspension (10u  PFU ml-1) was dialysed overnight 
against KC1 (0-250 mol P 1) and then filtered through 
0-22-/mi filter. The sample concentration was adjusted to 
ensure that the count per second fell in the range 
5 x 104—1 x 106. MS2 suspension (1011 PFU m l"1) was 
then exposed to PHMB (2, 20, 200 and 800 ppm ) for 
2 min. Light scattering measurements ran for 240 s using
a laser angle of 90° and were made in triplicate. To 
analyse the results effectively, the percentage of particles 
o f a different size were pulled together into arbitrary size 
categories.
Protein analysis
MS2 exposure to biocide prior to protein analysis was 
performed at two different PHMB concentrations, 200 
and 800 ppm. Controls were tested against deionized 
water.
A volume o f the purified MS2 (0-375 ml; 1011 PFU ml-1) 
was mixed with 0125 ml o f biocide. After 10-min contact 
time, a cold acetone precipitation of proteins was per­
formed mixing 0-3 ml o f the sample with 1-2 ml o f cold 
acetone. After incubation at -20°C  for 3 h, the sample 
was centrifuged at 15 000 g  for 15 min at 4°C. The super­
natant was discharged, and the pellet was air-dried for 
5-10 m in to drive off the acetone.
The pellet was then resuspended with 20 fi\ o f 2x 
SDS sample buffer (1514%  w /v Tris-HCl pH 6-8, 20% 
v/v  glycerol, 4% w /v  SDS, 0-2% w /v 2-mercaptoethanol 
(2-ME) and 0 001% w /v bromophenol blue) and boiled 
for 3 min. The sample was allowed to  cool at room 
temperature and a quick centrifugation (8000 g  for 10 s 
at 15°C) was carried to remove any insoluble materials. 
Ten microlitres o f sample (c. 0-5 mg ml-1 of proteins) 
was loaded onto a polyacrylamide 20% homogeneous 
gel (Amersham Pharmacia Biotech AB, Buckinghamshire, 
UK). Gels were developed by silver staining (Phast- 
System separation technique file no. 110; Pharmacia AB) 
using the automated developing chamber of the Phast- 
System (Amersham Pharmacia Biotech AB). The con­
centration o f the proteins was measured according to 
Gerhart et a l (1994).
Attachment o f PHMB to phage proteins was measured 
qualitatively with a colorimetric assay based on the prop­
erty of PHMB to change the pK of certain indicator, such 
as Eosin Y (Gilbert et al. 1990). The proteins separation 
was run in duplicate gels. One gel was silver stained, 
whereas the other was dyed with Eosin Y. The gel was 
first fixed in 7% v /v  acetic acid for 10 min and then for 
another 20 min in 50% v /v  methanol. A washing step 
was performed for 20 min. The gel was finally soaked in 
10% w /v sodium acetate (100 ml), 0-024% w /v Eosin y 
(250 ml) and water (150 ml), until pink bands were visi­
ble (1 h). A last step of washing was performed to wash 
away all the dye not attached to the biocide. Controls, 
which consisted o f PHMB mixed with deionized water 
(final concentration 200 and 800 ppm) and processed 
through the cold acetone precipitation were used to  assess 
the presence of the biocide in solution after the SDS- 
PAGE protocol.
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Results
Controls
The neutralizer (6% w /v  Tween 80; 0-45% w /v lecithin 
and 0-1% w /v  L-histidine) showed no toxicity against the 
host cell or MS2 (Table 1). Furthermore, it quenched 
effectively the biguanides (Table 1). A < 0-33 logi0 reduc­
tion in PFU ml-1 was observed with MS2, and 
a < 0-52 log10 reduction in CFU ml-1 was measured with 
the host cell, both after treatment with vantocil™  TG 
and COSMOCIL™ CQ. Such a low reduction in number 
was deemed not to be significant.
A neutralizer was not used for the protein analysis and 
electron microscopical studies in order not to dilute the 
phage suspension. For these studies, the overall damage 
caused by PHMB was o f interest. It was not the purpose 
o f this specific investigation to link damage to time point.
Virucidal activity of PHMB
The maximum log10 reduction in num ber observed with 
VANTOCIL™ TG and COSMOCIL™ CQ at a concen­
tration o f 800 ppm  was 102 ± 0-41 and 107 ± 0-30 logio 
within 30-min exposure (Table 2). The activity o f the bio­
cide at concentrations o f 200 or 800 ppm was indepen­
dent o f contact time for VANTOCIL™ TG ( a n o v a ; 
F3,i6 = 0-70; P > 0-05) or COSMOCIL™ CQ ( a n o v a ;
Table 1 Neutraliser toxicity and neutraliser efficacy to quench the activity of VANTOCIL™ TG and COSMOCIL™ CQ. Data are expressed as log10 
reduction in number (CFU ml-1 or PFU ml-1)
Neutraliser efficacy to quench PHMB at different ratio
VANTOCIL™ TG COSMOCIL™ CQ
Neutraliser toxicity 1/1 2/1 1/1 2/1
Escherichia coli 
MS2
0 0 0 *
0 01 ± 0-28
0-28 ± 0 -1 6  
0-01 ± 0-28
0-52 ± 0-36 
0-33 ± 0-32
0-41 ± 0-23 
0-31 ± 0-31
0 -44 ± 0  -18 
0-18 ± 0-04
PHMB, polyhexamethylene biguanide. 
*No reduction in number was measured.
Table 2 Suspension test results. VANTOCIL™ 
as log10
TG and COSMOCIL™ CQ at concentrations of 200 and 800 ppm against MS2. Data are expressed
Logio reduction in PFU ± SD
Contact 
time (min) pH
VANTOCIL™ 
TG 200 ppm
VANTOCIL™ 
TG 800 ppm
COSMOCIL™ 
CQ 200 ppm
COSMOCIL™ 
CQ 800 ppm
1
5
10
30
7-61 ± 0-18 
7-64 ± 0-21 
7-64 ± 0-23 
7-64 ± 0-22
1-06 ± 0-61 
1-15 ± 0-53 
1-12 dt 0-55 
1-15 ± 0-64
0-44 ± 0-67 
0-61 ± 0-59
0-77 ± 0-85
1-02 ±0-43
0-00*
0-00*
0-00*
0-83 ± 0-02
0-54 ± 0-36 
0-76 ± 0-45
0-77 ± 0-40
1-07 ±0-30
*No reduction in number was measured.
Electron microscopy
One millilitre o f concentrated phage stock (1011 PFU 
ml-1) was treated with 1 ml o f biocide. After 10-min 
exposure, 20 fd  of sample was mixed with 30 pi o f 2% 
methylamine tungstate for 10 min. A drop o f the nega­
tively stained phage was placed on a nickel- o r copper- 
coated grid and left drying for 20 min. The excess o f 
liquid was removed with filter paper. The grid was exam­
ined in a Philips EM 400T electron microscope operating 
at 80 kV accelerating voltage at magnification of 
x28 000-44 000. Control consisted o f MS2 treated in with 
distilled deionized water instead o f PHMB.
Statistical analysis
Suspension tests were performed five times in duplicates. 
All data were transformed in logio to assure norm al dis­
tribution. RF was calculated as log10 (PFU ml-1 initial 
inoculum) -  log10 (PFU ml-1 after exposure). The other 
tests described earlier (protein analysis and hydrophobic- 
ity) were performed on three separate occasions in 
duplicate. Any differences among results were analysed 
by parametric test, one-way a n o v a  test. If the test 
resulted significant, post hoc Tukey test was used to 
underline which couple of variables resulted different. 
The dynamic light scattering results were analysed using 
the x2 test.
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F3>i6 = 1*61; P > 0-05), except for the latter after 30-min 
contact where a significant ( a n o v a ; F 3>i 6 = 11-8; 
P < 0-05) higher reduction in MS2 was observed at a 
concentration of 200 ppm. The activity of VANTOCIL™ 
TG at 200 and 800 ppm did not differ significantly (f-test, 
P > 0-05), even though RFs at 200 ppm appeared higher 
than at 800 ppm.
Hydrophobicity tests
MS2 was shown to be hydrophilic with 92% of viral par­
ticles partitioned in the aqueous phase when mixed with 
cholesterol (data not shown). The number of phage 
recovered in the aqueous phase was taken into account 
when the effect of the biguanides on hydrophobicity was 
tested. For comparison purpose, the sensitivity of the 
enumeration method was taken into account to calculate 
the number of phage in the aqueous phase. As a result, 
the number of phage counted in the aqueous phase where 
no pretreatment occurred was adjusted to 100% (Fig. 1). 
VANTOCIL™ TG and COSMOCIL™ CQ clearly 
modified the surface properties of the phage resulting in
100 
-o 80
CD§ 60 
•c ^
g. 20
200 8005-20
SS-40
-60 PHMB concentration-ppm
Figure 1 Hydrophobicity test results. Values expressed the % of the 
phage partitioned in the nonaqueous phase. Violet lozenge: VANTO­
CIL™ TG tested with MATH; black square; COSMOCIL™ CQ tested 
with MATH; red triangle VANTOCIL™ TG tested using the cholesterol 
assay; green circle COSMOCIL™ CQ tested using the cholesterol 
assay.
a statistically significant increase in hydrophobicity 
(Cholesterol test: VANTOCIL™ TG a n o v a ; F1>8 = 7-4; P 
< 005; COSMOCIL™ CQ, a n o v a ; F ^  = 162-1;
P < 0-05; MATH test: VANTOCIL™ TG, a n o v a ; F1i8 = 
146-4; P < 0 05; COSMOCIL™ CQ, a n o v a ; F1>8 = 32-6; 
P < 0 05) (Fig. 1). Indeed, MS2 became so hydrophobic 
that no phage particles were recovered from the aqueous 
phase. Generally hydrophobicity increased with increasing 
concentrations of PHMB (Fig. 1). The negative results 
observed with lower concentrations of PHMB, might 
be explain with the addition of Tween 80 in the choles­
terol suspension. Tween 80 is a surfactant which 
might help desegregation of clumps and produce higher 
count.
Dynamic light scattering
Dynamic light scattering is a technique which determines 
the size distribution of particles in solution. When a 
beam of light passes through a suspension, particles 
scatter light which is detected by a device. The detector 
measures the time-dependent fluctuations of the scattered 
intensity. These fluctuations derive by the random 
thermal (Brownian) motion of the particles, and the 
distance among them is therefore constantly varying. The 
time-dependent fluctuations are then analysed to calculate 
the particle sizes distribution (Berne and Pecora 1976). 
Here, to simplify the readings, five arbitrary size range 
categories were used. The results were expressed as per­
centage of intensity which reflects the mean value of the 
number of viral particles/aggregates within the size range 
taken on three separate readings. Control (i.e. untreated) 
MS2 showed some degrees of aggregation which might be 
explained with high concentration of phage particles used 
in this test (Fig. 2). However, as the concentration of 
VANTOCIL™ TG (Fig. 2) or COSMOCIL™ CQ (Fig. 3) 
increased, the size of the particles/aggregates increased 
significantly (*2 test, P < 0 01). At a concentration of
Figure 2 MS2 treated with VANTOCIL™ TG. 
Distribution of five size groups of MS2 
aggregates in function of the % intensity of 
the light scattered. The magnitude of each 
histogram is proportional to the % of the 
total scattered intensity caused by the 
particles of the corresponding group size.
MS2 exposure: Control (black); VANTOCIL™ 
TG at 2 ppm (light yellow) and at 20 ppm 
(yellow); VANTOCIL™ TG at 200 ppm 
(orange) and at 800 ppm (red).
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Figure 3 MS2 treated with COSMOCIL™
CQ. Distribution of five size groups of MS2 
aggregates in function of the % intensity of 
the light scattered. The magnitude of each 
histogram is proportional to the % of the 
total scattered intensity caused by the 
particles of the corresponding group size.
MS2 exposure: Control (black); COSMOCIL™ 
CQ at 2 ppm (yellow) and at 20 ppm (light 
green); COSMOCIL™ CQ at 200 ppm (green) 
and at 800 ppm (dark green).
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Figure 4 SDS-PAGE. (a) Silver-stained 
SDS-polyacrylamide gels of MS2 phages trea­
ted with VANTOCIL™ TG and COSMOCIL™ 
CQ. The arrows indicate the two proteins 
which formed MS2, coat protein (13-7 kDa) 
and A protein (44 kDa). (b) Eosin Y-stained 
gel. The pink staining indicates the presence 
of polyhexamethylene biguanide.
800 ppm, all MS2 particles were in aggregates of a size 
>300 nm (Figs 2 and 3).
Protein analysis
Protein analysis showed that PHMB did not alter MS2 
protein profile (Fig. 4). The protein pattern of the 
untreated phage (control; Fig. 4) composed of three main 
protein bands was highly reproducible between the exper­
iments (n = 3). The same amount of proteins was loaded 
on the gel pre and postphage treatment. The gel dyed 
with the Eosin Y showed the presence of the PHMB on 
the phage protein, and the intensity of the stain increased 
at 800 ppm.
Electron microscopy
Electron microscopy was used as a qualitative measure­
ment of damage caused to the phage following treatment. 
Electron microscopy observations might not correlate 
with inactivation data (Maillard et al. 1995a), as viral
inactivation might not necessarily be linked to gross- 
structural damage. Here, 30 separate fields of vision were 
observed. Untreated phage particles showed distinct 
icosahedral capsid of MS2 and did not present any alter­
ation caused by the sample preparation for EM investiga­
tion. Treatment with either VANTOCIL™ TG 800 ppm 
or COSMOCIL™ CQ 800 ppm showed evidence of dam­
age capsid (data not shown) when compared to the 
untreated phages. At the lower concentration of 200 ppm, 
evidence of broken capsid following treatment was also 
observed (data not shown).
Discussion
MS2 bacteriophage has been used as a virus model to test 
the efficacy of various biocides because of its structural 
similarity with enterovirus and comparable resistance pro­
file (Jones et al. 1991; Davies et al. 1993; Koivunen and 
Heinonen-Tanski 2005; Sickbert-Bennett et al. 2005). In 
this study, VANTOCIL™ TG and COSMOCIL™ CQ only 
produced a 1 log10 reduction within 30-min exposure.
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These results from a standard suspension test are in 
accordance with the literature, which reports a similar 
reduction in MS2 num ber following treatm ent with a 
range of biocides (Davies et a l  1993; Woolwine and 
Gerberding 1995). Notably, chlorhexidine, another bigua­
nide, was reported to produce 90% reduction in MS2 in 
a suspension (Maillard et a l  1994) and carrier tests 
(Woolwine and Gerberding 1995). A m ore recent study 
(Sickbert-Bennett et a l 2005) on chlorhexidine hand wash 
reported a 2 log10 reduction in the bacteriophage.
Here, the biguanides were shown to attach to  the phage 
proteins (Fig. 4b). Moreover, treated phage showed severe 
gross-structural damage, which was deemed to  be related 
to biocide exposure rather than sample treatm ent for EM 
investigation, because the untreated phages showed no 
structural alteration. These observations are similar to  the 
reported effect o f chlorhexidine against FI 16 bacterio­
phage. The overall activity o f chlorhexidine (1% w /v) 
against FI 16 was shown to be modest w ith <1 log10 
reduction following a 20-min exposure (Maillard et a l 
1993). Energy-dispersive analysis o f X-ray investigation 
reported chlorhexidine not to bind the phage (Maillard 
et a l 1995b), although there was no gross alteration of 
the phage protein band profile following treatm ent with 
the biguanide (Maillard et a l  1996). However, gross but 
specific damage to  the phage structure was identified 
(Maillard et a l 1995a), showing the deleterious effect of 
the biguanide against phage particles. One can note the 
similarity in the results from chlorhexidine-exposed phage 
with the data presented in this study on PHMB effect 
against MS2.
The lack o f any increase in  activity with increasing 
exposure time provides some useful inform ation as to 
the interactions o f the biguanides with the viral particles. 
Such inactivation kinetic is usually explained from either 
the depletion o f the active biocide or the presence of 
‘resistant’ organisms. The form ation of viral aggregates 
has been shown to lead to the survival o f viral particles 
following biocide exposure (Sharp et al. 1975, 1976; 
Espinosa et a l  2008), notably with chlorine (Jensen et a l 
1980; Young and Sharp 1985). The propensity o f parti­
cles to aggregates depends upon surface properties and 
notably hydrophobicity (Persson and Gekas 1994). Here, 
the results o f two separate experiments provided a clear 
indication that the hydrophobicity o f MS2 changed dra­
matically following exposure to  high concentrations of 
PHMB (Fig. 1). An increase in hydrophobicity is likely 
to result in a decrease in polar surface on the viral 
capsid leading to  aggregation. Generally, viruses remain 
dispersed in salt solutions near physiological strength 
and at high pH  (Floyd and Sharp 1979). The degree of 
clumping is also related to  the virus pi. MS2 has a p i 
of 3*9 and exhibited significant aggregation when
pH  < p i (Langlet et al. 2008). In this study, the pH dur­
ing PHMB exposure was 7-6 ±0-1, hence the MS2 parti­
cles carried an overall negative charge on their surface 
which should keep the particles dispersed in the aqueous 
medium. However, exposure to PHMB long positively 
charge polymers decreases the polarity o f the phage par­
ticles, leading to the formation o f clumps in a polar 
medium such as the SM buffer and water. The forma­
tion o f aggregates which increased in size with increasing 
concentrations of PHMB was demonstrated by dynamic 
light scattering. Viral aggregate size >300 nm was 
observed following exposure to VANTOCIL™ TG or 
COSMOCIL™ at a concentration of 800 ppm (Figs 2 
and 3). Based on the evidence from other studies (Sharp 
et a l 1975, 1976; Jensen et al. 1980; Young and Sharp 
1985; Espinosa et a l  2008) and our data demonstrating 
the formation of aggregates following exposure to 
PHMB, it would be tempting to associate the lack of 
activity o f the biguanide to the formation o f aggregates 
with the understanding that viral particles inside the 
clump are protected from the deleterious effect o f the 
biguanide.
However, one has also to consider that the formation 
of viral aggregate will affect the measurement of phage 
survival by plaque assay. Indeed, an increase in the num ­
ber o f aggregates and /o r the size o f aggregates would 
effectively decrease the number o f plaques observed after 
incubation with the host bacteria, and lead to an overesti­
mation o f the efficacy o f the biguanide. In this study, the 
lack o f increase in virucidal activity with increase PHMB 
concentration together with evidence of significant (y2 
test, P < 0 01) increase in aggregate size between exposure 
to 200 and 800 ppm  of PHMB indicates that the presence 
o f aggregate might not be linked with a decrease in 
plaque formation and a subsequent overestimation of 
activity. The use o f Tween 80 in the neutralizing solution 
for the suspension test might have also helped in breaking 
up the aggregate.
This study aimed to understand the interactions 
between PHMB and viruses to improve their virucidal 
activity. We demonstrated that exposure to PHMB 
resulted in the formation of viral aggregates, likely as a 
result o f change in phage surface hydrophobicity. We 
hypothesize that the formation of such clumps hindered 
dramatically the virucidal activity of these biguanides, 
although further evidence of the role o f viral aggregates as 
an explanation for the modest virucidal efficacy o f PHMB 
is needed. O ther protocols based on the detection of anti­
gens or viral genome rather than the formation of plaques 
(infectivity study) might not be affected by the formation 
o f viral aggregates, although the use of molecular tech­
niques suffers from some drawbacks (Sattar et a l 1989; 
Richards 1999).
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Effect of surfactants, tem p era tu re , 
and sonication on th e  virucidal activity 
of polyhexam ethylene biguanide against 
th e  bacteriophage MS2
Federica Pinto, MSc, Jean-Yves Maillard, PhD, BSc, and Stephen P. Denyer, FRPharmS 
Cardiff, United Kingdom
Background: Virucidal com pounds are essential in preventing the transm ission  o f  viral infection in the health care environm ent. Under­
standing their m echanism s o f action is necessary to im prove their efficacy. Inactivation o f  viruses is less docum ented than that o f  bacteria 
notably because different types o f virus have diverse response to m icrobicides, m aking difficult to establish an inactivation pattern. 
Methods: The effect o f viral aggregates on the virucidal activ ity  o f  p o ly h ex a m eth y len e  biguanide-based m icrobicide VANTOCIL™ 
TG (Arch Chem icals, Manchester, UK) against the  bacteriop h age MS2 w as investigated by using in com bination  a standard su sp en ­
sion efficacy test under different conditions and d yn am ic light scattering m easuring the p resence and size o f  aggregates. 
Results: Temperature had a key role in increasing sign ifican tly  the  virucidal activity o f  VANTOCIL™ TG, reducing virus concentration  
by 4-logio w ithin 10 m inutes at 40°C. The high tem perature w as linked  to a reduction o f  viral aggregates desp ite the exposure to the 
biguanide. In addition, the viral inactivation k inetic b eca m e sign ifican tly  m ore linear at 30°C and 40°C. Such results w ere also  
observed with sonication during treatment, w here a first-order k in etic  w as observed. However, the  addition o f surfactants, even  
though there w as evidence o f a decrease in viral clu m ps, d id  n ot e n h a n c e  th e  virucidal activity o f  p o lyh exam eth ylen e biguanide. 
Conclusion: The presence o f viral aggregates w as an im portant factor in th e  virucidal efficacy o f  the biguanide as dem onstrated by  
the correlation am ong high temperature, decrease in aggregates, and in crease in activity, although it is p ossib le  that high tem per­
atures might also cause conform ational ch an ges o f  the viral capsid , increasing the sensitiv ity  o f virions to the m icrobicide.
Key Words: Polyhexam ethylene biguanide; naked virus; tem perature; aggregation.
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Adequate and efficient disinfection procedures m in­
imize the incidence of surface contamination and the 
transmission of viral infection in the health care envi­
ronment. 1 The enhancement of disinfection procedures 
with the use of physical agents and of appropriate clean­
ing/disinfectant formulations has been studied in vari­
ous fields.2 4 The inactivation of nonenveloped viruses 
by microbicides is usually more difficult to accom plish 
than the inactivation of bacteria, probably because of 
the lack of metabolic processes and to the simplicity 
of their structure.5
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Viral inactivation kinetics may theoretically exhibit 
a first-order reaction where the concentration of the vi­
rus decreases linearly with time.5 6 However, environ­
mental variables, such as concentration, contact time, 
organic load, temperature and pH,7 and intrinsic virus 
properties (mostly absence of an envelope)8 can alter 
the kinetics of disinfection, causing a deviation from 
the ideal linear inactivation. Viruses can also form ag­
gregates in solution notably because of the hydropho­
bic properties of their capsid. The formation of such 
clumps has been found to impede the appropriate con­
tact with microbicides.9 n
Polyhexamethylene biguanide (PHMB) is a broad-spec- 
trum microbicide, commonly used as a disinfectant in 
hospitals, swimming pools, and food processing. The 
compound is active against bacteria interacting with the 
cytoplasmic membrane and causing alterations of mem­
brane integrity.12 PHMB was also found effective against 
enveloped viruses, specifically against HIV type 1 and her­
pes simplex virus,13 14 but its activity against naked viruses 
has not been well established. To understand further the 
mechanisms of action of PHMB against naked virus and 
the role of viral aggregates, we measured the effects of 
temperatures, sonication, and surfactants on both aggre­
gates formation and on the efficacy of the microbicide.
2 Pinto, M aillard, an d  D enyer
METHODS 
Phage propagation
The bacteriophage MS2 (NCIMB 10108; ATCC 15597- 
B1) was used as a surrogate for nonenveloped mamma­
lian viruses. MS2 has been considered an appropriate 
model virus because of its structural and behavioral 
similarity to enteroviruses when challenged with micro­
bicides.1516 MS2 was propagated in Escherichia coli 
(NCIMB 9481) following the protocol described by Wool­
wine et al.17
MS2 stock suspension was obtained by pipetting 
5 mL of phage buffer (5 % vol/vol 1 mol/L Tris/HCl, pH
7.4, 0.2% wt/vol MgS04, and 0.5% wt/vol gelatine) 
onto a plaque assay plate showing at least 50 plaques. 
The top agar layer was scraped and centrifuged for 
15 minutes at 11,000# at 4°C. The supernatant was fil­
tered through a 0.22-jxm m em brane filter and stored 
between 4°C and 5°C until used.
Suspension tests under different conditions
The microbicide VANTOCIL™ TG (MW 2678) (Arch 
Chemicals, Manchester, UK) is an aqueous solution of 
20 % PHMB and was tested at 800 ppm active ingredient, 
which is a typical concentration used in commercially 
available hard surface liquid disinfectant products.
The suspension test was based on prEN 13610,18 and 
4 contact times (1, 5, 10, and 30 minutes) were investi­
gated. Briefly, 1 mL MS2 (109 plaque-forming units 
[PFU]/mL) was mixed with 9 mL the microbicide. After 
the appropriate contact time, 1 mL mixture was neu­
tralized with 9 mL Tween 80 (60 g/L), lecithin (4.5 g/L), 
and L-histidine (1 g/L) for 2 minutes. Next, a plaque as­
say count16 was used to measure the concentration of 
surviving phages. Controls consisted of replacing the 
microbicide with deionized water.
The suspension tests were performed at different 
temperatures: 10°C, 20°C, 30°C, 40°C, and 50°C, using 
a water bath to keep the tem perature constant during 
the whole treatment. Solutions used were equilibrated 
at the appropriate temperature before use. Phage sur­
vived was also investigated for each studied tem pera­
ture without the presence of microbicide.
The sonication treatm ent was applied to the suspen­
sion test for the whole contact time. It was performed 
in a Soniprep 150 sonicator (MSE, London, UK) at 
23 kHz and at wave amplitude of 10 |xm. Briefly, the 
sonicator probe was lowered down to the test vessels 
containing the phage suspension and the microbicide, 
and sonication was performed for the appropriate con­
tact time. In addition, sonication was performed at 2 
different temperatures: 10°C where the test vessel 
was kept in a water bath, and at room temperature. 
However, in this case, the temperature increased in
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the vessel to 30°C between 1 and 5 minutes and to 
40°C between 10 and 30 minutes. Control tests were 
performed to check phage survival under such condi­
tions without the presence of microbicide.
Finally, 3 formulations composed of VANTOCIL™ TG 
(800 ppm PHMB) and a range of surfactants at different 
concentrations were tested. These formulations, labeled 
FI, F2, and F3 (Arch Chemicals, Manchester, UK), were 
as follows: FI (DI water, 67.37%; VANTOCIL™ TG, 
25%; Armeen 2MCD, 5%; 32% HC1, 2.63%; pH 4.20), 
F2 (DI water, 70%; VANTOCIL™ TG, 25%; Neodol 23-
6.5, 5%; pH 5.70), and F3 (DI water, 70%; VANTOCIL™ 
TG, 25%; Synperonic 91/6 5%; pH 5.70).
Neutralizer-toxicity and efficacy tests were performed 
before the suspension test on both phage and host cell. 
Briefly, 1 mL overnight host cell suspension (approxi­
mately 109 colony-forming units [CFU]/mL) was mixed 
with 9 mL neutralizer. After 10 minutes exposure time, 
1 mL sample was serially diluted and plated, and colo­
nies were counted after 24-hour incubation at 37°C. 
The neutralizer toxicity test was similar with MS2; 
1 mL phage suspension (approximately 109 PFU/mL) 
and 9 mL neutralizer were mixed together for 10 min­
utes. Next, 1 mL sample was serially diluted, and surviv­
ing bacteriophages were enumerated as described above.
The efficacy of the neutralizer to quench effectively 
PHMB was performed with both the host bacteria and 
MS2. One milliliter overnight host cell (approximately 
109 CFU/mL) or phage suspension (approximately 109 
PFU/mL) was added to a disinfectant/neutralizer mix­
ture (1/1 ratio) and left for 10 minutes and serially di­
luted. Bacterial and phage survived following exposure 
were measured as described above.
Analysis of viral aggregates
The size of aggregates after phage treatment at 10°C 
and 40°C was measured using dynamic light scattering 
with N4plus (Beckman Coulter; Fullerton, CA). Purified 
virus suspension (1011 PFU/mL) was dialyzed overnight 
against KC1 (0.250 mol/L) and then filtered through 
0.22 |xm filter. The sample concentration was adjusted 
to ensure that the count per second fell in the range 
5 X 104 to 1 X 106. MS2 suspension (1011 PFU/mL) was 
then exposed to PHMB (2 ppm, 20 ppm, 200 ppm, and 
800 ppm) for 2 minutes at 10°C and at 40°C. Light scat­
tering measurements ran at 10°C and 40°C for 200 sec­
onds using a laser angle of 90° and were made in 
triplicate. To analyze the results effectively, the percent­
age of particles of a different size was pulled together 
into arbitrary size categories.
Statistical analysis
The phage concentration measured in the controls 
was used to calculate the logi0 reduction after treatment.
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Each suspension test was repeated 3 times in duplicate. 
pH and temperature were measured in the different 
test vessel. Any differences among results were analyzed 
by parametric test, 1-way ANOVA test. Where analysis 
showed significant differences, post hoc Tukey test was 
used to underline which couple of variables produced 
the difference. Light scattering results were analyzed by 
the x2 test.
R E SU L T S
The neutralizer was shown to have no toxicity 
against MS2 and the host cell and to quench effectively 
PHMB (data not shown). Rise in temperature, and son- 
ication treatment at a constant tem perature or with 
increasing temperatures (between 30°C and 40°C), 
increased the number of plaques observed. No signifi­
cant increase was observed at 10°C (0.13- ±  0.14- 
logio PFU/mL) or 20°C (0.21- ±  0.37-log10 PFU/mL), 
although a modest but significant increase (ANOVA 
test, P <  .05) at 30°C (0.43- ± O.19-log10 PFU/mL) and 
40°C (0.28- ± O.l5-log10 PFU/mL) without sonication 
was found. Likewise, a significant increase (ANOVA 
test, P ^  .05) was obtained when samples were soni­
cated at 10°C (0.55- ± 0.29-log10 PFU/mL) and between 
30°C and 40°C (0.52- ± 0.09-log10 PFU/mL). These un­
expected results can be explained by the presence of a 
small number of viral aggregates in the phage suspen­
sion used for the suspension test, although large 
clumps were not observed (Figs 1 and 2). Following 
an increase in temperature or sonication, it is possible 
that these small clumps are broken down, resulting in a 
small increase in PFU observed. As a result, these 
results were taken into account when the reduction 
factors were calculated when phages were exposed to 
PHMB under these conditions.
Changes in temperature had a profound effect on 
the virucidal activity of VANTOCIL™ TG. Treatments 
from 30°C and above increased significantly (ANOVA 
test, P ^  .05) the virucidal efficacy of PHMB against 
MS2. The efficacy of PHMB increased significantly 
with time (ANOVA test, P ^  .05) at these temperatures 
(Fig 3). At 30°C, 2.76-log10 reduction was achieved after 
30 minutes, whereas, at 40°C, 2.39-log10 was reached 
only after 5 minutes, and, at 50°C, VANTOCIL™ TG pro­
duced 5.30-log10 reduction in MS2 after 5 minutes 
(Thble 1). At lower temperatures (10°C to 20°C), PHMB 
activity was low against MS2 and achieved less than 
l-log10 reduction in number.
Sonication was applied to the test vessel at 2 differ­
ent temperatures: a controlled low tem perature (10°C) 
and at room temperature, in which case the tem pera­
ture in the test vessel was raised to 30°C between 
1 and 5 minutes and to 40°C between 10 and 30 min­
utes. Results from sonicated samples were compared
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Fig I. MS2 treated with VANTOCIL™ TG at 
2 ppm, 20 ppm, 200 ppm, and 800 ppm active 
ingredient at 40°C. Distribution of 3 size groups of 
MS2 aggregates in function of the percent intensity 
of the light scattered. The magnitude of each 
histogram is proportional to  the percentage of the 
total scattered intensity caused by the particles of 
the corresponding group size.
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Fig 2. MS2 treated with VANTOCIL™ TG at 
2 ppm, 20 ppm, 200 ppm, and 800 ppm active 
ingredient at I0°C. Distribution of 5 size groups of 
MS2 aggregates in function of the percent intensity 
of the light scattered. The magnitude of each 
histogram is proportional to  the percentage of the 
total scattered intensity caused by the particles of 
the corresponding group size.
with the suspension tests performed at the same tem­
perature without sonication. Specifically, the sonica­
tion treatment without refrigeration was compared 
with the suspension test at 30°C and at 40°C for 
1 and 5 minutes and 10 and 30 minutes contact time, 
respectively.
PHMB was more efficient at the higher temperature 
tested (Thble 1). At a low temperature, the addition of 
sonication significantly increased (ANOVA test, 
P ^  .05) the virucidal activity after 30 minutes expo­
sure only, although the enhanced killing effect was 
only by 1 log]0- At a higher temperature, sonication
99999992325
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Fig 3. Kinetics curves of efficacy of VANTOCIL™
TG at 800 ppm against MS2 tested by suspension 
test. Grey lines represent treatm ents with 
sonication; black lines represent treatm ent without 
sonication at different tem peratures (from I0°C to  
50°C). V800: VANTOCIL™ TG at 800 ppm. Values 
are the mean of 3 experiments. Bars represent
standard deviation.
did not improve significantly (ANOVA test, P >  .05) the 
virucidal activity of VANTOCIL™ TG.
The 3 formulations (FI, F2, and F3) tested did not 
enhance the efficacy of VANTOCIL™ TG. They achieved 
similar reduction in MS2 number as with the PHMB 
tested alone at 20°C (Thble 1).
Figure 3 showed the observed inactivation curves 
for the different treatments. Significant linear correla­
tions were achieved at 30°C (r = —0.93, P ^  .05) and 
40°C (r = -0.88, P <  .05) and after treating MS2 with 
constant sonication (10°C: r =  -0 .98 , P <  .05; 30°CI 
40°C: r  = -0.96, P <  .05).
In the analysis of the size aggregates, 40 nm was 
considered the threshold over which aggregation hap­
pened because MS2 measures 26 nm. At 40°C small 
clumps (maximum sizes, 155 ± 11.5 nm) started to 
develop with PHMB concentrations of 200 ppm 
(X2 test, P <  .05) (Fig 1). When the coliphage was trea­
ted at 10°C (Fig 2), the aggregates started to form at
2 ppm (x2 test, P ^  .05) with sizes of 51.6 ± 9.2 nm.
As the PHMB concentration reached 800 ppm, the
clumps measured over 1000 nm. The temperature
influenced significantly the sizes of clumps (ANOVA,
Fi.i6= 119.71, P <  .05).
DISCUSSION
Microbicides efficacy is dependent on environmen­
tal factors and on the type of viruses. This paper ana­
lyzed the relevance of aggregation in reducing the 
virucidal activity of a PHMB-based microbicide, VAN­
TOCIL™ TG, against a nonenveloped virus. The pres­
ence of viral aggregates has been implicated in virus 
survival and persistence of infectivity after challenge 
with microbicides.19 By testing the microbicide in
V800T10 
V800 T20 
V800 T30 
V800 T40 
V800 T50 
V800 T10 son 
V800 T30-40 son
synergy with temperature, sonication, or surfactants, 
aggregation appeared to be a relevant factor affecting 
the efficacy of the microbicide. The role of aggregation 
in preventing virucidal activities is controversial. Some 
authors reported the role of aggregate as a viral resis­
tance mechanism to chemical microbicides, such as 
bromine against reovirus,10 and to physical agents, 
such as ultraviolet light against vaccinia virus.20 Con­
versely, other authors concluded that aggregation did 
not influence the inactivation of poliovirus-I by chlo­
rine.21 Some additional reasoning has been based on 
the use of disinfection kinetics, which has been de­
scribed to be analogous to a chemical reaction.22 
Thus, it has been postulated that, to achieve an efficient 
inactivation of viruses, the reaction should follow a 
first-order kinetics. Differences in viral structure, 
microbicides, and environmental conditions will cause 
a deviation from the first-order kinetics. Observing the 
kinetics curves in Fig 3, a “tailing o ff’ effect is visible, 
mostly after treatment at 10°C, 20°C, and 50°C. The “tail­
ing o ff’ shape is usually explained by the microbicide 
depletion or by the presence of a more resistant viral 
subpopulation because of aggregation, conformational 
change of the viral capsid, or genetic variation.23
In this study, one of the factors responsible of the 
departure from the first-order kinetics of VANTOCIL™ 
TG inactivation against MS2 at 20°C appeared to be ag­
gregation. A significant linear relation was found after 
treatments at 30°C and 40°C, and clumps sizes were 
measured to be maximum 155 ± 11.5 nm. These diam­
eters at high temperatures were much smaller than the 
ones measured at 10°C, where clumps were more than 
1000 nm in size, and at 20°C (data not shown). The 
treatment at 50°C did not produce a first-order inactiva­
tion kinetic. However, it can be noted that the log10 re­
duction observed at this temperature was at the limit of 
detection of the assay.
Sonication increased significantly the reduction of the 
phage only at 10°C with an exposure time of 30 minutes. 
Furthermore, significant first-order kinetics occurred 
when the microbicide was tested in synergy with sonica­
tion, which has been used to enhance microbicides effi­
cacy thanks to its capacity of breaking up clumps.24
Formulations are often used to enhance the efficacy 
of disinfection. The concept is based on a synergistic 
action.25 Among surfactant properties, solubilization 
ability is important, as well as their ability to break 
up microbial clumps. Here, the 3 surfactant-containing 
formulations did not increase the virucidal activity of 
VANTOCIL™ TG.
Temperature had a profound effect on the activity of 
PHMB against a nonenveloped virus. In addition to dis­
persing the viruses uniformly, temperature could also 
alter the stability of viral capsid. Such properties have 
been extensively studied because of implications in
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Table I. Suspension test with and without sonication
RF
Contact tim e (min)
VANTOCIL™ TG 800ppm T (°C ) 1 5 10 30
Sonication 10 0.37 ±  0.24 0.36 ±  0.20 058 ±0.05 1.89 ± 0 3 8
20(0-1 min) * 
30 (1-5 min) 
40 (10-30 min)
0.82 ±  0.06 1.43 ±0.12 3.43 ±031 5.20 ±0.98
No sonication 10 0.43 ± 0 5 4 0.45 ±  0.28 050 ±0.08 056 ±0.36
20 0.43 ±  0.34 052 ±  0.05 0.88 ±0.17 050 ±0.02
30 0.64 ±0.09 1.39 ±0.09 1.46 ±0.10 2.76 ± 0.34
40 1.49 ±0.05 2.39 ±  0.30 4.10 ±0.02 5.19 ±0.30
50 2.49 ±0.15 530 ±  0.42 5.79 ±  0.38 5.36 ± 038
Formulation
FI
20 0.39 ±0.14 0.99 ±  0.25 051 ±0.11 037 ± 058
F2 20 0.10 ±0.08 0.00 ±0.15 037 ±0.17 0.88 ±  0.06
F3 20 0+ 0+ 0.02 ±  039 0*
NOTE Values are the mean of 3 experiments.
RF, reduction factor: calculated as logio (PRJ/mL initial inoculum) — logio (PFU/mL after exposure); T, temperature. 
’Temperature increased with duration of sonication. 
f No reduction in phage number observed.
drugs design, inactivation strategies for vaccines devel­
opment, and enhancement of antiviral activity.26'29 For 
instance, temperatures induced changes in quaternary 
structure of Norwalk virus capsid, which were charac­
terized by a loss of continuity in the icosahedral geom­
etry.26 Canine parvovirus capsid responded to 
increased temperature by higher DNA exposure and 
by an increased permeability to negative stain.28 
Here, high temperature did not affect phage survival. 
However, it is possible that an increase in capsid per­
meability enhanced the penetration of PHMB and its 
virucidal activity in a temperature-dependent manner.
In conclusion, aggregation is believed to play a part 
for the low virucidal activity of PHMB at 20°C. Ttemper- 
ature resulted to have a key role in the enhancement of 
the efficacy of the PHMB microbicide, helping virions 
dispersion, as shown by light scattering, and possibly 
increasing the virus susceptibility because of confor­
mational changes. We tested the microbicide through 
a suspension test, which does not necessarily reflect 
conditions of disinfection practice of virus-contami­
nated surface. However, this study is a first screening 
of the potential activity of PHMB-based microbicides 
against naked virus. Further investigations are needed 
to understand specifically the mechanisms of action in­
volved and thereafter improve the in-use efficacy of the 
biguanide.
The authors thank Paula McGeechan for her advice on PHMB.
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